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1 Introduction 
Along with the continuous growth of the global population, humankind is constantly 
increasing its demand for energy, food, and consumables. The economic development 
over the last century has contributed to an unprecedented level of wealth and quality of 
life for billions of people. Among the natural sciences, chemistry has been one of the 
major driving forces for this development.  
In 1913, only four years after Haber’s initial demonstration of his ammonia synthesis, 
Bosch had managed to establish the commercial production of ammonia at BASF.[1] Since 
then, the Haber-Bosch-process laid the foundation for the production of nitrogen 
fertilizers, which were and still are a key to global agricultural productivity.[1-2] Accordingly, 
Haber and Bosch were awarded the Nobel Prize in Chemistry in 1918[3] and 1931,[4] 
respectively. This is but one example of the enormous impact that large-scale chemical 
processes can have on a global scale. Throughout the last century, chemical processes 
kept contributing to economic and social development.  
Unfortunately, the ecological impact was not always directly realized. Beginning in the 
1960s, society became increasingly aware of the environmental issues associated with the 
widespread use of chemicals and their production processes.[5] As a response to these 
growing problems, changes in the design of chemical production were gradually 
introduced. Thus, these efforts resulted in the continuous development of new concepts 
and more sustainable approaches during the following decades. In 1991, Trost introduced 
the concept of atom economy,[6] which reformed how chemists approached organic 
synthesis.[7] His idea was then essentially incorporated into the 12 Principles of Green 
Chemistry published by Anastas and Warner in 1998.[8] 
Within their work, Anastas and Warner also established catalysis as a fundamental tool to 
achieve more sustainable development. In the years prior to the publication of the 12 
Principles of Green Chemistry, the field of catalysis had witnessed a tremendous 
development. Thus, the Nobel Prize for Chemistry in 2001 was awarded to W. S. 
Knowles,[9] R. Noyori,[10] and B. Sharpless[11] for their work on asymmetric hydrogenation 
and oxidation methods.[12] The recognition catalysis received was further increased when 
Y. Chauvin,[13] R. Grubbs,[14] and R. R. Schrock[15] received the Nobel Prize for Chemistry in 
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2005,[16] acknowledging their work regarding olefin metathesis. Finally, in 2010, R. F. Heck, 
E.-i. Negishi,[17] and A. Suzuki[18] were honored for the development of palladium-
catalyzed cross-couplings in organic synthesis.[19] In this context, the Nobel Prize for 
Chemistry in 2007 awarded to G. Ertl[20] should also be mentioned.[21] Especially, the 
impact of cross-coupling reactions on organic synthesis can hardly be overestimated as it 
fundamentally changed the way chemists addressed the synthesis of structurally complex 
molecules such as drugs and agrochemicals. These Nobel Prizes further underline the 
importance Anastas and Warner already attributed to the field of catalysis.  
As mankind is nowadays still facing the consequences of its increased demand for energy 
and resources, the race for the development of new and more sustainable methods is still 
ongoing. As in the last century, chemistry will continue to be a key factor for a sustainable 
and environmentally benign growth, of both wealth and improved living conditions of the 
global population. 
1.1 Transition Metal-Catalyzed C–H Activation 
C–C and C–Het bond formations enabled by metal-catalyzed cross-coupling reactions had 
a tremendous influence on the production of fine chemicals, active pharmaceutical 
ingredients (APIs), and agrochemicals and are nowadays a well-established tool in organic 
synthesis.[22] Despite the indisputable impact, cross-coupling strategies have innate 
drawbacks.  
 
Figure 1.1: Comparison between cross-coupling strategies and C–H activation. 
 
Introduction 
3 
As it becomes evident from Figure 1.1, traditional cross-coupling strategies greatly rely on 
the use of prefunctionalized starting materials. As these have to be prepared in additional 
synthetic steps, their use inherently lowers the step-economy[23] as well as the atom-
economy of the overall synthesis. In addition, the cross-coupling reaction itself generates 
stochiometric amounts of by-products.[24] Furthermore, the required organometallic 
reagents cause problems of their own, as they display adverse properties in regard to 
stability or toxicity.  
Accompanying the increasing emphasis on sustainability, the recent decades have 
witnessed tremendous advances in the field of transition metal-catalyzed C–H 
functionalization reactions.[25] The direct site-selective functionalization of C–H bonds 
circumvents the need for pre-functionalization and thereby reduces waste generation, 
hence lowering the economic and ecologic costs of the synthesis. The overall higher 
resource economy[26] of the C–H functionalization strategy has been the major driving 
force behind its development during the last decades. 
Yet, the avoidance of pre-functionalized starting materials creates a new challenge 
regarding the desired C–H functionalization. As C–H bonds are ubiquitous in organic 
molecules[27] and their respective bond dissociation energies (BDEs) are usually quite 
similar,[28] effective discrimination among the C–H bonds is crucial for a selective 
functionalization. This is usually achieved in one of three ways (Figure 1.2). Two out of the 
three strategies rely on the use of either electronically or sterically biased substrates. 
Although effective, these two methods are severely limited in their substrate scope and 
therefore in their general applicability. More broadly applicable and therefore of 
considerably higher significance is the directing group-based approach.[29] By pre-
coordination of the transition metal, this strategy allows for the site-selective 
functionalization of C–H bonds in close proximity to the Lewis-basic directing group.[30] 
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Figure 1.2: a) Discrimination between C–H bonds. b) Mode of action of the directing group. 
The tremendous potential of this approach is displayed by the late-stage functionalization 
of complex and highly functionalized molecules such as peptides,[31] functional 
materials,[32] and complex alkaloids.[33]  
As the transition metal-facilitated cleavage of the C–H bond is the common key step in 
the above-mentioned C–H functionalization strategies, it has been heavily studied. These 
efforts resulted in a profound knowledge of the underlying mechanisms which are 
depicted in Figure 1.3.[34] A C–H bond cleavage by a) oxidative addition is commonly 
encountered with electron-rich, low-valent complexes of late transition metals.[34c,34f] 
Since an oxidative process is not feasible for early transition metals with a d0 electron 
configuration the predominant mechanism regarding the C–H cleavage is b) σ-bond 
metathesis or d) 1,2-addition.[34d,34f] In contrast to the early transition metals, electron-
deficient late transition metals usually react via c) an electrophilic activation 
process.[34c,34d] Especially during the last two decades e) base-assisted C–H metalation 
received increased attention.[34b,34c] 
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Figure 1.3: Mechanistic pathways for the C–H cleavage step. 
Within the regime of base-assisted C–H metalation, several distinct mechanistic scenarios 
for the key C–H bond cleavage have been proposed (Figure 1.4). Concerted metalation-
deprotonation (CMD),[35] ambiphilic metal-ligand activation (AMLA),[34e,36] and base-
assisted internal electrophilic substitution (BIES)[34a,37] describe the interaction between 
C–H bond, metal center and carboxylate ligand. While they all proceed via a six-
membered transition state, CMD and AMLA are usually associated with electron-deficient 
substrates and are controlled by intrinsic C–H acidity, whereas BIES is commonly assigned 
to electron-rich substrates. In stark contrast, intramolecular electrophilic substitution 
(IES)[38] proceeds via a four-membered transition state and is usually encountered with 
metal-alkoxide complexes. 
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Figure 1.4: Transition states for the C–H cleavage in base-assisted C–H metalation. 
Yet, a considerable amount of the disclosed C–H functionalization reactions during the 
last decades exploited the high reactivity of precious transition metal catalysts based on 
palladium,[39] iridium,[40] and rhodium.[41] Despite their high potential for C–H 
functionalization, these metals are expensive and display considerable toxicity.[25] The 
search for suitable alternatives is therefore an ongoing and highly active research topic 
within the field of transition metal-catalyzed C–H functionalization.[25]  
 
1.2 Copper-Catalyzed C–H Functionalization 
In comparison to the precious transition metals, copper has several considerable 
advantages. First, its high natural abundance[42] results in a price which is only a fraction 
of the one of the precious transition metals. Second and of equal importance are its 
benign properties regarding toxicity. In addition, its readily accessible oxidation states 
allow for facile one- or two-electron processes. Thus, radical pathways and pathways 
relying on bond formation via organometallic intermediates are well established with 
copper catalysts.[43] These properties make copper-based catalysts highly attractive and 
led to their widespread use in chemistry.[44] Since a comprehensive discussion of their use 
in organic chemistry is beyond the scope of this introduction, this chapter will focus on 
the applications of copper catalysts for C–H arylations and the formation of C–Het bonds.  
 
1.2.1 Copper-Catalyzed C–H Arylations 
Groundbreaking studies regarding transition metal-enabled arylations date back to the 
beginning of the 20th century.[45] As early as 1901, Ullmann reported the reductive 
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coupling of haloarenes. Using stoichiometric amounts of copper, he was able to prepare 
symmetrically substituted biaryls from bromoarenes 1 (Scheme 1.1a).[45e] Notably, 
chloroarenes were also viable substrates. Two years later Ullmann also disclosed a 
protocol for the N–H arylation of anilines 2 to yield diphenylamines.[45d]  
In 1905 Ullmann and Sponagel disclosed their work regarding the phenylation of phenol 
(3a) (Scheme 1.1b).[45c] Notably, this represents the first example of the catalytic use of 
copper for C–X (X = N, O) bond formations. Only one year later Goldberg published her 
remarkable work on N–arylation reactions with aniline derivative 2a, thereby substantially 
broadening the scope of copper-catalyzed reactions (Scheme 1.1c).[45b]  
 
Scheme 1.1: Ullmann and Goldberg’s seminal work on arylation reactions. 
In this context, the copper-catalyzed condensation of 2-bromobenzoic acid with 
β-dicarbonyls as reported by Hurtley in 1929 should also be mentioned.[46] These early 
examples for copper-catalyzed C–C, C–O, and C–N bond formations developed by 
Ullmann, Goldberg and Hurtley exemplify the potential of copper for regioselective 
arylations. The mechanism of the Ullmann condensation reactions has been intensively 
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investigated since their first appearance but is still disputed.[47] Commonly accepted by 
now is the role of copper(I) ions as the primary catalytically active species, as proposed by 
among others Paine[48] and Jutand.[49] The larger part of the mechanism is still subject to 
debate and the proposals include a) oxidative addition of the aryl halide to the copper(I) 
species, b) the formation of aryl radical intermediates resulting from either single electron 
transfer (SET) or halide atom transfer (AT), c) σ-bond metathesis trough a four-membered 
intermediate, and d) π-complexation of copper(I) by the aryl halide.[47]  
Initial evidence for the feasibility of copper-catalyzed C–H arylations was provided by 
stoichiometric reactions reported by Nilsson[50] and Wahren[51] in 1968 and 1973 
respectively. In their work on palladium-catalyzed arylations of N-methylimidazole (7a), 
Miura and coworkers observed a pronounced effect of copper(I) iodide on the 
regioselectivity of the reaction (Scheme 1.2a).[52] While in both cases the formation of the 
diarylated N-methylimidazole 8aa was observed, the reaction did not deliver the C-2 
arylated product 9aa in the absence of copper. Vice versa in the presence of 
2.00 equivalents of copper(I) iodide, the regioselectivity was altered and no C-5 arylated 
product 10aa was obtained.  
Scheme 1.2: Palladium-catalyzed arylation of imidazole 7a and copper-mediated arylation of 
12a. 
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In addition, copper(I) iodide itself proved capable of mediating the C-2 arylation of 
N-methylbenzimidazole (12a) (Scheme 1.2b).The authors attributed the highly effective 
formation of benzimidazole 13aa to an aromatic nucleophilic substitution reaction of the 
iodobenzene (11a) assisted by the base and a copper(I) species.[53]  
After rationalizing that the observations of Miura and coworkers could result from the 
involvement of organocopper intermediates, Daugulis and coworkers started to 
investigate the possibility of a copper-catalyzed arylation protocol. These efforts led to 
their report of the copper-catalyzed C–H arylation in 2007 (Scheme 1.3).[54] Key to their 
success was the use of alkoxide bases which allowed for a facile generation of the 
proposed organocopper intermediate in a catalytic fashion. Notably, mechanistic 
experiments suggested that a benzyne-type mechanism was operative when the stronger 
alkoxide base KOtBu was employed.[54] 
 
Scheme 1.3: C–H Arylation of benzoxazole (14a) with aryl iodides as reported by Daugulis. 
This seminal report renewed the interest in copper-catalyzed arylation reactions. Thus in 
2008 the scope was extended to electron-deficient as well as polyfluorinated arenes[55] 
and later in the same year, both electron-rich and electron-poor heterocycles were 
proven to be viable substrates (Scheme 1.4).[56] 
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Scheme 1.4: Selected examples of copper-catalyzed C–H arylations. 
 
As a part of this work, Daugulis and coworkers described the synthesis of a 
pentafluorophenyl-copper phenanthroline complex 22 from copper(I) chloride  
(Scheme 1.5a). The authors could show that complex 22 was also formed in situ under the 
catalytic conditions. Furthermore, it was shown that arylcopper complex 22 reacts with 
aryl iodides 11 to yield the biaryl products .[56]  
Based on their mechanistic studies, the authors proposed that the heterocyclic C–H bond 
could either undergo direct cupration with the in situ formed copper(I) tert-butoxide, or 
that copper-assisted deprotonation of benzothiophen (23) followed by lithium-copper 
transmetalation would lead to the formation of the arylcopper species 24. The reaction 
of 24 with aryl iodide 11 then delivers the biaryl product 25 (Scheme 1.5b). 
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Scheme 1.5: Synthesis of aryl copper complex 22 and mechanistic proposal. 
Also in 2008, Miura and coworkers independently reported a similar copper-mediated  
C–H arylation.[57] Contributing to the further development of the field, Ackermann 
independently published the C–H arylation of triazoles 27 by copper catalysis, thereby 
providing an easy route to fully substituted 1,2,3-triazoles 28 (Scheme 1.6).[58] 
 
Scheme 1.6: Copper-catalyzed C–H arylation of triazoles 27. 
By now these seminal reports by Daugulis, Miura, and Ackermann have led to a manifold 
of copper-catalyzed arylation protocols and the field is well-established as of today (Figure 
1.5).[25,59]  
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Figure 1.5: Applications of copper-catalyzed C–H arylations with aryl halides. 
Despite the tremendous achievements in the field, these copper-catalyzed C–H arylation 
protocols require the use of elevated temperatures to achieve satisfying results. This 
requirement still constitutes a major drawback in the field. 
 
1.2.2 Copper-Catalyzed C–X Bond Formations 
The above discussed early examples disclosed by Ullmann and Goldberg not only showed 
the potential of copper-catalysts for arylation reactions, but also underlined the potential 
of copper-catalysts for C–N and C–O bond formations in general. While these reactions 
usually required high reaction temperatures, the development of suitable ligands, as 
pioneered by the groups of Liebeskind,[60] Buchwald,[61] Taillefer,[62] and Ma,[63] allowed 
for considerably lower reaction temperatures and catalyst loadings. 
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The following chapter will address the utilization of copper catalysts for the conversion of 
C–H bonds into C–X (X = N, O, S, Se) bonds, with a focus on the use of copper catalysts for 
C–N bond formations and C–H chalcogenation reactions. In 2006, the groups of Yu and 
Chatani independently reported an aerobic copper-promoted ortho-C–H functionalization 
of phenylpyridine (35a) with tosyl amide and aniline respectively (Scheme 1.7).[64] 
 
Scheme 1.7: Copper-mediated C–H amination reactions reported by Yu and Chatani. 
These seminal reports showcased for the first time the potential of simple copper salts for 
C–Het formations, yet in a stoichiometric fashion. In 2009, the scope of these copper(II)-
mediated transformations was expanded to a variety of heterocycles possessing slightly 
acidic C–H bonds by the group of Schreiber.[65] 
The field was further advanced by among others the group of Daugulis. In 2013, Daugulis 
and coworkers disclosed their work on copper(II)-catalyzed aminations. By exploiting the 
strongly coordinating, bidentate directing group 8-aminoquinoline (AQ), the authors were 
able to achieve the amination of benzamide 38b with morpholine (39) in very good yields 
(Scheme 1.8a).[66] Additionally, their developed protocol displayed a broad substrate 
scope and high functional group tolerance.  
Thus, electron-rich and electron-deficient substrates were well tolerated and a range of 
diversely substituted secondary and primary alkyl amines could be employed in the 
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reaction. Yet, the latter gave considerably lower yields. Furthermore, picolinamide 40a 
also proved to be a competent substrate and the corresponding product 41a could be 
isolated in 43% yield (Scheme 1.8b). Remarkably, the copper-catalyzed amination only 
delivered the mono-functionalized products.  
 
Scheme 1.8: Copper-catalyzed aminations with bidentate directing groups reported by Daugulis.  
Since Daugulis’ seminal contribution, the field of chelation-assisted copper-mediated or 
copper-catalyzed C–H amination reactions of (hetero)arenes was significantly advanced 
by among others the groups of Carretero, Chen, and Yu.[67] While requiring stochiometric 
amounts of copper, Yu’s protocol tolerated an exceptionally wide range of heteroarenes 
(Scheme 1.9).[67a] 
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Scheme 1.9: Selected examples of heteroarene C–H amidation. 
In his early work from 2006, Yu also disclosed an example of a copper(II)-catalyzed ortho-
acetoxylation of 2-arylpyridines 35 (Scheme 1.10).[64a] Using O2 as terminal oxidant, the 
authors were able to convert a range of decorated 2-arylpyridines 35 to the corresponding 
acetoxylated products. By employing a stoichiometric amounts of copper(II) acetate, the 
authors were also able to obtain mono-hydroxylated products. 
 
Scheme 1.10: Catalytic acetoxylation as reported by Yu. 
As for the field of copper(II)-mediated amination reactions, the contribution by Yu and 
coworkers sparked further interest in copper(II)-mediated or catalyzed C–O bond 
formations. Thus, the area underwent tremendous advances in the following years.[68] 
Yet, the underlying mechanisms remained unclear for a prolonged time.  
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Employing the well-defined macrocyclic copper(III)-aryl complexes reported by Ribas in 
2002,[69] the Stahl group was able to generate compelling evidence for the involvement of 
copper(III)-intermediates,[70] in both the C–O and the C–N[70c] bond coupling reactions. 
Within their mechanistic studies, they could show that arylcopper(III)-complex 52 
delivered the methoxylated arene 53 in quantitative yield upon treatment with methanol 
(Scheme 1.11).[70b] 
 
Scheme 1.11: Stoichiometric reaction using well-defined copper(III)-aryl complex 52. 
In 2013, the Daugulis group reported the 8-aminoquinoline-directed copper(II)-catalyzed 
aryloxylation of benzamides 38.[71] The copper-catalyzed C–H bond formation tolerated a 
wide range of decorated phenols 3, including thioethers, halogen-substituents and esters, 
and the corresponding products 54 were usually obtained in moderate to good yields 
(Scheme 1.12). In addition to phenol derivatives, the copper(II)-catalytic regime also 
proved applicable to several alkoxides.  
 
Scheme 1.12: Copper(II)-catalyzed aryloxylation as reported by Daugulis. 
Yu’s work from 2006 not only sparked the interest in C–H aminations and oxygenations 
but also included the first examples of a directed copper(II)-mediated 
thioetherfication.[64a] Both thiophenol (55a) and dimethyldisulfide (56a) proved to be 
suitable substrates to deliver the corresponding thioethers 57 and 58 (Scheme 1.13).  
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Scheme 1.13: Copper(II)-mediated C–S bond formation using different sulfur reagents. 
In 2009, Fukuzawa and coworkers used diphenyl disulfide (59a) as a benign reagent for 
the sulfenylation of benzoxazoles 14.[72] Catalytic amounts of copper(I) iodide in the 
presence of a bipyridine ligand under an atmosphere of oxygen were able to deliver the 
sulfenylated products in excellent yields (Scheme 1.14). 
 
Scheme 1.14: Copper-catalyzed sulfenylation of benzoxazoles 14.  
One year later, the group of Cheng reported an undirected C–H chalcogenation of 
electron-rich arenes (Scheme 1.15).[73] The performed mechanistic studies included a 
reaction of 61 with stoichiometric amounts copper(I) thiophenolate in the presence of 
catalytic amounts of copper(I) iodide which delivered the product 62 in 65% yield. 
Additionally, the reaction was effectively catalyzed by copper(I) thiophenolate as well. 
These findings led the authors to propose a catalytic cycle with copper(I) thiophenolate 
as a key intermediate.[73] 
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Scheme 1.15: Undirected copper-catalyzed chalcogenation of electron-rich arene 61. 
The group of Daugulis rationalized that DMSO might not only be used as sulfenylation 
reagent for thiomethylation reactions,[74] but might also be a suitable solvent for these 
reactions, as it can promote thiol oxidation and thereby regenerate the disulfide in situ.[75]  
Thus in 2012, they disclosed the copper(II)-promoted sulfenylation of various C(sp2)–H 
bonds (Scheme 1.16).[76] Besides a variety of alkyl and aryl disulfides, trifluoromethyl 
disulfide (56b) also proved to be a suitable sulfenylation reagent and the resulting 
trifluoromethyl thioether 65db could be isolated in 63% yield (Scheme 1.16a). In addition, 
the copper(II)-promoted sulfenylation could also be performed when the bidentate 
picolinamide-based directing group was employed (Scheme 1.16b). 
 
Scheme 1.16: Copper(II)-mediated sulfenylation with bidentate directing groups. 
In stark contrast to this protocol relying on strong bidentate chelation, Ackermann and 
coworkers reported a copper(I)-mediated chalcogenation by triazole assistance.[77] In this 
remarkable work from 2016, the authors were able to show that weak coordination by 
the carbonyl group is able to outcompete strong coordination by the N,N-bidentate 
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coordination site. Thus, selective selenylations and sulfenylations of the C-5 position of 
the triazole ring were achieved, thereby providing facile access to fully substituted triazole 
67aa (Scheme 1.17).[77]  
 
Scheme 1.17: Facile copper(I)-promoted selenylation of triazole 27a. 
In 2015, the group of Kambe had reported a copper(II)-mediated thiolation of pyrimidyl-
substituted carbazoles and related heterocycles.[78] Although two equivalents of copper 
were required to achieve satisfying yields, their protocol allowed for the successful 
functionalization of valuable heterocycles, such as indole, carbazole, and 
benzo[h]quinolone (Scheme 1.18). 
 
Scheme 1.18: Copper(II)-mediated thiolation of valuable heterocycles as reported by Kambe. 
The selected examples in this chapter display only a fraction of the tremendous advances 
in the field of copper-mediated and copper-catalyzed C–H functionalizations. However, a 
large part of these reactions still requires the use of superstoichiometric amounts of 
copper salts and is often conducted at high temperatures. In addition, the often-observed 
reliance on strongly coordinating, bidentate directing groups remains a substantial 
limitation to the general applicability of the developed protocols.  
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1.3 Ruthenium-Catalyzed meta-C–H Functionalization 
While early contributions to the emerging field of C–H functionalization relied on precious 
palladium[79] and rhodium catalysts,[41b-d,80] the pursuit of cheaper and more sustainable 
catalysts soon led to the rise of ruthenium catalysts for C–H functionalization reactions.[81]  
The work of Murai, Chatani, and Kakiuchi regarding the ruthenium-catalyzed 
hydroarylation of alkenes[82] and Inoeu’s work on ruthenium-catalyzed arylation 
reactions[83] constitute two early examples in the field of ruthenium-catalyzed C–H bond 
functionalization. While a ruthenium-catalyzed hydroarylation of ethylene had been 
previously described by Lewis and Smith in 1986 (Scheme 1.19a),[84] the Murai reaction 
displayed a higher level of generality. Adapting the earlier work of Lewis and Smith, Murai 
and coworkers were able to obtain a wide range of hydroarylation products 74 in often 
quantitative yields and with excellent levels of selectivity.  
In 2001, Oi and Inoue reported the direct arylation of phenyl pyridines 35 with aryl 
bromides 1 (Scheme 1.19b).[83b] The benign properties of those bench-stable 
ruthenium(II)-catalysts in combination with their efficiency led to their widespread 
adaption in the context of C–H functionalization reactions.[81] Thus, the following years 
witnessed tremendous developments in the field of ruthenium-catalyzed C–H 
activation.[81,85]  
Despite the impact of the work of Oi and Inoue, it has to be acknowledged in this context 
that their work displayed low levels of reproducibility.[86] In 2008, Ackermann and 
coworkers reported a highly robust ruthenium-catalyzed C–H arylation protocol and 
elucidated the influence of carboxylic acids as additives,[87] this pronounced influence was 
later further elaborated by detailed mechanistic investigations.[88] In 2011, a research 
group at Merck was able to provide further insights into the reproducibility issues 
associated with Oi and Inoue’s work. Through careful analysis of the employed solvent 
NMP, they were able to trace back the observed effect to low-level impurities of γ-
butyrolactone.[86] 
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Scheme 1.19: Early work in the field of ruthenium-catalyzed C–H functionalization. 
Besides their high versatility and efficiency and thus their application in a plethora of 
transformations, nowadays ruthenium-catalysts receive a large part of their attention due 
to their unique ability to enable meta-C–H functionalization reactions. While meta-
selective C–H functionalizations have been realized with other metals, the applied 
strategies mainly rely on the principles depicted in Figure 1.6.[89]  
A straightforward strategy to obtain meta-decorated products is the use of a traceless 
directing group (Figure 1.6a). After initial ortho-functionalization, in situ removable of the 
directing group furnishes the meta-substituted product. At the beginning of this decade, 
examples featuring this strategy were reported by the group of Satoh and Miura.[90] Yet, 
the ensuing decarboxylation step required stoichiometric amounts of silver additives. 
Recently, Ackermann and coworkers reported a ruthenium(II)-catalyzed formal meta-
selective alkenylation.[91] In this case, the decarboxylation could be achieved without the 
traditionally employed silver or copper salts. 
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Figure 1.6: Strategies enabling meta-selective C–H bond functionalization. 
Substrate-controlled meta-selectivity (Figure 1.6b) is reliant on the substrate’s inherent 
reactivity and hence its substitution pattern. This approach has been achieved by iridium-
catalyzed C–H borylations[92] and more recently in rhodium-catalyzed C–H silylations.[93] 
As this strategy is clearly highly dependent on the properties of the substrate it is not 
broadly applicable.  
Since Catellani’s seminal reports,[94] the Catellani reaction has been broadly studied and 
has been used in for various applications.[39c,95] In this approach, norbornene acts as a 
transient mediator allowing for facile meta-C–H activation (Figure 1.6c). Already in 2005, 
the group of Lautens reported the synthesis of meta-substituted arenes using the 
Catellani reaction.[96] In this instance, a sequence of palladium-catalyzed alkylation and 
subsequent hydride reduction led to the formation of various meta-decorated arenes. 
More recently, protocols for the Catellani reaction based on a C–H activation approach 
have been published by the groups of Dong[97] and Yu (Scheme 1.20).[98] 
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Scheme 1.20: Catellani reaction delivering meta-substituted arenes.  
The group of Yu also developed the synthesis of meta-decorated arenes by C–H activation 
using engineered auxiliary structures (Figure 1.6d).[99] A different approach was 
established by the Kanai group in their work on the C–H borylation of benzamide 
derivatives in 2015.[100] The key of their strategy was the use of a structurally elaborate 
ligand. While the ligand itself is binding to the substrate by hydrogen-bonding secondary 
interactions, it simultaneously directs the transition metal catalyst towards the meta-C–H 
bond (Figure 1.6e). 
However, both methods require the synthesis of high molecular weight and structurally 
complex motifs which negatively impacts step and atom economy and therefore the 
overall footprint of the strategies.[89,101] In contrast to the strategies shown in Figure 1.6, 
ruthenium-catalyzed meta-C–H bond activation does not require any additional templates 
or complex ligands. Instead, cycloruthenation in the ortho-position of the directing group 
induces a σ-activation of the arene ring (Figure 1.7). This electronic influence facilitates 
the functionalization of the C–H bond para to the ruthenium center and therefore allows 
an overall meta-functionalization in respect to the directing group.[101] 
 
Figure 1.7: σ-Activation by cycloruthenation, exemplified with phenylpyridine (35a). 
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Early examples for stochiometric ruthenium σ-activation date back to the 1990s. In 1994, 
a report by Roper showed that the organometallic ruthenium complex 82 undergoes 
nitration para to the ruthenium center (Scheme 1.21a).[102] Notably, within the same 
month, van Koten independently reported the formation of a para-chlorinated product, 
which they had observed during their investigations of copper(II) mediated oxidative 
couplings with cyclometalated ruthenium complexes.[103]  
In 1998, Coudret and coworkers reported the preparation of complex 84 via electrophilic 
bromination of the ligand backbone (Scheme 1.21b), within this work the authors also 
demonstrated a related iodination.[104]  
 
Scheme 1.21: Early examples of C–H functionalizations involving ruthenium σ-activation. 
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Only one year later, Roper and Wright extended their initial work and disclosed the 
bromination of complex 86 (Scheme 1.21c). Additionally, the authors also reported the 
nitration of complex 86. Interestingly, a corresponding osmium complex displayed 
analogous reactivity.[105] 
Regardless of these early examples, the whole potential of ruthenium-enabled 
σ-activation was not fully recognized until 2011. In this year, Ackermann and coworkers 
reported the observation of the meta-functionalized product 88 in their investigations 
regarding the ruthenium-catalyzed ortho-alkylation of ketimine derivatives with primary 
alkyl bromides 89 (Scheme 1.22).[106] Although the meta-functionalized product was only 
obtained in minor quantities, this represents the first example of a ruthenium-catalyzed 
meta-C–H functionalization through σ-activation. 
 
Scheme 1.22: First observation of meta-selectivity in ruthenium-catalyzed C–H alkylations. 
Later the same year, Frost disclosed a meta-selective ruthenium-catalyzed C–H 
sulfonation of phenylpyridines 35.[107] This subsequent report proved that ruthenium-
catalyzed meta-functionalizations could be achieved with synthetically meaningful yields 
(Scheme 1.23). Furthermore, the authors could show that the ruthenium complex 
resulting from C–H cycloruthenation underwent quantitative sulfonation when treated 
with tosyl chloride (91). However, the yields in the subsequent report by Frost were found 
significantly reduced. 
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Scheme 1.23: Ruthenium-catalyzed meta-selective sulfonation as reported by Frost. 
In 2013, Ackermann and coworkers published a meta-selective ruthenium-catalyzed C–H 
alkylation with challenging secondary alkyl halides 93 (Scheme 1.24).[108] In addition to the 
broad scope with respect to the alkyl halides 93 and heteroarenes, the authors also 
provided substantial evidence for the involvement of a radical process. Catalytic amounts 
of TEMPO significantly inhibited the reaction, while a stoichiometric amount of TEMPO 
completely suppressed the catalytic activity.[108] 
 
Scheme 1.24: Ruthenium-catalyzed meta-selective secondary alkylation.  
In 2015, the groups of Ackermann and later Frost reported a related meta-C–H alkylation 
using tertiary alkyl halides (Scheme 1.25a).[109] The detailed mechanistic studies presented 
by Ackermann and coworkers, together with the results obtained by the Frost group, 
provided further evidence for a homolytic cleavage of the C–Br bond of the alkyl halide 
93. Experiments with stereochemically defined cis- and trans-cyclohexanes 93b, delivered 
the same diastereomeric product mixture, thereby indicating the involvement of a 
common cyclohexyl radical intermediate (Scheme 1.25b).[109a]  
Based on their observations, both groups proposed a bifunctional role of the employed 
ruthenium catalyst. In addition to its role in the C–H cleavage, the ruthenium catalyst is 
also involved in the cleavage of the C–Br bond of the alkyl halide via a SET-type process. 
Introduction 
27 
These new insights into ruthenium-catalyzed meta-C–H functionalization enabled by 
σ-activation sparked a great interest into the field.[101]  
 
Scheme 1.25: Ruthenium(II)-catalyzed tertiary C–H alkylation and key mechanistic studies. 
Within the same year, a meta-selective bromination protocol was independently reported 
by the groups of Greaney and Huang.[110] In 2017, this methodology was for the first time 
achieved with a reusable catalyst when Ackermann and coworkers introduced a 
heterogenous ruthenium-catalyst for the meta-C–H bromination (Scheme 1.26).[111] The 
robust, heterogeneous ruthenium on silica catalyst proved highly versatile and could be 
recycled up to five times without a notable loss of activity. 
 
Scheme 1.26: meta-C–H bromination catalyzed by a heterogeneous ruthenium catalyst. 
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The scope of ruthenium-catalyzed meta-selective C–H functionalizations has by now been 
extended to, among others, mono- and difluoroalkylations,[112] the alkylation of 
structurally complex substrates,[113] and nitrations.[114] The protocol disclosed by 
Ackermann and coworkers not only allowed for the functionalization of a wide range of 
pyridyl-substituted substrates, but also delivered a range of functionalized purine 
derivatives 99 (Scheme 1.27).[112a] 
 
Scheme 1.27: Ruthenium(II)-catalyzed meta-C–H difluoromethylation. 
While the field of ruthenium-catalyzed meta-C–H functionalization underwent 
considerable progress since Ackermann’s seminal observation in 2011, one persistent 
drawback so far has been the elevated reaction temperature. Given that nowadays a 
radical pathway is commonly accepted to be involved in the underlying mechanism of 
these transformations, it appears promising to investigate whether these transformations 
could be enabled by visible-light photocatalysis. 
 
1.4 Photoredoxcatalysis in Organic Transformations 
As light is usually an abundant and readily accessible energy source, the idea of utilizing it 
to drive chemical reactions has attracted the attention of generations of chemists.[115] 
Exemplary for this is that, already at the beginning of the 20th century, the Italian chemist 
and visionary Ciamician described a fascinating projection of the future. In his scenario, 
chemical production would solely rely on solar energy.[116] Accordingly, classical 
production sites would be replaced by vast reactors and buildings exclusively made from 
glass.  
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In the 1940s, Schenck and Ziegler disclosed their work regarding the synthesis of the 
natural product ascaridole (101).[117] Upon exposure to sunlight, a solution containing the 
precursor α-terpinene (102) and chlorophyll would yield meaningful quantities of 
ascaridole (101) after two to three days of irradiation with sunlight (Scheme 1.28).[117-118] 
 
Scheme 1.28: Synthesis of ascaridole (101) as reported by Schenck and Ziegler. 
This early example for the utilization of solar irradiation for the large-scale production of 
an API clearly underlines Ciamician’s vision. Especially the last two decades have 
witnessed tremendous advances in the field of photoredox catalysis with a particularly 
strong influence on organic synthesis.[115,119] Thus, a plethora of transformations using UV 
or visible light have since been reported. The following discussion will focus on the merger 
of photoredox and transition metal catalysis, coined metalla-photoredox catalysis. 
One of the earliest reports highlighting the potential of combining photocatalysis with 
classical transition metal-catalyzed coupling chemistry surfaced in 2007.[120] Within this 
seminal contribution, Akita and Osawa disclosed their findings regarding the influence of 
Ru(bpy)32+ on the palladium-catalyzed Sonogashira coupling of phenylacetylene (130a) 
with bromobenzene (1a) (Scheme 1.29).[121]  
 
Scheme 1.29: Effect of visible light on the palladium-catalyzed Sonogashira coupling. 
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As depicted in Scheme 1.29 the authors observed a pronounced effect of the 
photocatalyst on the efficacy of the Sonogashira coupling. When the photocatalyst was 
omitted or the reaction was conducted in the dark, the yield dropped drastically to 11%. 
Moreover, through monitoring the conversion during irradiation and in the absence of 
light, the authors could clearly show that visible light promoted the reaction.[121] However, 
Akita and coworkers did not disclose a full catalytic cycle, yet proposed that a facilitated 
formation of the active palladium(0) species via SET with the excited-state photocatalyst 
might be the underlying reason for the observed increase in reactivity.[120-121] 
In 2011, the group of Sanford published a dual photoredox C–H arylation protocol enabled 
by palladium-catalyzed C–H activation (Scheme 1.30).[122] The successful merger of 
transition metal-catalyzed C–H activation and photoredox catalysis allowed for the 
arylation to proceed at ambient temperature and in the absence of an external strong 
oxidant. Yet, in some cases, the reaction also proceeded in the absence of the ruthenium 
catalyst. 
 
Scheme 1.30: Visible light-promoted palladium-catalyzed arylation of 35c with diazonium salt 
105a. 
In their mechanistic proposal, Sanford and coworkers assigned a dual role to the 
employed photocatalyst. First, oxidative quenching of the excited photocatalyst by the 
diazonium salt 105 results in the fragmentation of 105 and thereby delivers an aryl radical 
106 (Scheme 1.31). Subsequently, the aryl radical adds to the palladacycle 107 generated 
by C–H palladation. The resulting palladium(III) intermediate 108 is further oxidized to a 
palladium(IV) species via a SET with [Ru(bpy)3]3+, thereby regenerating the photocatalyst 
and closing the photoredox cycle. Facile reductive elimination from this high-valent 
palladium(IV) species 109 delivers the product 77 and the catalytically active palladium(II) 
species 110. The proposal of Sanford and coworkers that the photocatalyst was not only 
responsible for the initial aryl radical formation but was also capable of modulating the 
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oxidation state of palladium in the coupling cycle further increased the interest in the 
emerging field.[120,122] 
 
Scheme 1.31: Mechanistic proposal for the visible-light enabled palladium-catalyzed arylation. 
One year later Sanford and coworkers were able to apply the previously established 
principle to the copper-catalyzed coupling of aryl boronic acids 111. Utilizing photoredox 
catalysis for the formation of the CF3˙ radical, as reported earlier by the MacMillan 
group,[123] the authors were able to achieve the trifluoromethylation of arylboronic acids 
111 at ambient temperature (Scheme 1.32).[124] 
 
Scheme 1.32: Copper-catalyzed trifluoromethylation of 111 enabled by photoredox catalysis. 
Also in 2012, Fu and Peters reported their findings concerning a photoinduced Ullmann 
C–N coupling.[125] In this initial work, they could show that the copper(I)-carbazolide 
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complex 114 undergoes arylation in the presence of iodobenzene (11a) when irradiated 
(Scheme 1.33a). Additionally, they demonstrated that complex 114 was also a capable 
catalyst for the arylation reaction itself (Scheme 1.33b).[125] 
 
Scheme 1.33: Fu and Peters’ initial results regarding the photo-induced Ullmann C–N coupling. 
After having established this proof of concept, Fu and Peters were able to further extend 
the range of photo-induced Ullmann couplings to additional arylations,[126] alkylations,[127] 
and C–O bond formations.[128] 
In 2015, the group of Kobayashi provided two further examples for copper-photoredox 
catalysis, namely the visible light-enabled Chan-Lam coupling[129] and a visible light-
mediated Ullmann C–N coupling of carbazole derivatives 117.[130] Taking the work from 
Fu and Peters as the outset for their own investigations, they could show that the 
presence of Ir(ppy)3 enabled the transformation to proceed under visible light irradiation, 
thus eliminating the need to use high-energy light sources (Scheme 1.34).[130] In this case, 
the authors proposed that the excited state Ir(ppy)3* would be quenched by an energy-
transfer mechanism with the in situ generated copper(I)-carbazolide complex. However, 
due to the lack of experimental support, the authors could not decisively rule out other 
possible mechanistic scenarios. 
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Scheme 1.34: Visible light-mediated Ullmann-type C–N coupling reported by Kobayashi. 
While the earlier examples of metallaphotoredox catalysis[120] were achieved using 
palladium- or copper-based transition metal catalysts, the group of Rueping successfully 
applied the concept to rhodium- and ruthenium-catalyzed C–H functionalization.[131] By 
exploiting the photocatalyst’s ability to modulate the oxidation state of the transition 
metal involved in the catalytic bond forming process, they could significantly facilitate the 
required reoxidation of the transition metal catalyst. Thus, they reported the rhodium- 
and ruthenium-catalyzed C–H olefination with air as benign oxidant (Scheme 1.35).[132] 
However, at these elevated reaction temperatures, such reactions are also viable in the 
absence of light.[29a,133] 
 
Scheme 1.35: Examples for rhodium- and ruthenium-photoredox catalysis by Rueping. 
In both cases, the authors could avoid the use of commonly employed external oxidants 
such as copper(II) or silver(I) salts. Through the action of the photoredox catalyst, the 
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oxygen present in the reaction could serve as a competent oxidant, thereby allowing the 
required reoxidation of the intermediate rhodium and ruthenium hydride complexes. Still, 
both transformations required elevated temperatures to ensure satisfactory conversion. 
Within the field of metallaphotoredox-catalysis, the combination of nickel- and 
photoredox catalysis with iridium-based photocatalysts has proven uniquely fruitful.[134] 
In 2014, the groups of Molander[135] and Doyle as well as MacMillan[136] simultaneously 
reported nickel-catalyzed couplings of alkyl radicals derived from alkyl trifluoroborates 
123 or in the case of the report from Doyle and MacMillan, from carboxylic acids, such as 
proline (124). 
 
Scheme 1.36: Dual nickel-photoredox catalysis. 
Both couplings displayed broad scope and high functional group tolerance. More 
importantly, both proposed mechanistic scenarios implied a dual role of the iridium-based 
photoredox catalysts (Scheme 1.37). In each case, the photoredox catalyst is involved in 
the generation of the alkyl radical 127 through a one-electron-oxidation of the alkyl 
substrate. The resulting radical is then captured by the nickel(II)-aryl species 128 
generated by oxidative addition of aryl halide 129. The photoredox catalyst is also 
responsible for the required reduction of the nickel(I)-species 130 generated by reductive 
elimination from nickel(III)-complex 131. 
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Scheme 1.37: Initially proposed mechanistic scenario for the dual nickel-photoredox couplings. 
Since Molander’s initial proposal for the mechanism of the nickel-catalyzed cross-coupling 
of aryl halides 129 and alkyl trifluoroborates, additional studies have highlighted the 
possibility of alternative mechanistic scenarios. In an ensuing report, Molander and 
Kozlowski have outlined a possible mechanism in which the alkyl radical 127 is captured 
by the nickel(0)-species 132.[137] Subsequent oxidative addition of the aryl halide 129 
would then result in the formation of intermediate 131. 
Furthermore, a recent report by the MacMillan group indicated that reductive elimination 
can also occur from an electronically excited nickel(II)-species.[138] Upon an energy 
transfer from the excited state photocatalyst, the resulting electronically excited 
nickel(II)-species can directly undergo reductive elimination, yielding the product and 
regenerating the active nickel(0) catalyst. 
In conclusion, the merger of transition metal catalysis and photoredox catalysis has 
proven to be a versatile tool for organic synthesis. Despite undeniable advances, the 
drawbacks inherent to cross-coupling reactions remain. In addition, the careful selection 
of each catalyst with respect to its properties remains a cumbersome endeavor.[139] This 
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is further complicated by the fact that the rates of the different steps within the catalytic 
cycles have to be matched precisely to ensure efficient transformations. To this end, the 
previously discussed work from Fu and Peters is noteworthy as it displays the ability of 
copper-based transition metal catalysts to enable otherwise challenging transformations, 
even in the absence of exogenous photocatalysts.[126-128] Furthermore, metallaelectro-
catalysis as recently pioneered by Ackermann and coworkers is nowadays becoming a 
valuable addition to the toolbox of organic chemistry and has been established as a benign 
alternative to photoredox catalysis.[26,140] 
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2 Objectives 
As outlined in the previous chapter, copper catalysts have a long-standing and successful 
history in C–H functionalization reactions due to their benign properties.[43,44b,44c] Despite 
the fact that copper catalysts have been previously reported to enable C–H sulfenylation 
and selenylation reactions,[64a,72-74,76] their use for the selective chalcogenation of the C-7 
position of indolines 133 has proven elusive thus far. Additionally, previously reported 
protocols often relied on stoichiometric amounts of copper complexes or bidentate 
directing groups. Furthermore, the protocol should also be applicable to the C-2 
chalcogenation of indoles 134 (Scheme 2.1). In addition, oxidation of the sulfenylated 
indolines 135 would grant access to the corresponding C-7 sulfenylated indoles 136. When 
employing diselenides 63, the copper-catalyzed C–H chalcogenation would also yield the 
selenylated indolines 137 and indoles 138, therefore the development of such a 
methodology is highly desirable.  
 
Scheme 2.1: Copper(II)-catalyzed chalcogenation of indolines 133 and indoles 134. 
 
Ruthenium and iridium polypyridyl complexes are prominently used in photoredox 
catalysis, yet the use of organic chromophores is often a valuable alternative.[119c,141] 
Among organo-photocatalysts, acridinium-based photocatalysts as pioneered by 
Fukuzumi,[142] offer unique opportunities.[143] Recently they have been used in dual 
catalytic systems with cobaloximes 139 to enable oxidative C–N and C–P couplings 
without the need of an external oxidant.[144] Previous photocatalytic Minisci-type 
alkylations are reliant on strong oxidants or precious transition metal catalysts.[145] As the 
dual acridinium cobalt catalytic system does not suffer these drawbacks, its application to 
decarboxylative C–H alkylation reactions appears highly beneficial (Scheme 2.2).  
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Scheme 2.2: Decarboxylative alkylation enabled by dual cobalt photoredox catalysis. 
 
Copper-catalyzed arylation reactions are known since the pioneering studies from 
Ullmann and Goldberg.[45a,45b,45e] Nearly one century later Miura, Daugulis and Ackermann 
introduced copper-catalysts for the C–H arylation of azoles 7, 12 and 14 and triazoles 
27.[52,54,56-58] Despite the considerable advances, copper-catalyzed arylations were still 
dependent on harsh reaction conditions, namely high reaction temperatures. The recent 
work from Fu and Peters[125-126,127b] indicated the ability of in situ generated copper-
complexes to undergo excitation by light, thereby enabling Ullmann-type couplings at 
ambient temperature. Since a related photo-induced copper-catalyzed C–H arylation 
could possibly also proceed at room temperature, establishing first photo-induced 
copper-catalyzed C–H transformations is highly desirable (Scheme 2.3).  
 
Scheme 2.3: Photo-induced copper-catalyzed C–H arylation. 
 
Since Ackermann’s seminal report of a ruthenium-catalyzed meta-selective C–H alkylation 
in 2011,[106] σ-activation by cycloruthenation has emerged as a powerful tool to facilitate 
meta-selective transformations.[101] Subsequent reports by Ackermann delivered 
conclusive evidence for a radical pathway and the involvement of the C–H 
cycloruthenated intermediate in the generation of the alkyl radical.[109] Despite the 
already achieved advances, the use of visible light to induce the key SET process might 
significantly lower the required temperatures and therefore lead to unprecedented mild 
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conditions for ruthenium-catalyzed meta-C–H alkylations. Ideally, this transformation 
would be achieved without an external photosensitizer and with visible light. 
 
Scheme 2.4: Visible light-enabled ruthenium-catalyzed meta-C–H alkylation. 
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3 Results and Discussion 
3.1 Copper-catalyzed C–H Chalcogenation of Indolines and Indoles 
The indole motif represents one of the most ubiquitous heterocyclic structures found in 
nature[146] and is often a key structure in compounds of interest to medicinal 
chemistry.[147] Since it is apparent that the diverse substitution patterns on the indole ring 
are the reason for the observed wide array of biological properties, the recent years have 
witnessed great efforts towards the direct, positional-selective functionalization of 
indoles.[148] Yet, the majority of those transformations, including among others 
arylations,[149] cyanations,[150] or alkenylations,[151] exploits the innate reactivity of the 
indole core and is therefore restricted to the electron-rich C-2 or C-3 positions.  
Hence, C–H functionalization reactions regarding the C-7 position are considerably less 
explored. Nevertheless, the use of sterically demanding directing groups at the nitrogen 
atom allowed for the direct functionalization of the C-7 position.[152] Another approach is 
the C-7 functionalization of the corresponding indoline 133 and subsequent oxidation to 
the corresponding indole 136. The viability of this method has so far been elaborated with 
palladium,[153] rhodium,[154] iridium,[155] and ruthenium,[156] yet more favorable first-row 
transition metal-based catalysts have remained elusive for these transformations. 
 
3.1.1 Optimization Studies and Evaluation of N-Substitution 
Orienting optimization studies were performed by Dr. P. Gandeepan and revealed that, 
among the investigated solvents, only aromatic solvents proved viable for the desired 
transformation.[157] While both copper(I) and copper(II) salts were suitable precatalysts, 
Cu(OAc)2·H2O delivered the best results. In addition, further screening of additives yielded 
no further enhancement.[157] Therefore, the simple and user-friendly catalytic system 
depicted in Scheme 3.1 was chosen as a starting point for the ensuing studies. 
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Scheme 3.1: Initial conditions for the copper-catalyzed thiolation of indolines.[157] 
To further investigate the influence of additional oxidants, several oxidants were probed 
(Table 3.1).  
Table 3.1: Effect of oxidants on the copper-catalyzed C–H thiolation.a 
 
Entry Oxidant Yield (%) 
1 PhI(OAc)2 23 
2 MnO2 69b 
3 K2S2O8 57 
4 oxone -- 
5 air 66 
a Reaction conditions: 133a (0.30 mmol), 59 (0.30 mmol), Cu(OAc)2H2O (20.0 mol %), mesitylene (1.5 mL), 
oxidant (0.30 mmol), 140 °C, 20 h, yield of isolated product. b 59a (0.36 mmol). 
 
While the organic oxidant (diacetoxyiodo)benzene (PIDA) significantly lowered the 
catalytic efficacy (entry 1), the inorganic oxidants MnO2, K2S2O8, and oxone showed either 
no significant effect (entries 2 and 3) or completely diminished the catalytic efficiency 
(entry 4).  
These results suggested that ambient air is a sufficiently strong oxidant for the 
transformation (entry 5). Although oxygen is often considered as an ideal oxidant,[158] 
reactions in flammable organic solvents involving pure oxygen pose a certain safety 
hazard, especially at elevated temperatures.[159] However, the significantly lower oxygen 
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concentration in ambient air reduces the associated risks significantly. Since many 
previously disclosed copper based thiolation reactions required considerably higher 
catalyst loadings, [64a,74,76,78,160] the comparatively low catalyst loading of only 20 mol % is 
also noteworthy.  
Finally, the N-substitution pattern was evaluated. Acetyl and carboxamide substitution 
failed to deliver the desired thiolation products 151a and 152a, thus proving ineffective 
for the desired C–H thiolation (Scheme 3.2).  
 
Scheme 3.2: Evaluation of the directing group in the copper(II)-catalyzed C–H thiolation.  
Reaction conditions: 149 (0.30 mmol), 59a (0.30 mmol), Cu(OAc)2H2O (20.0 mol %), mesitylene 
(1.5 mL), 140 °C, 20 h, yield of isolated product. 
 
3.1.2 Scope of the Copper-Catalyzed C–H Chalcogenation 
With the optimized catalytst, the scope of the copper-catalyzed thiolation was explored. 
First, a range of diversely substituted disulfides 56 and 59 was investigated 
(Table 3.2). 
Table 3.2: Scope of the copper(II)-catalyzed C–H thiolation with disulfides 56 and 59.a 
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Entry Disulfide  Product  Yield [%] 
1 
  
66 
59a 135aa 
2 
 
 
63 
59b 135ab 
3 
 
 
40 
59c 135ac 
4 
 
 
51 
59d 135ad 
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Entry Disulfide  Product  Yield [%] 
5 
  
-- 
59e 135ae 
6 
  
-- 
56d 135af 
a Reaction conditions: 135a (0.30 mmol), 56 or 59 (0.30 mmol), Cu(OAc)2H2O (20.0 mol %), 
mesitylene (1.5 mL), 140 °C, 20 h, yield of isolated product. 
While a methyl group in the 4-position of the diaryl disulfide 59b had no significant 
influence on the outcome of the reaction and was well tolerated (entry 2), halogen 
substitution at the 4-position resulted in lowered yields (entries 3–4). Yet, the bromo-
substituted diaryl disulfide 59d still yielded the corresponding indoline 135ad with a 
satisfactory yield, which is of significance in respect to possible further derivatization of 
the corresponding product 135ad. 2-Pyridyl- or alkyl substituted disulfides 59e and 56d 
completely failed to deliver the corresponding products (entries 5–6). In case of the 
2-dipyridyl substituted disulfide 59e, this can most likely be attributed to competing 
coordination of 59e to the copper(II)-catalyst. 
In addition to the studied disulfides 59, the scope of the copper(II)-catalyzed C–H 
thiolation in regard to the substitution pattern of the indoline was thoroughly 
investigated. To this end, a broad range of diversely substituted indolines 133 was 
subjected to the optimized reaction conditions (Table 3.3). 
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Table 3.3: Scope of the copper(II)-catalyzed C–H thiolation with indolines 133.a 
 
Entry Indoline  Product  Yield [%] 
1 
  
72 
133b 135ba 
2 
 
 
66 
133b 135bb 
3 
  
52 
133c 135ca 
4 
  
62 
133d 135da 
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Entry Indoline  Product  Yield [%] 
5 
 
 
60 
133d 135db 
6 
  
62 
133e 135ea 
7 
  
69 
133f 135fa 
8 
  
65 
133g 135ga 
9 
 
 
63 
133g 135gb 
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Entry Indoline  Product  Yield [%] 
10 
  
55 
133h 135ha 
a Reaction conditions: 133 (0.30 mmol), 59 (0.30 mmol), Cu(OAc)2H2O (20.0 mol %), mesitylene 
(1.5 mL), 140 °C, 20 h, yield of isolated product. 
Methyl substituents in the C-2 or C-5 position of the indolines 133b and 133d had no 
pronounced effect on the outcome of the reaction. Only with the methyl group in the 3-
position a slightly lower yield was observed (entries 1–5). Furthermore, electron-
withdrawing functional groups, as well as electron-donating groups were well tolerated 
(entries 6–7). In addition to the fluoro-substituted indoline 133f, the synthetically 
meaningful chloro- and bromo-substituents were also well accepted, and the 
corresponding products 135ga and 135ha were obtained in satisfying yields (entries 8–
10).  
Organoselenium compounds have received considerable attention due to their possible 
applications in medicinal research.[161] Therefore, it is noteworthy that the catalyst was 
not limited to disulfides 59. Thus, a range of substituted indolines 133 and diselenides 63 
could be employed to give efficient access to indoline-7-selenol derivatives 137 (Table 
3.4). 
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Table 3.4: Scope of the copper(II)-catalyzed C–H selenylation with diselenides 63.a 
 
Entry Indoline  Product  Yield [%] 
1 
  
57 
133a 137aa 
2 
 
 
53 
133a 137ab 
3 
  
56 
133b 137ba 
4 
  
54 
133d 137da 
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Entry Indoline  Product  Yield [%] 
5 
  
62 
133f 137fa 
6 
 
 
63 
133f 137fb 
7 
  
53 
133g 137ga 
a Reaction conditions: 133 (0.30 mmol), 63 (0.30 mmol), Cu(OAc)2H2O (20.0 mol %), mesitylene 
(1.5 mL), 140 °C, 20 h, yield of isolated product. 
In general, the copper(II)-catalyzed C–H selenylation showed similar applicability 
compared to the previously discussed thiolation, yet with slightly lowered yields (entry 1). 
While methyl substitution on either indoline 133 or diselenide 63 had little influence 
(entries 2–4), halogen substituents were well tolerated again (entries 5–7). Overall, the 
copper(II)-catalyzed C–H chalcogenation proceeded with good yields and high levels of 
positional selectivity. 
Additionally, it was investigated if the copper(II)-based catalyst could also be utilized to 
achieve the direct thiolation of indoles 134. To this end, a variety of diversely decorated 
indoles 134 and diaryl disulfides 59 was utilized (Table 3.5 and Table 3.6). 
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Table 3.5: Scope of the copper(II)-catalyzed C–H thiolation of indoles 134 with disulfides 59.a 
 
Entry Disulfide  Product  Yield [%] 
1 
  
62 
59a 72aa 
2 
 
 
68 
59b 72ab 
3 
  
25 
59f 72af 
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Entry Disulfide  Product  Yield [%] 
4 
 
 
60 
59g 72ag 
a Reaction conditions: 134 (0.30 mmol), 59 (0.30 mmol), Cu(OAc)2H2O (20.0 mol %), mesitylene 
(1.5 mL), 140 °C, 20 h, yield of isolated product. 
All employed disulfides 59 were competent substrates for the copper(II)-catalyzed C–H 
thiolation. Apart from the reaction with the ortho-substituted substrate 59f (entry 3), all 
products 72 were obtained with moderate yields, again in a comparable fashion to the 
yields observed in the C–H thiolation of indolines 133.  
Table 3.6: Scope of the copper(II)-catalyzed C–H thiolation of indoles 134.a 
 
Entry Indole Product  Yield [%] 
1 
  
75 
134b 72ba 
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Entry Indole Product  Yield [%] 
2 
 
 
63 
134c 72ca 
3 
 
 
48 
134d 72da 
4 
 
 
57 
134e 72ea 
5 
 
 
51 
134f 72fa 
a Reaction conditions: 134 (0.30 mmol), 59a (0.30 mmol), Cu(OAc)2H2O (20.0 mol %), mesitylene 
(1.5 mL), 140 °C, 20 h, yield of isolated product. 
All the probed indoles 134 delivered the corresponding C-2-substituted products 72 in 
moderate to good yields. For the 3-methyl substituted indole 134b an increased yield was 
observed (entry 1). In addition, a methyl group in the 5-position did not exert a 
pronounced effect but was well tolerated (entry 2), as were halogen substituents 
(entries 4–5). Although the C-3 functionalized products were not observed in any of the 
other cases, the result with indole 134b might indicate the presence of a competing 
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reaction involving the more electron-rich C-3 position. Given the electronic properties of 
the C-3 position, a cleavage of the S–S bond of the disulfide 59 via an electrophilic 
substitution involving the electron-rich C-3 position of the indole core can be considered 
as a likely side reaction.  
Besides this finding, the copper(II)-catalyzed thiolation showed complete C-2 selectivity, 
and no evidence for the formation of the C-3 or C-7 substituted product was obtained. 
This further illustrates the preferred formation of the 5-membered metallacycle involved 
in the functionalization of the C-2 position over the 6-membered metallacycle involved in 
the C-7 functionalization.[152a]  
The overall robust nature of the copper(II) catalyst was further showcased by the facile 
selenylation of indole 134b. Both diselenides 63a and 63b could be employed in the 
copper(II)-catalyzed selenylation and the resulting products were obtained in good yields 
(Scheme 3.3).  
 
Scheme 3.3: Copper(II)-catalyzed C–H selenylation of indole 134 with diselenides 63.  
Reaction conditions: 134b (0.30 mmol), 63 (0.30 mmol), Cu(OAc)2H2O (0.06 mmol, 20.0 mol %), 
mesitylene (1.5 mL), 140 °C, 20 h, yield of isolated product. 
However, in case the diselenides 63 were used, it was necessary to block the C-3 position. 
A reaction with unsubstituted indole 134a resulted only in sluggish product formation. In 
comparison to the previously employed disulfides 59, diselenides 63 possess a 
considerably higher electrophilicity and an overall increased reactivity towards SN2 type 
Results and Discussion 
54 
reactions.[162] It is, therefore, likely that a selenylation of the electron-rich C-3 position[163] 
is competing when the C-3 position is not blocked.  
Despite the broad applicability of the copper(II)-catalyzed chalcogenation, some 
limitations were encountered during the attempts to further widen the scope of the 
developed methodology. Thus, ditellurides 153 could not be employed in the reaction, 
and furthermore the copper(II)-catalyzed thiolation of other biologically relevant 
nitrogen-containing heterocycles, such as carbazole (155a) or tetrahydroquinoline 156a 
delivered the corresponding products only in low yields (Scheme 3.4). 
 
Scheme 3.4: Limitations of the copper(II)-catalyzed C–H chalcogenation. Reaction conditions: 133, 
155a or 156a (0.30 mmol), 59a or 153a (0.30 mmol), Cu(OAc)2H2O (20.0 mol %), mesitylene 
(1.5 mL), 140 °C, 20 h, yield of isolated product. 
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3.1.3 Mechanistic Studies  
With the scope of the copper-catalyzed C–H chalcogenation established, several 
mechanistic experiments were conducted in order to delineate the copper catalyst’s 
mode of action. In addition, these findings may also yield further insights into the 
observed regioselectivity. 
 
3.1.3.1 Reaction in the Presence of Typical Radical Scavengers 
Radical intermediates are frequently proposed to be key intermediates in copper-
catalyzed C–X bond forming reactions (X = N, O, S).[68] It was therefore examined, whether 
the copper(II)-catalyzed chalcogenation involves the formation of radical intermediates 
and therefore proceeds via a SET-type mechanism. To this end, several reactions with 
commonly employed radical scavengers were conducted (Table 3.7).  
Table 3.7: Effect of radical scavengers on the copper(II)-catalyzed C–H thiolation.a 
 
Entry Radical scavenger Yield [%] 
1 -- 66 
2 TEMPO 23 
3 BHT -- 
4 galvinoxyl free radical -- 
a Reaction conditions: 133a (0.30 mmol), 59a (0.30 mmol), Cu(OAc)2H2O (20.0 mol %), mesitylene 
(1.5 mL), radical scavenger (0.30 mmol), 140 °C, 20 h, yield of isolated product. 
In all cases, the catalytic reaction was significantly inhibited. When TEMPO was used as 
radical scavenger, the catalyst’s activity was drastically reduced (entry 2), furthermore the 
presence of either BHT or galvinoxyl completely suppressed product formation (entries 
3–4). Although no adduct of the radical scavengers with possible radical intermediates 
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was observed in the ESI-HRMS analysis of the reaction mixture, these findings suggest that 
a SET-type mechanism is involved in the reaction.  
 
3.1.3.2 H/D-Exchange Experiments 
Deuteration studies were conducted, using fully isotopically labeled CD3OD as co-solvent. 
First, an experiment involving indoline 133a and disulfide 59a was conducted, revealing a 
considerable deuterium incorporation of 47% in the C-7 position of the reisolated 
substrate. Expectedly, no deuterium incorporation in the product 135aa was detected 
(Scheme 3.5).  
 
Scheme 3.5: H/D-exchange experiment with isotopically labeled co-solvent CD3OD. 
An additional experiment in the absence of the disulfide 59a resulted in increased 
deuterium incorporation of 67% at the C-7 position of the indoline [D]n-133a (Scheme 
3.6), indicating that disulfide 59a has no major role in the observed deuteration. 
 
Scheme 3.6: H/D-exchange experiment in the absence of disulfide 59a using indoline 133a. 
An otherwise identical experiment using indole 134a as substrate led to deuterium 
incorporation exclusively in the C-2 position of the indole structure, thereby reconfirming 
the previously observed regioselectivities (Scheme 3.7).  
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Scheme 3.7: H/D-exchange experiment in the absence of disulfide 59a using indole 134a. 
This result can be rationalized when the ring size of the intermediate metallacycle is 
considered. While C–H metalation in the C-2 position results in the formation of a 
5-membered cupra(II) cycle, C–H metalation of the C-7 position would deliver an 
unfavorable 6-membered metallacycle.[152c]  
3.1.4 Proposed Catalytic Cycle 
Based on the mechanistic findings, the following catalytic cycle was proposed (Scheme 
3.8). First, facile and reversible chelation-assisted C–H cleavage with the substrate 133a 
delivers the cyclometalated copper(II) species 158. In a second step, 158 is oxidized by a 
sulfenyl radical 159 thereby generating copper(III) complex 160. This proposal is 
supported by prior reports of copper(III) complexes stabilized by sulfide ligands.[76,164] 
Subsequent reductive elimination yields the desired product 135aa and generates the 
corresponding copper(I) species. The regeneration of the active catalyst is achieved by 
interaction of the copper(I) species with the disulfide 59a and air. The copper(I) species is 
reoxidized by a SET-type process with the disulfide, thereby regenerating the active 
copper(II) catalyst. Meanwhile, the associated cleavage of the disulfide S–S bond 
generates the sulfenyl radical and an arylthiolate anion. Finally, thiolate oxidation by 
O2[165] delivers the disulfide. 
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Scheme 3.8: Proposed catalytic cycle of the copper(II)-catalyzed C–H chalcogenation. X = OAc. 
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3.2 Visible-Light-Induced Decarboxylative C–H Adamantylation 
First isolated from crude oil in 1933,[166] the adamantane scaffold rapidly received 
considerable attention from the chemical community. After the first chemical synthesis in 
1941,[167] Schleyer's seminal synthesis in 1957[168] made the adamantane moiety widely 
available and it quickly found application in medicinal chemistry.[169] Similarly, 
benzothiazole and benzoxazole are key structures in numerous biologically active 
compounds.[170]  
Despite the general availability of protocols for the C-2 selective alkylation of benzazoles, 
most of them rely on the use of alkyl halides.[171] Minisci-type alkylations of heteroarenes, 
utilizing carboxylic acids and their derivatives as environmentally more benign alkyl 
sources, have emerged as a versatile tool for organic synthesis,[172] starting from Minisci’s 
seminal report in 1971.[173] Although light-induced Minisci-type C–H alkylation protocols 
have been disclosed recently, these methods often rely on the use of precious transition 
metals as the catalysts.[145,174] The use of a dual catalytic system comprised of an 
acridinium salt as organic photocatalyst and a cobaloxime for the reoxidation of the 
photocatalyst had not been disclosed for Minisci-type C–H alkylation reactions so far. 
3.2.1 Optimization Studies and Scope 
Orienting preliminary optimization studies regarding the visible-light-induced 
decarboxylative C–H adamantylation were performed by P. Gandeepan. The effect of 
different solvents, photocatalysts, and base additives was hence investigated, leading to 
the catalyst depicted in Scheme 3.9.[175] The key feature of the catalyst is the combination 
of an acridinium based photocatalyst 161 and cobaloxime 139a. 
Results and Discussion 
60 
 
Scheme 3.9: Optimized catalyst of the decarboxylative C–H Adamantylation. 
With the optimized conditions in hand, the scope of the visible-light-induced C–H 
adamantylation regarding benzothiazoles was explored (Table 3.8). 
Table 3.8: Visible-light-induced decarboxylative C–H adamantylation with benzothiazoles 140.a 
 
Entry Benzothiazole  Product  Yield [%] 
1   83 
140a 142a 
2   53 
140b 142b 
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Entry Benzothiazole  Product  Yield [%] 
3   59 
140c 142c 
4   71
b 
140d 142d 
5   54 
140e 142e 
6   59 
140f 142f 
7   54 
140g 142g 
8 
  
44b 
140h 142h 
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Entry Benzothiazole  Product  Yield [%] 
9 
  
32b 
140i 142i 
10   18 
140j 142j 
a Reaction conditions: 140 (0.40 mmol), 141 (1.20 mmol), 161 (5.00 mol %), 139a (8.00 mol %), 
K2HPO4 (1.20 mmol), DCE/H2O (3:1, 2.0 mL), 24 h, yield of isolated product. b 48 h. 
Both electron-donating as well as electron-withdrawing substituents in the C-6 position 
of the benzothiazoles 140 were well tolerated, delivering moderate to good yields, while 
electron-donating substituents delivered slightly higher yields (entries 2–3). In the case of 
benzothiazole 140d, the reaction time had to be increased to 48 h in order to ensure a 
satisfying conversion (entry 4).  
Halogen substituents were also accepted and no significant difference in the respective 
yields was observed. Thus, the benzothiazoles 140f and 140g containing synthetically 
meaningful chloro- and bromo-substituents delivered the corresponding products with 
59% and 54% yield, respectively (entries 6 and 7). Unfortunately, a free hydroxyl group in 
the C-6 position diminished the catalytic efficacy. 
In addition, valuable carbonyl groups, such as ester or ketone, were tolerated to some 
extent, although the reaction time had to be increased to 48 h to guarantee a meaningful 
conversion (entries 8–9). The cyano-substituted benzothiazole 140j failed to deliver the 
product 142j in synthetically useful yields. In this case the corresponding 2,3-
dihydrobenzothiazole could be isolated with 30% yield.  
Results and Discussion 
63 
This result indicates that strongly electron-withdrawing groups, such as cyano, may 
decrease the electron density of the proposed intermediate to a level that interferes with 
the postulated reoxidation of the intermediate resulting from the radical attack vide infra 
(chapter 3.2.3). 
Furthermore, a range of diversely-substituted benzoxazoles 14 was subjected to the 
established reaction conditions (Table 3.9). 
Table 3.9: Visible-light-induced decarboxylative C–H adamantylation with benzoxazoles 14.a 
 
Entry Benzoxazole  Product  Yield [%] 
1   
45 
14b 143b 
2   
42 
14c 143c 
3   50 
14d 143d 
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Entry Benzoxazole  Product  Yield [%] 
4   46 
14e 143e 
5   
40 
14f 143f  
a Reaction conditions: benzoxzazole 14 (0.40 mmol), 141 (1.20 mmol), 161 (5.00 mol %), 
139a (8.00 mol %), K2HPO4 (1.20 mmol), DCE/H2O: 3:1 (2.0 mL), 48 h, yield of isolated product.  
The probed benzoxazoles 14 were converted with lower efficiency and the reaction time 
had to be extended to 48 h. With the prolonged reaction time, the C-5 and C-6 substituted 
benzoxazoles delivered the corresponding products in moderate yields. Alkyl substituents 
in the C-5 or C-6 position were well tolerated (entries 1 and 3). In addition, bromo- and 
chloro-substituents were also accepted (entries 2 and 4). Benzoxazole 14f containing the 
valuable ester group delivered the product 143f in 40% yield (entry 5).  
Next, it was probed whether the visible-light-induced decarboxylative adamantylation 
could be extended to further biologically relevant nitrogen-containing heterocycles 
(Scheme 3.10). Accordingly, the biologically active purine alkaloid 162 and its derivative 
163 were subjected to the optimized reaction conditions. The caffeine derivative 164 was 
obtained in good yield, and even the structurally complex analog 165 could still be isolated 
in 43% yield.  
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Scheme 3.10: Visible-light-induced decarboxylative C–H adamantylation of purine derivatives 162 
or 163. Reaction conditions: 162 (0.40 mmol), 141 (1.20 mmol), 161 (5.00 mol %), 139a 
(8.00 mol %), K2HPO4 (1.20 mmol), DCE/H2O: 3:1 (2.0 mL), yield of isolated product. b 163 
(0.30 mmol). 
Additionally, it was shown by Dr. P. Gandeepan that benzimidazoles could be employed 
as substrates.[175] However, limitations were encountered while probing further 
heterocycles. Thus, benzofuran, indole, imidazole, pyridine, and quinoline substrates 
remained unreactive in the visible-light-induced C–H adamantylation.  
An additional limitation is the restriction to adamantane carboxylic acid as no other 
carboxylic acids could be employed in the decarboxylative C–H alkylation. Since it is 
expected that at least other tertiary carboxylic acids should display similar reactivity, this 
result is surprising to some extent. In the case of benzyl-substituted carboxylic acids, the 
dibenzylic species resulting from the radical-radical coupling was observed by GC-MS 
analysis. This observation suggests that the decarboxylative process is still operative even 
though no product formation was detected in these cases.  
Minisci-type alkylations[173] are usually performed under acidic conditions.[172a,172c] This 
ensures protonation of the N-heterocyclic substrate and the associated lowering of the 
LUMO energy drastically increases the reactivity towards nucleophilic radicals.[172a] In 
sharp contrast to this, the visible-light-induced decarboxylative C–H adamantylation is 
performed under neutral to slightly basic conditions and hence lacks this additional 
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activation of the heterocyclic substrates. This lack of additional activation might be 
responsible for the observed limitations. 
Still, the visible-light-induced decarboxylative C–H adamantylation allowed the facile 
adamantylation of a range of diversely decorated benzothiazoles 140 and benzoxazoles 
14 and even allowed the functionalization of naturally occurring as well as synthetic 
purine alkaloids. 
 
3.2.2 Mechanistic Studies 
Regarding the intriguing findings concerning the C–H adamantylation, an investigation of 
the underlying mechanism was conducted next. In order to gain mechanistic insights into 
the reaction and to delineate its mode of action, a series of experiments was conducted. 
 
3.2.2.1 Influence of Radical Scavengers on the C–H Adamantylation 
Because of the high probability that the reaction involves several SET-type processes and 
the assumption that the adamantane radical is a key intermediate, a series of experiments 
in the presence of radical scavengers was conducted (Table 3.10). In all cases, the catalytic 
efficiency was significantly reduced. Yet, only in the presence of galvinoxyl the catalytic 
activity was completely diminished (entry 3). Nevertheless, these results are highly 
indicative of a SET-type process being operative. 
Table 3.10: C–H Adamantylation in the presence of typical radical scavengers.a 
 
Entry Radical scavenger (X equiv) Yield [%] 
1 -- 83 
2 TEMPO (1.00 equiv) 34 
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Entry Radical scavenger (X equiv) Yield [%] 
3 galvinoxyl free radical (1.00 equiv) -- 
4 BHT (1.00 equiv) 53 
5 BHT (3.00 equiv) 36 
a Reaction conditions: 140a (0.40 mmol), 141 (1.20 mmol), 161 (5.00 mol %), 139a (8.00 mol %), 
K2HPO4 (1.20 mmol), radical scavenger (X equiv), DCE/H2O (3:1, 2.0 mL), yields of isolated product. 
Additional evidence for the formation of the adamantane radical was obtained through 
ESI-HRMS analysis (Figure 3.1). In a sample removed from the reaction mixture after 
irradiation, the radical adduct 166 of the radical scavenger TEMPO and the adamantane 
radical could be detected. 
 
Figure 3.1: ESI-HRMS spectra of a sample taken from the reaction mixture. 
 
3.2.2.2 Competition Experiment Between Benzothiazoles 
In order to investigate the influence of the electronic nature of the benzothiazoles 140 an 
intermolecular competition experiment with electron-rich and electron-deficient 
benzothiazoles 140e and 140b was conducted (Scheme 3.11). Although no big difference 
between the reactivity of the two substrates was observed, the experiment revealed 
electron-deficient benzothiazoles to be slightly preferentially converted. This finding is in 
agreement with the postulated attack of the nucleophilic adamantane radical at the C-2 
position of the corresponding benzothiazole. 
measured  
calculated  
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Scheme 3.11: Intermolecular competition experiment between benzothiazoles 140e and 140b. 
 
3.2.2.3 Influence of Light by On/Off-Plot 
To clearly determine the visible light-dependent nature of the C–H adamantylation, the 
reaction progress was monitored during several cycles of irradiation and stirring in the 
dark (Figure 3.2). No product formation was observed in the absence of light, while in 
contrast, the reaction proceeded smoothly when beeing irradiated. This finding provides 
additional strong evidence for the light-driven nature of the decarboxylative C–H 
adamantylation. 
 
Figure 3.2: Effect of visible-light irradiation on the C–H adamantylation. 
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3.2.2.4 Fluorescence-Quenching Experiments 
To obtain a better understanding of the exact effect of the visible-light irradiation, a series 
of fluorescence-quenching experiments was conducted. These experiments should allow 
to identify key interactions of the excited state photocatalysts with the substrates. 
Benzothiazole (140a) displayed a clear quenching effect, while 1-adamantane-carboxylic 
acid showed no quenching of the excited state photocatalyst (Figure 3.3). Based on the 
conducted experiments it cannot be distinguished whether a dynamic or static quenching 
process is operative in this case.[176] 
 
Figure 3.3: Fluorescence-quenching of 161 with a) benzothiazole (140a) and b) with 
1-adamantanecarboxylic acid (141). 
It has been previously reported by Nicewizc that benzothiazole (140a) can be oxidized by 
the excited state of an acridinium based photocatalysts.[177] Therefore the obtained 
results are coherent with the previously published ones. Furthermore, it is expected that 
the adamantanecarboxylate undergoes oxidation by the exited photocatalyst prior to 
decarboxylation. Thus, 1-adamantanecarboxylic acid should not display any quenching 
effect. Accordingly, this finding is also in agreement with the proposed underlying 
mechanism vide infra.  
During the attempt to study the properties of the adamantanecarboxylate salts major 
solubility issues in the organic solvent were encountered. Thus, the 
adamantanecarboxylate tetrabutyl-ammonium salt 167[178] was prepared and 
subsequently studied (Figure 3.4). The TBA salt displayed significant quenching 
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capabilities even at significantly lower concentrations. Yet, in this case, no linear 
correlation was observed. This result indicates that both static and dynamic quenching 
processes are operative in this case, leading to the observed non-linear correlation 
between the quencher concentration and the quotient of the fluorescence intensities.[176] 
 
Figure 3.4: Fluorescence-quenching of 161 adamantanecarboxylate tetrabutyl-ammonium salt 167. 
Fluorescence-quenching experiments with acridinium salt 161 and a similar cobaloxime 
139 have recently been reported by Lei[179] and suggest that a quenching process between 
the excited acridinium catalyst and the cobaloxime 139a is also a likely possibility in the 
present C–H adamantylation. 
3.2.3 Proposed Catalytic Cycle 
Based on literature precedence and the results from the mechanistic studies, the 
following catalytic cycle was proposed (Figure 3.5). Initially, excitation of the acridinium 
photocatalyst by blue light takes place and generates the excited species of the 
photocatalyst [Acr-Mes]+*. Given the high oxidation potential (Ered = 1.88 V vs SCE)[180] of 
the excited state of the Fukuzumi catalyst,[142-143,181] subsequent one-electron oxidation 
of the adamantanecarboxylate 168 (Eox = 1.20 vs SCE)[178] delivers the oxygen-centered 
carboxyl radical. Further evidence for the step is found in recently reported  
protocols[181-182] and the result of the fluorescence-quenching experiment regarding 
adamantane carboxylate. The following decarboxylation yields the adamantane radical 
169, as supported by the outcome of the experiments with radical scavengers. 
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Subsequent attack of the radical at the C-2 position of benzothiazole 140a delivers 
intermediate 170. Simultaneously, the reduced state of the photocatalyst [Acr–Mes]˙ 161˙ 
is reoxidized by a SET-type process with the cobalt(III)-species 171, yielding the active 
photocatalyst and a cobalt(II)-species 172. Oxidation of intermediate 170 by the cobalt(II)-
species 172 and subsequent deprotonation and rearomatization delivers the product 
142a and generates a cobalt(I) species. The following reaction of the cobalt(I) species 173 
with a proton generated during the reaction, delivers a cobalt(III)-hydride complex 174. 
At last, hydrogen evolution from complex 174 closes the catalytic cycle. 
 
Figure 3.5: Proposed catalytic cycle of the decarboxylative C–H adamantylation. 
As it becomes evidently clear from the proposed catalytic cycle, the properties of the 
attacking radical are of major importance. This offers another possible explanation for the 
reactivity observed during the investigations of the scope of the C–H adamantylation. 
Although alkyl radicals are generally considered to possess a nucleophilic character,[172a] 
the actual nucleophilicity for each radical may still vary considerably.[183] In addition to the 
inherent nucleophilicity, originating from its tertiary character,[184] it might be that the 
reactivity of the adamantane radical is further enhanced by its distinct structural 
properties that do not allow for a planar geometry of the radical.[185]  
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3.3 Light-Induced Copper-Catalyzed C–H Arylation of Azoles at Room Temperature 
Since Ullmann’s and Goldberg’s pioneering studies[45b,45e] regarding copper-catalyzed 
arylation reactions, copper catalysts have become a highly versatile platform for a large 
range of organic transformations.[25,43,44c,44d,68,186] In 1998, an initial report by Miura and 
coworkers revealed the effect of copper(I) iodide on the regioselectivity of the studied 
palladium-catalyzed arylation of N-methylimidazole (7a).[52] Given the drastic changes in 
regioselectivity, their findings suggested the involvement of an organocopper 
intermediate in the arylation reaction. In 2007, Daugulis and coworkers reported the 
direct copper-catalyzed C–H arylation.[54] This seminal report of Daugulis demonstrated, 
for the first time, the viability of inexpensive and environmentally benign copper catalysis 
for heterocyclic C–H arylation reactions. In the following years the scope of copper-
catalyzed C–H arylations was extended to electron-deficient polyfluorinated arenes,[55] 
and other prominent heterocycles by the groups of inter alia Daugulis,[56] Miura[57,187] and 
Ackermann.[58,188] Despite the undisputable progress in the field, all these reactions still 
require relative harsh conditions and elevated reaction temperatures. A copper-catalyzed 
C–H arylation proceeding at room temperature had thus far not been reported.  
 
3.3.1 Copper-Catalyzed C–H Arylation of Azoles Under UV-Irradiation 
3.3.1.1 Optimization and Scope 
Optimization studies regarding the copper-catalyzed C–H arylation were largely 
performed by Dr. Fanzhi Yang. Among the various tested conditions, the combination of 
copper(I) iodide and N-methylated glycine (Me2NCH2CO2H) in the presence of LiOtBu in 
Et2O proved to be ideal (Scheme 3.12a).[189] In addition, it was shown by Dr. Yang that the 
reaction could be conducted under visible light when Ir(ppy)3 was employed as 
photocatalyst (Scheme 3.12b). 
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Scheme 3.12: Copper-catalyzed C–H arylation of benzothiazole (140a) with a) no exogenous 
photocatalyst and b) in the presence of Ir(ppy)3. 
The optimized conditions shown in Scheme 3.12 were chosen as a starting point for 
further improving the catalyst. Especially the influence of the concentration and the 
catalyst loading were investigated (Table 3.11). 
Table 3.11: Influence of solvent, concentration and scale on the copper-catalyzed C–H arylation.a 
 
Entry Solvent Yield [%] 
1 Et2O 70 
2 Et2O 34b 
3 nBu2O 52 
4 Et2O 85c 
5 Et2O 84d 
6 Et2O/H2O (9:1) -- 
a Reaction conditions: 140a (0.25 mmol), 11c (1.25 mmol), CuI (20.0 mol %), Me2NCH2CO2H 
(30.0 mol %), LiOtBu (0.75 mmol), solvent (1.0 mL), 254 nm, 16 h, yield of isolated product. b 140a 
(0.50 mmol). c Et2O (0.75 mL). d Under air. 
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First, the previously developed conditions were reaffirmed (entry 1). The reaction proved 
sensitive to changes in scale or concentration. If conducted at a larger scale the yield of 
the reaction dropped to 34% (entry 2). Yet, an increase in concentration led to a 
significantly improved isolated yield of 85% (entry 4). In addition, the reaction proved 
insensitive to air (entry 5) but did not tolerate the addition of water (entry 6). Regarding 
these new findings it was investigated if the catalyst loading could be decreased 
(Table 3.12). 
Table 3.12: Influence of the catalyst loading on the copper-catalyzed C–H arylation.a 
 
Entry CuI (X mol %) Yield [%] 
1 20 73 
2 20 73b 
3 15 59 
4 10 60 
a Reaction conditions: 140a (0.25 mmol), 11c (1.25 mmol), CuI (20 mol %), Me2NCH2CO2H 
(30.0 mol %), LiOtBu (0.75 mmol), Et2O (0.75 mL), 254 nm, 16 h, yield isolated product. b Et2O 
(0.50 mL). 
While a further increase in the concentration had no positive effect on the catalyst’s 
efficiency (entries 1 vs 2), a reduction of the catalyst loading had a detrimental effect on 
the yield (entries 3 and 4).  
To investigate the catalyst’s versatility the slightly modified catalyst was applied to the 
synthesis of the natural product texamine (146a) and its derivatives (Table 3.13). 
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Table 3.13: Copper-catalyzed C–H arylation of oxazoles 144 in the synthesis of texamine 
derivatives.a 
 
Entry Aryl iodide  Product  Yield [%] 
1  
 
62 
11a texamine (146a) 
2 
 
 
60 
11c 146c 
3 
 
 
64 
11d 146d 
4 
 
 
71 
11e 146e 
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Entry Aryl iodide  Product  Yield [%] 
5  
 
72 
11f 146f 
6  
 
69 
11g 146g 
a Reaction conditions: 144 (0.25 mmol), 11 (1.25 mmol), CuI (20.0 mol %), Me2NCH2CO2H 
(30.0 mol %), LiOtBu (0.75 mmol), Et2O (1.0 mL), air, 254 nm, 16 h, yield of isolated product. 
The copper-catalyzed photo-induced C–H arylation protocol tolerated a wide range of 
diversely decorated aryl iodides 11 and the texamine derivatives 146 were obtained in 
moderate to good yields. It is especially noteworthy that the 1-chloro-4-iodobenzene 
(11g) was well-tolerated and no product associated to a possible protodehalogenation 
was observed (entry 6). The investigation of the scope also revealed a slight preference 
for electron-deficient aryl iodides 11.  
In addition, the newly found conditions were also tested in the C–H arylation of 
benzoxazole 14 (Scheme 3.13). Halogen substituents in the meta- or para-position of the 
iodoarenes 11e and 11g were well tolerated and the corresponding products 15ge and 
15gg were obtained in good yields. Although the reactions were conducted under ambient 
atmosphere, the yields proved to be comparable to the other investigated substrates.[189] 
This further highlights the robust nature of the copper catalyst.  
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Scheme 3.13: Copper-catalyzed C–H arylation of benzoxazole 14g. Reaction conditions: 14g 
(0.25 mmol), 11 (1.25 mmol), CuI (20.0 mol %), Me2NCH2CO2H (30.0 mol %), LiOtBu (0.75 mmol), 
Et2O (1.0 mL), air, 254 nm, 16 h, yield of isolated product. 
In a later study, the influence of the electronic nature of the benzothiazole substrates 140 
was investigated by N. Imse as part of his bachelor thesis.[190] To this end, a range of 
diversely substituted benzothiazoles 140 was subjected to the optimized conditions 
established in the work of Dr. Fanzhi Yang (Table 3.14).[189] 
Table 3.14: Copper-catalyzed C–H arylation of benzothiazoles 140.a 
 
Entry Benzothiazole  Product  Yield [%] 
1  
 
57 
140b 145bc 
2  
 
46 
140c 145cc 
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Entry Benzothiazole  Product  Yield [%] 
3  
 
55 
140d 145dc 
4  
 
39 
140e 145ec 
5  
 
44 
140f 145fc 
6  
 
21 
140g 145gc 
7  
 
23 
140h 145hc 
a Reaction conditions: 140 (0.25 mmol), 11c (1.25 mmol), CuI (20.0 mol %), Me2NCH2CO2H 
(30.0 mol %), LiOtBu (0.75 mmol), Et2O (1.0 mL), 254 nm, 16 h, yield isolated product. 
In stark contrast to the results obtained with substituted aryl iodides 11, the electronic 
nature of the substituents on the benzothiazole 140 had a significant influence on the 
performance of the C–H arylation. In all cases, the yield was clearly reduced compared to 
the unsubstituted benzothiazole 140a. Even a methyl substituent in the C-6 position led 
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to a lowered yield (entry 1). When halogen substituents were present, the obtained yields 
decreased to the range of 40% (entries 4 and 5). Interestingly, both fluoro- and chloro-
substituents did not have a negative impact on the catalytic efficiency, if present on the 
aryl iodide.[189] Bromo-substitution in the C-6 position further decreased the yield, as did 
an ester group (entries 6 and 7). 
In conclusion, these results indicate that the photo-induced C–H arylation protocol is 
sensitive to the electronic nature of the benzothiazole 140 or the azole substrate in 
general. This pronounced substrate dependence was already briefly discussed by Peters 
and Fu in their work on photo-induced copper-catalyzed N–H arylation reactions,[126] and 
will be discussed in more detail in chapter 3.3.3. 
 
3.3.2 Visible-Light-Induced Copper-Catalyzed C–H Arylation 
In 2012, Ackermann and coworkers demonstrated the viability of a copper-catalyzed 
intramolecular arylation of triazoles in their studies regarding the synthesis of annulated 
triazoles.[188] Thus, it was investigated whether the previously established light-induced 
copper-catalyzed arylation protocol could be employed for the intramolecular arylation 
of triazoles. The iodo-substituted triazole 27b was chosen as a model substrate and 
subjected to a range of reactions conditions (Table 3.15). 
Table 3.15: Intramolecular C–H arylation of triazole 27b.a 
 
Entry Solvent Light source Yield [%] 
1 Et2O UV-C lamps (λmax=254 nm) 10 
2 Et2O UV-C lamps (λmax=254 nm) 11b 
3 THF UV-C lamps (λmax=254 nm) 38 
4 DMF UV-C lamps (λmax=254 nm) (47) 
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Entry Solvent Light source Yield [%] 
5 1,4-dioxane UV-C lamps (λmax=254 nm) 19 
6 THF blue LEDs 24 
7 THF UV-C lamp (λmax=254 nm) 43c 
8 DMF blue LEDs 36 
9 THF -- -- 
10 THF UV-C lamps (λmax=254 nm) 33c,d 
11 THF blue LEDs --, 96% rsm.c,d 
a Reaction conditions: 27b (0.25 mmol), CuI (20.0 mol %), LiOtBu (0.75 mmol), Et2O (1.0 mL), 
254 nm, 16 h. Yields determined by 1H-NMR with mesitylene as internal standard, isolated yield 
in brackets. b Me2NCH2CO2H (30.0 mol %). c No CuI. d No base. 
While the annulated product was not observed in any case, the corresponding 
dehalogenated product 175 was frequently obtained. The highest yield of the undesired 
byproduct was obtained when DMF was used as the solvent (entry 4), but the use of THF 
also delivered the byproduct in similar yields (entry 7). Interestingly, the dehalogenation 
reaction occurred independently of the presence of copper iodide or base when the 
reaction was conducted under UV-C irradiation (entries 7 and 10). While the 
dehalogenation did also occur when blue LEDs were used as light source (entries 6 and 8), 
it required the presence of copper iodide and base (entry 11), indicating that the copper 
catalyst was vital for the C–I bond cleavage in this case. 
Although the formation of the annulation product was not observed, these findings 
suggested that a visible light-induced arylation protocol without the use of an additional 
photocatalyst might be feasible. To investigate this possibility, benzothiazole 140a was 
chosen as a model substrate and subjected to a range of reaction conditions (Table 3.16). 
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Table 3.16: Preliminary results for the visible light-induced C–H arylation of benzothiazole 140a.a 
 
Entry Ligand Yield [%] 
1 -- 45 
2 1,10-phenanthroline 12 
3 PPh3 trace 
4 IPr HCl 39 
5 Me2NCH2CO2H 40 
a Reaction conditions: 140a (0.25 mmol), 11e (1.25 mmol), CuI (20.0 mol %), ligand (30.0 mol %), 
LiOtBu (0.75 mmol), Et2O (1.0 mL), yield of isolated product. 
The initial experiments revealed that the C–H arylation could be performed under visible-
light irradiation. Furthermore, the reaction proceeded most efficiently in the absence of 
an additional ligand (entry 1), while prominent ligands, like 1,10-phenanthroline or 
triphenylphosphine, significantly lowered the catalytic performance (entries 2 and 3). 
Subsequently, the influence of the copper salt was investigated. Besides the initially 
tested copper(I) iodide a variety of copper salts gave the desired arylated product 145ae 
with comparable yields (Table 3.17). 
Table 3.17: Influence of the copper salt on the visible light-induced C–H arylation of 140a.a 
 
Entry [Cu] Yield [%] 
1 -- -- 
2 CuCl 54 
3 CuBr 50 
4 CuTc  34 
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Entry [Cu] Yield [%] 
5 Cu(MeCN)4PF6 42 
6 CuCl2 45 
7 Cu(OTF)2 43 
8 Cu(OAC)2·H2O 51 
9 Cu(TFA)2·H2O 42 
a Reaction conditions: 140a (0.25 mmol), 11e (1.25 mmol), [Cu] (20.0 mol %), LiOtBu (0.75 mmol), 
Et2O (1.0 mL), air, yield of isolated product. 
In the absence of a copper catalyst, the arylated product 145ae was not detected (entry 
1). Among the investigated copper(I) salts (entries 2–5), copper (I) chloride proved to be 
ideal (entry 2). Notably, several copper(II) salts were also suitable copper sources (entries 
6–9). When copper(II) acetate monohydrate was employed a nearly identical yield was 
obtained (entry 8). Furthermore, the influence of the solvent was investigated (Table 
3.18). 
Table 3.18: Influence of the solvent on the visible light-induced C–H arylation.a 
 
Entry Solvent Yield [%] 
1 THF 20 
2 nBu2O 17 
3 DME 28 
4 1,4-dioxane -- 
5 MeCN 12 
6 PhMe trace 
7 mesitylene -- 
8 DMF -- 
9 DCE -- 
a Reaction conditions: 140a (0.25 mmol), 11e (1.25 mmol), CuI (20.0 mol %), LiOtBu (0.75 mmol), 
solvent (1.0 mL), air, yield of isolated product. 
Results and Discussion 
83 
The visible-light-induced C–H arylation proved to be highly dependent on the solvent. All 
the probed solvents performed considerably worse than the previously used Et2O. Among 
the range of probed solvents, nearly only ethereal solvents were tolerated (entries 1–3), 
while other commonly used solvents failed to deliver the arylated product (entries 4–9). 
In addition, other bases proved unsuitable for the reaction (Table 3.19). 
Table 3.19: Influence of the base on the visible light-induced C–H arylation of 140a.a 
 
Entry Base Yield [%] 
1 NaOMe -- 
2 NaOEt -- 
3 KOtBu -- 
4 K3PO4 -- 
a Reaction conditions: 140a (0.25 mmol), 11e (1.25 mmol), CuI (20.0 mol %), base (0.75 mmol), 
solvent (1.0 mL), air, yield of isolated product. 
Since no synthetically meaningful yields could be achieved by the sole use of a copper-
catalyst, a series of commonly used photocatalyst was evaluated in the visible-light-
induced copper-catalyzed C–H arylation. Although the use of an additional photocatalyst 
has drawbacks regarding the cost efficiency and overall economy of the reaction, its use 
might allow a more effective light absorption and therefore higher yields. To this end, a 
series of organic and transition metal-based photocatalysts varying in their excited state 
oxidation and reduction capabilities were investigated in the visible-light-induced C–H 
arylation (Table 3.20). 
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Table 3.20: Influence of additional photocatalysts on the visible light-induced C–H arylation.a 
 
Entry Photocatalyst (X mol %) Yield [%] 
1 -- 54 
2 DCN (5.00 mol %) 38 
3 Eosin Y (sodium salt) (5.00 mol %) 39 
4 Rhodamine 6G (5.00 mol %) 19 
5 4,4-Dimethoxybenzophenone (5.00 mol %) 37 
6 Rose Bengal (5.00 mol %) 41 
7 [Acr–Mes]+(ClO4)⁻ (5.00 mol %) 27 
8 TiO2 (50.0 mol %) 47 
9 Ru(bpy)3Cl2 (5.00 mol %) 35 
10 Ir(ppy)3 (2.00 mol %) 54 
11 Ir(ppy)3 (2.00 mol %) --b 
12 176 (2.00 mol %) 43 
13 177 (2.00 mol %) 53 
14 178 (2.00 mol %) 47 
15 179 (2.00 mol %) 48 
16 180 (2.00 mol %) 32 
a Reaction conditions: 140a (0.25 mmol), 11e (1.25 mmol), CuI (20 mol %), photocatalyst, LiOtBu 
(0.75 mmol), Et2O (1.0 mL), air, yield of isolated product. In case of Ir-based photocatalyst, the 
reaction was conducted under N2 and in DMF. b No base. 
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In case an organic photocatalyst was employed slightly lower yields were obtained 
(entries 2–7), the strong excited state oxidant acridinium photocatalyst however 
performed significantly worse (entry 7). The heterogeneous photocatalyst TiO2 had no 
significant effect (entry 8). If a ruthenium-based photocatalyst was employed, a slightly 
lower yield was obtained (entry 9). Next, a series of diverse iridium-based photocatalysts 
was investigated. The reaction with the commonly used Ir(ppy)3 delivered the product in 
54% yield (entry 10), a nearly identical result to the reaction in the absence of a 
photocatalyst. In this case, the presence of LiOtBu was still required (entry 11). The tert-
butyl-substituted iridium photocatalyst 177 delivered the product in a nearly identical 
yield compared to Ir(ppy)3, while the methyl-substituted 176 showed a slightly lower 
performance (entries 12 and 13). In general, iridium complexes with electron poor 
phenylpyridine ligands possess a lower excited state reduction potential but an increased 
lifetime of the excited state of the photocatalyst,[119d] which might lead to higher 
efficiency of the key SET step.[191] Yet, the fluoro-substituted iridium complexes 178 and 
179 showed similar activity in the C–H arylation (entries 14 and 15). Only the cationic 
iridium complex 180 displayed significant lower activity (entry 16). In summary, the use 
of an additional photocatalyst did not improve the outcome of the visible-light-induced 
C–H arylation. Although this is the first example of an external-photocatalyst free, copper-
catalyzed visible light-induced arylation by means of C–H activation, the project was not 
further pursued, since it seemed questionable whether the reaction could deliver 
synthetically meaningful yields.  
3.3.3 Mechanistic Studies and Proposed Catalytic Cycle 
During his seminal study on the photo-induced copper-catalyzed arylation of azoles, Dr. 
Fanzhi Yang performed several mechanistic experiments. In summary, the C–H arylation 
proved sensitive to the presence of the radical scavenger galvinoxyl, indicating that a SET-
type process might be operative in the transformation.[189]  
Unfortunately, attempts to isolate or to independently prepare possible reaction 
intermediates failed. However, the catalytic system utilizing Ir(ppy)3 as photocatalyst 
allowed for further mechanistic investigations regarding the effect of the photoredox 
catalyst. To this end, fluorescence-quenching experiments were conducted with Ir(ppy)3 
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and a series of potential quenchers (Figure 3.6. and Figure 3.7). Neither 3-iodotoluene 
(11c) nor benzothiazole (140a) showed any quenching capability indicating that there is 
no interaction of them with the excited state of the photocatalyst Ir(ppy)3.  
 
Figure 3.6: Fluorescence-quenching of Ir(ppy)3 with a) with 3-iodotoluene (11c) and b) with 
benzothiazole (140a). 
 
Interestingly, when the fluorescence-quenching studies were performed in MeCN as 
solvent, copper(I) iodide displayed no quenching (Figure 3.7a). This can most likely be 
attributed to the formation of an unreactive copper-acetonitrile complex.[192] In DMSO 
copper(I) iodide showed quenching of the excited state of Ir(ppy)3 (Figure 3.7b). These 
results are in agreement with studies by Kobayashi and coworkers regarding the visible-
light-induced N-arylation of heterocycles.[130] Since 3-iodotoluene (11c) does not show 
any quenching, these results also indicate that the proposed aryl radical is not formed by 
an oxidative quenching process of the excited state of Ir(ppy)3. 
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Figure 3.7: Fluorescence-quenching of Ir(ppy)3 with a) copper(I) iodide in MeCN and b) with 
copper(I) iodide in DMSO. 
Based on these initial results and literature precedence a catalytic cycle can be proposed 
(Scheme 3.14). The reaction of copper(I) chloride with an excess of LiOtBu delivers a 
copper(I) ate complex 181.[193] This step has also been shown to be operative for copper(II) 
chloride,[194] which explains the small difference between the different copper salts 
observed during the optimization. In a second step, the copper(I) ate-complex promotes 
facile C–H cleavage generating copper complex 182. This copper complex 182 undergoes 
excitation by either visible or UV-light yielding the excited complex 182*. A subsequent 
SET generates copper(II) complex 183 and after homolytic cleavage of the C–I bond the 
aryl radical 106a. The aryl radical attacks the copper(II) complex 183 thereby generating 
copper(III) complex 184. Subsequent reductive elimination liberates the product and 
regenerates the active catalyst through reaction with an additional molecule LiOtBu, 
thereby closing the catalytic cycle. 
Since the key step is the SET process from the excited copper(I) complex 182* to the aryl 
iodide 11a, the reaction heavily depends on the reduction potential of this species and 
therefore on the electronic nature of 182*. Because substituents on the benzothiazole are 
likely to significantly influence these electronic properties, the proposed catalytic cycle 
offers a satisfying explanation for the observed strong influence of substituents on the 
benzothiazole 140 on the obtained yield.  
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Scheme 3.14: Proposed catalytic cycle for the light-induced copper-catalyzed C–H arylation. 
 
3.4 Visible-Light-Induced Ruthenium-Catalyzed Meta-C–H Alkylation 
While the use of well-established directing groups allowed for the development of a 
plethora of ortho-selective C–H functionalization reactions,[81,195] the corresponding 
meta-selective C–H functionalizations continue to be scarce. However, meta-
functionalized products are accessed by either exploiting the steric properties, the use of 
a hydrogen-bonding enabling linker, or the use of templates.[89,101] While the first 
approach is inherently limited in its scope, the other two methodologies suffer severe 
drawbacks regarding atom economy, caused by the necessity to introduce and remove 
the linker or template. Seminal work by Ackermann et al. revealed that ruthenium 
complexes can be employed for the meta-selective functionalization of arenes.[108] Based 
on this σ-activation strategy,[89,101] several C–H functionalization reactions have been 
disclosed by now.[109a,110b,111-112,113,196] Yet, a transformation proceeding at ambient 
temperature had remained elusive until recently.[197] By merging the ruthenium-based σ-
Results and Discussion 
89 
activation strategy with visible-light photocatalysis, this limitation might be overcome as 
will be discussed in the following chapter. 
3.4.1 Ruthenium-Catalyzed meta-C–H Difluoromethylation 
As the starting point for the investigations regarding the viability of a visible light-enabled 
ruthenium-catalyzed C–H functionalization reaction, the difluoromethylation of arenes 
(Scheme 3.15) previously reported by Ackermann was selected.[112a] 
 
Scheme 3.15: Ruthenium-catalyzed difluoromethylation as reported by Ackermann. 
Given the comparatively low reaction temperature and reports describing the feasibility 
of the C–H cycloruthenation step at ambient temperature,[198] it was expected that an 
intermediate ruthenacycle could be formed. Subsequent reaction of this ruthenacycle 
with a photochemically generated difluoroalkyl radical would further drive the reaction. 
This hypothesis was additionally backed by reports disclosing the use of difluoro 
bromoacetate (100) in photochemical protocols.[199] Thus, initial optimization revealed 
that small amounts of the desired product could be obtained under the probed reaction 
conditions (Table 3.21).  
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Table 3.21: Initial experiments regarding the visible-light-induced ruthenium-catalyzed C–H 
difluoromethylation.a 
 
Entry [Ru] Photocatalyst Additive Base Yield [%] 
1 [Ru(OAc)2(p-cymene)] -- PPh3 K2CO3 8 
2 [Ru(OAc)2(p-cymene)] Ir(ppy)3 PPh3 K2CO3 7 
3 [Ru(OAc)2(p-cymene)] Ru(bpy)3Cl2·6 H2O PPh3 K2CO3 11 
4 [Ru(OAc)2(p-cymene)] Ir(ppy)3 i-PrNEt2 Na2CO3 3 
5 [Ru(OAc)2(p-cymene)] Ir(ppy)3 NEt3 Na2CO3 -- 
6 [Ru(OAc)2(p-cymene)] Ru(bpy)3Cl2·6 H2O i-PrNEt2 Na2CO3 traces 
7 [Ru(O2CMes)2(p-cymene)] -- PPh3 K2CO3 4 
8 [Ru(O2CMes)2(p-cymene)] Ir(ppy)3 PPh3 K2CO3 5 
9 [Ru(O2CMes)2(p-cymene)] Ru(bpy)3Cl2·6 H2O PPh3 K2CO3 2 
a Reaction conditions: 35a (0.30 mmol), 100 (0.90 mmol), [Ru] (10.0 mol %), additive (20.0 mol %), 
photocatalyst (2.00 mol %), base (0.60 mmol), 1,4-dioxane (1.5 mL), 25–30 °C, 16 h. Yield by 19F-
NMR with 2-chloro-4-fluorotoluene as internal standard.  
While the initially probed conditions confirmed that the proposed difluoromethylation 
reaction was indeed possible, no distinct correlation was observed during these 
preliminary studies. Both investigated ruthenium carboxylate complexes, 
[Ru(OAc)2(p-cymene)] and [Ru(O2CMes)2(p-cymene)] delivered the product 185a in 
comparable yields (entries 1–6 and 7–9). Yet, a clear influence of the remaining factors, 
namely the photocatalyst and additive could not be recognized. Therefore, the additive 
was omitted in the following, more detailed investigations (Table 3.22). 
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Table 3.22: Investigations regarding the influence of the ruthenium- and photocatalyst.a 
 
Entry [Ru] Photocatalyst Base Yield [%] 
1 [Ru(OAc)2(p-cymene)] Ir(ppy)3 Na2CO3 40 (36) 
2 [Ru(OAc)2(p-cymene)] Ir(ppy)3 Na2CO3 traces
b 
3 [Ru(OAc)2(p-cymene)] -- Na2CO3 2 
4 [Ru(OAc)2(p-cymene)] -- Na2CO3 5
c 
5 -- Ir(ppy)3 Na2CO3 1 
6 [Ru(O2CMes)2(p-cymene)] Ir(ppy)3 Na2CO3 2 
7 [Ru(OAc)2(PPh3)2] Ir(ppy)3 Na2CO3 12 
8 [Ru(O2CAd)2(PPh3)2] Ir(ppy)3 Na2CO3 7 
9 [RuCl2(PPh3)2] Ir(ppy)3 Na2CO3 2 
10 [Ru(MeCN)6](BF4)2 Ir(ppy)3 Na2CO3 5 
11 RuCl3·x H2O  Ir(ppy)3 Na2CO3 13 
12 [RuCl2(p-cymene)]2  Ir(ppy)3 Na2CO3 16 
13 [Ru(OAc)2(p-cymene)] Ir(ppy)3 Na2CO3 32
d 
14 [Ru(OAc)2(p-cymene)] Ru(bpy)3Cl2·6 H2O Na2CO3 3 
15 [Ru(OAc)2(p-cymene)] Ru(bpy)3Cl2·6 H2O K2CO3 7 
16 [Ru(OAc)2(p-cymene)] Ir(ppy)3 Na2CO3 41
e 
a Reaction conditions: 35a (0.30 mmol), 100 (0.90 mmol), [Ru] (10.0 mol %), photocatalyst 
(2.00 mol %), base (0.60 mmol), 25–30 °C, 1,4-dioxane (1.5 mL), 16 h. Yield by 19F-NMR with 
2-chloro-4-fluorotoluene as internal standard, yield of isolated product in brackets. b No light. 
c 60 °C. d 100 (1.50 mmol). e Two Kessil A-A360N. 
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With [Ru(OAc)2(p-cymene)] along with Ir(ppy)3 as photocatalyst, and Na2CO3 as base the 
desired product 185a could be isolated in 36% yield (entry 1). Control experiments 
revealed the essential nature of the light irradiation (entry 2), the photocatalyst (entries 
3 and 4) and the ruthenium complex (entry 5) and. In addition, even at a reaction 
temperature of 60 °C no significant product formation was observed (entry 4). Other 
ruthenium complexes proved to be inferior to the initially employed 
[Ru(OAc)2(p-cymene)] complex (entries 6–12). Furthermore Ir(ppy)3 showed a 
significantly higher catalytic efficacy than the commonly used Ru(bpy)32+ photocatalyst 
(entries 14 and 15). Lastly, a larger excess of 100 (entry 13) or an increase in the irradiation 
intensity (entry 16) did not improve the outcome of the reaction. Furthermore, the 
influence of the solvent and base was investigated (Table 3.23). 
Table 3.23: Influence of the solvent and base on the ruthenium-catalyzed difluoromethylation.a 
 
Entry Solvent Base Yield [%] 
1 DMF Na2CO3 6 
2 DCE Na2CO3 10 
3 MeCN Na2CO3 9 
4 DCM Na2CO3 11 
5 o-xylene Na2CO3 34 
6 m-xylene Na2CO3 traces 
7 t-BuPh Na2CO3 7 
8 1,4-dioxane/MeCN (2:1) Na2CO3 12 
9 1,4-dioxane/MeCN (4:1) Na2CO3 11 
10 1,4-dioxane NaOAc 5 
11 1,4-dioxane KOAc 2 
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Entry Solvent Base Yield [%] 
12 1,4-dioxane K2CO3 13 
13 1,4-dioxane Cs2CO3 2 
14 1,4-dioxane K2HPO4 13 
15 1,4-dioxane NaHCO3 7 
16 1,4-dioxane 2,4,6-collidine -- 
17 1,4-dioxane DABCO 2 
a Reaction conditions: 35a (0.30 mmol), 100 (0.90 mmol), [Ru(OAc)2(p-cymene)] (10.0 mol %), 
Ir(ppy)3 (2.00 mol %), base (0.60 mmol), solvent (1.5 mL), 16 h. Yield by 19F-NMR with 2-chloro-4-
fluorotoluene as internal standard. 
Among the investigated solvents (entries 1–9), only o-xylene delivered comparable results 
(entry 5) while most of the solvents were ineffective in promoting the reaction. The same 
result was obtained when different bases were probed (entries 10–17). In conclusion, the 
combination of Na2CO3 and 1,4-dioxane proved to be ideal for this transformation. 
Finally, the influence of different photoredox catalysts was investigated (Table 3.24). 
Among the probed photoredox catalysts only the derivatives of Ir(ppy)3 were competent 
in promoting the reaction. Alkyl substituted 176 and 177 (entries 1 and 2) showed a 
slightly higher catalytic efficiency than the fluoro-substituted derivatives 178 and 179 
(entries 3 and 4). The more electron-withdrawing phenylpyridine ligands in 180 and 186 
further had a detrimental effect on the performance of the photocatalyst (entries 5 and 
6). Unfortunately, the employed organic photoredox catalysts failed to promote the 
reaction (entries 8–10). Furthermore, the copper(I)-based photocatalysts were also not 
competent to catalyze the reaction (entries 11 and 12).  
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Table 3.24: Influence of the photocatalyst on the visible light-enabled ruthenium-catalyzed 
C–H difluoromethylation. 
 
Entry Photocatalyst Yield [%] 
1 176 (2.00 mol %) 23 
2 177 (2.00 mol %) 26 
3 178 (2.00 mol %) 12 
4 179 (2.00 mol %) 6 
5 180 (2.00 mol %) 4 
6 186 (2.00 mol %) traces 
7 187 (2.00 mol %) 8 
8 4-CzPN (2.00 mol %) -- 
9 Rhodamine 6G (5.00 mol %) -- 
10 Rose Bengal (5.00 mol %) -- 
11 [Cu(Me-phen)2]Cl (5.00 mol %) -- 
12 [Cu(dap)2]Cl (5.00 mol %) 3 
a Reaction conditions: 35a (0.30 mmol), 100 (0.90 mmol), [Ru(OAc)2(p-cymene)] (10.0 mol %), 
photocatalyst (X mol %), Na2CO3 (0.60 mmol), 1,4-dioxane (1.5 mL), 25–30 °C, 16 h. Yield by 
19F-NMR with 2-chloro-4-fluorotoluene as internal standard. 
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Since no synthetically meaningful yields could be obtained, the optimization was not 
further pursued at this point. Nevertheless, preliminary mechanistic experiments were 
conducted to gain insights into the underlying mechanism. To this end, fluorescence 
quenching experiments with Ir(ppy)3 indicated that the excited state of Ir(ppy)3 can be 
quenched by ethyl bromodifluoroacetate (100), suggesting an oxidative quenching 
scenario to be operative in the investigated reaction (Figure 3.8). 
 
 
Figure 3.8: Fluorescence quenching of Ir(ppy)3 with ethyl dibromofluoroacetate (100). 
One explanation for the poor performance of the ruthenium-catalyzed C–H 
difluoromethylation could be a rapid deactivation of the photocatalyst. A possible 
pathway for catalyst deactivation is the difluoroalkylation of the phenylpyridine ligands 
on the iridium center. This additional functionalization would most likely affect the 
catalyst’s redox potential and thereby might render it inactive. This proposed deactivation 
pathway has been recently investigated by Stephenson and coworkers.[200] An alternative 
scenario, that would result in the same outcome, is a ligand exchange at the iridium(III) 
center. Upon product formation, the alkylated product would exchange one or more of 
the coordinated phenylpyridine moieties and thereby induce catalyst deactivation.  
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3.4.2 Ruthenium-Catalyzed meta-C–H Alkylation 
3.4.2.1 Optimization 
After the initial investigation regarding the activated difluoro bromoacetate (100), further 
studies by Dr. P. Gandeepan revealed that unactivated secondary alkyl bromides 93 could 
deliver the corresponding meta-alkylated phenylpyridines 94 under blue light irradiation, 
yet at temperatures in the 60 °C range. Unfortunately, when the reaction temperature 
was decreased to ambient temperature, considerably lower yields of the products were 
obtained.  
Thus, it was probed whether tertiary alkyl bromides 95 could actually provide the meta-
alkylation products 96 at room temperature. To this end, several conditions, including 
parameters such as solvent (Table 3.25), base (Table 3.26) and transition metal (Table 
3.27) were investigated.  
Table 3.25: Influence of the solvent on the meta-C–H alkylation with 95a.a 
 
Entry Solvent Yield [%] 
1 1,4-dioxane 80 
2 DME 70 
3 THF 61 
4 DMA  79 
5 DCE -- 
6 DMF 21 
7 MeCN traces 
8 PhMe  -- 
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Entry Solvent Yield [%] 
9 m-xylene  -- 
10 tBuPh  -- 
a Reaction conditions: 35a (0.40 mmol), 95a (1.20 mmol), [RuCl2(p-cymene)]2 (5.00 mol %), 
(C6H5O)2P(O)OH (30.0 mol %), K2CO3 (0.80 mmol), solvent (2.0 mL), 25–30 °C, 24 h, yield of isolated 
product.  
Probing a set of various solvents revealed that ethereal solvents were best suited for the 
reaction (entries 1–3). In addition, among the other probed solvents only DMA delivered 
comparable results (entry 4). Other prominently used solvents, such as DMF, MeCN, or 
the chlorinated solvent DCE were also ineffective for the meta-C–H alkylation (entries 5–
7). Furthermore, aromatic solvents were also not suitable (entries 8–10).  
Next, a range of bases, commonly used in ruthenium-catalyzed meta-C–H 
functionalization reactions, was investigated in the tertiary C–H alkylation (Table 3.26). 
Table 3.26: Influence of the base on the meta-C–H alkylation with 95a.a 
 
Entry Base Yield [%] 
1 -- -- 
2 K2CO3 80 
3 Na2CO3 47 
4 KOAc  19 
5 NaOAc 30 
6 K3PO4 70 
a Reaction conditions: 35a (0.40 mmol), 95a (1.20 mmol), [RuCl2(p-cymene)]2 (5.00 mol %), 
(C6H5O)2P(O)OH (30 mol %), base (0.80 mmol), 1,4-dioxane (2.0 mL), 25–30 °C, 24 h, yield of 
isolated product.  
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While the presence of a base proved essential for the transformation to proceed (entry 
1), a range of bases could be employed. Potassium carbonate proved ideal (entry 2), but 
the reaction with sodium carbonate also delivered the corresponding product in 47% yield 
(entry 3). In contrast, the corresponding acetates delivered the product in considerably 
lower yields (entries 4-5). Potassium phosphate showed a similar effectiveness as 
potassium carbonate (entry 6).  
Furthermore, the influence of the transition metal catalyst was investigated. To this end, 
a range of different ruthenium complexes and other prominent transition metal catalysts 
was probed in the visible light-induced meta-C–H alkylation (Table 3.27) 
Table 3.27: Influence of the transition metal catalyst on the meta C–H alkylation with 95a.a 
 
Entry Catalyst Yield [%] 
1 [RuCl2(p-cymene)]2 (5.00 mol %) 80 
2 [Ru(OAc)2(p-cymene)] (10.0 mol %) 35
b 
3 [Ru(O2CMes)2(p-cymene)] (10.0 mol %) 18
b 
4 [Ru(NCtBu)6][PF6]2 (10.0 mol %) -- 
5 [Ru2Cl3(p-cymene)2][PF6] (5.00 mol %) 83 
6 Pd(OAc)2 (10.0 mol %) -- 
7 [Cp*RhCl2]2 (10.0 mol %) -- 
8 [Cp*IrCl2]2 (10.0 mol %) -- 
a Reaction conditions: 35a (0.40 mmol), 95a (1.20 mmol), catalyst, (C6H5O)2P(O)OH (30.0 mol %), 
K2CO3 (0.80 mmol), 1,4-dioxane (2.0 mL), 25–30 °C, 24 h, yield of isolated product. b Yield by 1H-
NMR with CH2Br2 as internal standard. 
The [Ru(OAc)2(p-cymene)] or [Ru(O2CMes)2(p-cymene)] complexes showed significantly 
lower activities in comparison to [RuCl2(p-cymene)]2 (entries 1–3). The cationic 
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[Ru(NCtBu)6][PF6]2 nitrile complex did not give any reactivity (entry 4). In contrast, the 
cationic [Ru2Cl3(p-cymene)2][PF6] complex showed similar activity to the dimeric 
[RuCl2(p-cymene)]2 complex (entry 5). Interestingly, palladium-, rhodium- and iridium-
based catalysts all failed to deliver the desired product 96aa (entries 6–8), thus 
highlighting the unique power of the employed ruthenium catalysts.  
Furthermore, the influence of an additional photocatalyst was investigated by Dr. P. 
Gandeepan, yet improved results were not obtained.[197a] At last, a series of control 
experiments was conducted to further investigate the influence of each reaction 
parameter (Table 3.28). 
Table 3.28: Control experiments.a 
 
Entry Deviation from standard conditions Yield [%] 
1 none 80 
2 20 h instead of 24 h 76 
3 16 h instead of 24 h 74 
4 no [RuCl2(p-cymene)]2 -- 
5 no light  -- 
6 no light, but 40 °C  -- 
7 no light, but 60 °C -- 
8 no light, but 80 °C  -- 
9 no ligand  24 
10 PPh3 (30.0 mol %) instead of (C6H5O)2P(O)OH trace  
aReaction conditions: 35a (0.40 mmol), 95a (1.20 mmol), [RuCl2(p-cymene)]2 (5.00 mol %), 
(C6H5O)2P(O)OH (30.0 mol %), K2CO3 (0.80 mmol), 1,4-dioxane (2.0 mL), 25–30 °C, 24 h, yield of 
isolated product.  
A reduction of the reaction time led to slightly reduced yields (entries 2 and 3). 
Importantly, the meta-C–H alkylation did not proceed in the absence of the ruthenium 
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catalyst (entry 4). The same result was obtained when the reaction was conducted in the 
dark (entry 5), even if the temperature was stepwise increased to 80 °C (entries 6–8). 
While the transformation proceeded in the absence of an additional ligand (entry 9), 
triphenyl phosphine completely diminished the catalytic efficiency (entry 10). The 
conducted control experiments provided strong support for the proposed light-
dependent nature of the transformation as no conversion could be achieved in the 
absence of light, even at significantly elevated temperatures.  
Finally, the performance of different directing groups was explored under the established 
conditions (Scheme 3.16). Pyrazole 189a was obtained in a satisfying yield, given that the 
temperature was raised to 60 °C. Under otherwise identical conditions, pyrimidine 191a 
could only be isolated in low yield, while imidazole 188a and triazole 190a were not 
obtained. In regard to further late-stage functionalizations of the obtained products, the 
reaction yielding pyrazole 189a is of high significance, since the pyrazole ring can be 
readily converted to the valuable amino group.[201] 
 
Scheme 3.16: Competence of diverse directing groups in the visible-light-driven ruthenium-
catalyzed meta-C–H alkylation. Reaction conditions: 147 (0.40 mmol), 95a (1.20 mmol), 
[RuCl2(p-cymene)]2 (5.00 mol %), (C6H5O)2P(O)OH (30.0 mol %), K2CO3 (0.80 mmol), 1,4-dioxane 
(2.0 mL), 24 h, yield of isolated product. 
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3.4.2.2 Substrate Scope 
With the optimized reaction conditions established through thorough investigations, the 
scope of the visible-light-promoted ruthenium-catalyzed meta-C–H alkylation was 
investigated. To this end, a variety of tertiary alkyl bromides 95 was subjected to the 
previously determined reaction conditions (Table 3.29).  
Table 3.29. Scope of the ruthenium-catalyzed meta-selective C–H alkylation with alkyl bromides 
95.a 
 
Entry Alkyl bromide  Product  Yield [%] 
1  
 
80 
95a 96aa 
2  
 
63 
95b 96ab 
3  
 
82 
95c 96ac 
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Entry Alkyl bromide  Product  Yield [%] 
4  
 
71 
95d 96ad 
5  
 
82 
95e 96ae 
6  
 
80 
95f 96af 
7 
 
 
25b 
95g 96ag 
a Reaction conditions: 35a (0.40 mmol), 95 (1.20 mmol), [RuCl2(p-cymene)]2 (5.00 mol %), 
(C6H5O)2P(O)OH (30.0 mol %), K2CO3 (0.80 mmol), 1,4-dioxane (2.0 mL), 25–30 °C, 24 h, yield of 
isolated product. b 48 h. 
Most of the probed alkyl bromides 95 delivered the products in good to very good yields, 
comparable to the reaction with tert-butyl bromide (95a). Cyclic alkyl bromides 95b and 
95c were also well tolerated (entries 2 and 3), with the cylcopentyl-substituted bromide 
95c giving slightly better results. Furthermore, different chain lengths or an aryl 
substituent in the alkyl bromide 95f delivered the corresponding products 96ad-96af in 
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very good yields (entries 4–6). However, in case the challenging free hydroxyl group was 
present in the alkyl bromide 95g, the reaction time had to be extended to 48 h and the 
obtained yield dropped to 25% (entry 7). Yet the hydroxyl group did not suppress the 
catalytic activity completely. 
Subsequently, the effect of the different substituents on the phenylpyridines 35 was 
investigated. Thus, a range of diversely decorated phenylpyridines was probed in the 
ruthenium-catalyzed meta-selective tertiary C–H alkylation (Table 3.30).  
Table 3.30: Scope of the ruthenium-catalyzed meta-selective C–H alkylation  
with phenylpyridines 35.a 
 
Entry Phenylpyridine  Product Yield [%] 
1 
  
76 
35c 96ca 
2 
  
72 
35d 96da 
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Entry Phenylpyridine  Product Yield [%] 
3 
  
64 
35e 96ea 
4 
  
29 
35b 96ba 
5 
  
57 
35f 96fa 
6 
  
27 
35g 96ga 
7 
  
38 
35h 96ha 
a Reaction conditions: 35 (0.40 mmol), 95a (1.20 mmol), [RuCl2(p-cymene)]2 (5.00 mol %), 
(C6H5O)2P(O)OH (30.0 mol %), K2CO3 (0.80 mmol), 1,4-dioxane (2.0 mL), 25–30 °C, 24 h, yield of 
isolated product. 
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Substituents in the C-4 position of the pyridine ring were well tolerated and gave the 
corresponding products in only slightly lower yields compared to the unsubstituted 
phenylpyridine 35a (entries 1–3). Regarding the substituents on the phenyl ring, a 
significant influence of the position of the substituent was observed. While a methoxy 
group in the C-2 position of the phenyl ring was tolerated and the corresponding product 
was obtained in 57% yield (entry 5), the yield dropped drastically if a methoxy group was 
introduced in the C-4 position (entry 4). Electron-withdrawing substituents, such as 
fluorine led to significantly lowered yields when present on either the pyridine or 
phenylring (entries 6 and 7). Besides this observation, a clear trend could not be derived.  
Simultaneously, the scope of the ruthenium-catalyzed meta-selective alkylation regarding 
secondary alkyl bromides 93 and α-bromoesters was investigated by Dr. P. Gandeepan. 
With prolonged reaction times, the corresponding products were obtained in good 
yields.[197a]  
It is noteworthy that the reaction could be easily scaled to 2.00 mmol given that the 
reaction time was prolonged (Scheme 3.17).  
 
Scheme 3.17: Ruthenium-catalyzed meta-selective C–H alkylation on larger scale. 
In addition to the benign scaling properties, the protocol proved suitable for further late-
stage diversification. Thus, the pyridine product 96aa could be readily converted into the 
corresponding piperidine 192 (Scheme 3.18). Given the high prevalence of the piperidine 
moiety in natural products[202] and pharmaceutical compounds,[203] this facile late-state 
diversification further highlights the importance of the developed methodology. 
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Scheme 3.18: Reduction of phenylpyridine 96aa to piperidine 192. 
 
3.4.2.3 Mechanistic Studies and Proposed Catalytic Cycle 
After the substrate scope of the light-enabled ruthenium-catalyzed meta-selective 
alkylation had been established, the underlying mechanism of the transformation was 
investigated. To this end, a series of mechanistic experiments was conducted. 
3.4.2.3.1 Reaction in the Presence of Radical Scavengers 
To probe if the reaction proceeds under the involvement of a SET-type process several 
experiments in the presence of radical scavengers were performed (Table 3.31). The 
catalytic efficiency was completely diminished in the presence of either TEMPO or 
galvinoxyl (entries 2–3). In addition, BHT and 1,1-diphenylethylene also significantly 
reduced the obtained yield (entries 4–5). All these results are indicating that a SET-type 
process is involved in the product formation. 
Table 3.31: meta-C‒H Alkylation in the presence of typical radical scavengers. 
 
Entry Radical scavenger (10.0 mol %) Yield [%] 
1 -- 80 
2 TEMPO -- 
3 galvinoxyl free radical -- 
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Entry Radical scavenger (10.0 mol %) Yield [%] 
4 BHT 48 
5 1,1-diphenylethylene 17 
aReaction conditions: 35a (0.40 mmol), 95a (1.20 mmol), [RuCl2(p-cymene)]2 (5.00 mol %), 
(C6H5O)2P(O)OH (30.0 mol %), radical scavenger (10.0 mol %) K2CO3 (0.80 mmol), 1,4-dioxane 
(2.0 mL), 25–30 °C, 24 h, yield of isolated product. 
Yet, when 1,1-diphenylethylene was employed as radical scavenger, the corresponding 
product of the radical addition of the tert-butyl radical to the activated double bound 
could not be detected. However, when the reaction was conducted in the presence of 
TEMPO, the corresponding radical adduct 193 could be detected by ESI-HRMS (Figure 3.9). 
Furthermore, no product was detected in this measurement. This observation delivers 
further evidence for the formation of a tert-butyl radical during the meta-C–H alkylation 
reaction. 
 
Figure 3.9: ESI-HRMS spectra of a sample taken from the reaction mixture, directly after 
irradiation. 
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3.4.2.3.2 Competition Experiments Between Alkyl Bromides 
To investigate the influence of the nature of the alkyl bromide, a series of competition 
experiments was conducted.  
First, a competition experiment employing tert-butyl bromide (95a) and cycloheptyl 
bromide (93c) was conducted (Scheme 3.19). After 24 h, the reaction was stopped, and 
the mixture was analyzed by 1H-NMR spectroscopy. The experiment clearly showed that 
the tertiary alkyl bromide 95a was converted preferentially. This indicates that the 
nucleophilic character of the intermediate radical has a significant influence on the C–H 
alkylation and suggest that a more nucleophilic character of the radical is beneficial. 
 
Scheme 3.19: Competition experiment between alkyl bromides 95a and 93c. 
Interestingly, for competition experiments featuring α-bromoester 100 only trace 
amounts of the corresponding products 96aa or 94ac and 185a could be detected 
(Scheme 3.20). Although the resulting products of a possible radical-radical coupling were 
not detected, these findings might be explained by the occurrence of such a coupling 
process between the nucleophilic alkyl radicals, generated from the secondary or tertiary 
alkyl bromides, and the electrophilic radical generated through the cleavage of the C–Br 
bond of the α-bromoester 100. 
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Scheme 3.20: Competition experiments with alkyl bromides 95a/93c and α-bromoester 100. 
 
3.4.2.3.3 Effect of Visible-Light-Irradiation 
In order to further investigate the influence of the light irradiation on the meta-C–H 
alkylation, the reaction progress was monitored during several cycles of irradiation and 
stirring in the dark. At each data point indicated in Figure 3.10, the yield was determined 
by 1H-NMR spectroscopy. The obtained data clearly shows, that the transformation does 
not proceed in the absence of irradiation and thus further supports the light-dependent 
nature of the reaction. 
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Figure 3.10: Effect of visible-light irradiation on the tertiary meta-C–H alkylation. 
 
3.4.2.3.4 Reactions Using Well-Defined Ruthenium Complexes as Catalysts 
To gain further insights into the underlying mechanism of the visible-light-enabled 
ruthenium-catalyzed meta-C–H alkylation, a series of experiments employing well-
defined ruthenium complexes was conducted. First, the ruthenacycle 194 was employed 
as catalyst (Scheme 3.21). 
 
Scheme 3.21: meta-C–H alkylation using ruthenacycle 194 as catalyst. 
The experiment showed that ruthenacycle 194 was catalytically competent even in the 
absence of the phosphate ligand, yet a significantly reduced yield was obtained. A similar 
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experiment with the phosphate ligand present was conducted by Dr. P. Gandeepan and a 
nearly quantitative yield was obtained if the diphenyl phosphate was present.[197a] In 
combination, these findings suggest that the phosphate ligand has a crucial role in the 
ruthenium-catalyzed meta-C–H alkylation.  
Furthermore, experiments featuring the two cyclometalated ruthenium complexes 195 or 
196 shown in Scheme 3.22 were conducted. Both ruthenacycles showed pronounced 
catalytic activity when employed as catalyst. However, reduced yields were obtained in 
comparison to the standard reaction conditions.  
 
Scheme 3.22: meta-C–H alkylation using cyclometalated ruthenacycles 195 or 196 as catalyst. 
 
3.4.2.3.5 Fluorescence-Quenching Experiments 
Given the catalytic activity of the investigated ruthenium complexes, ruthenacycle 194 
and 196 were selected for further investigations regarding their interaction with light and 
a possible SET-type process with the alkyl bromide. To this end, several fluorescence 
quenching experiments were conducted. Complex 196 did not display any fluorescence 
quenching when tert-butyl bromide (95a) was added (Figure 3.11). In addition, similar 
experiments conducted by Dr. P. Gandeepan revealed that neither the ruthenacycle 94 
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nor the corresponding mesityl carboxylate-ruthenacycle did display any quenching 
effect.[197a] 
 
Figure 3.11: Fluorescence quenching of complex 196 with 95a. 
 
Figure 3.12: Fluorescence quenching of ruthenacycle 194 in the presence of substrate 35a 
(10.0 equiv) with 95a. 
However, a quenching effect was observed in the case of the chloro-ruthenacycle 194, 
when an excess of phenyl pyridine (35a) and sub-stoichiometric amounts of diphenyl 
phosphate were also present (Figure 3.13). In the absence of the ligand no quenching was 
detected in this case (Figure 3.12). 
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Figure 3.13: Fluorescence quenching of chloro-ruthenacycle 194 in the presence of substrate 35a 
(10 equiv) and diphenyl phosphate (30 mol %). 
Regarding the pronounced effect of the phosphate ligand observed in the reactions with 
the well-defined ruthenacycles, it is likely that an in situ formed cyclometalated ruthenium 
complex bearing a phosphate ligand is the photo-catalytically active species. Attempts to 
independently prepare such a complex failed and thus this hypothesis could not be further 
investigated.  
 
3.4.2.4 Proposed Catalytic Cycle 
Based on the conducted mechanistic studies and literature precedence, the following 
catalytic cycle is proposed (Scheme 3.23). A phosphate-assisted[34b,34c,197a] C–H 
ruthenation delivers the cyclometalated ruthenium complex 197. As indicated by UV-Vis 
experiments this complex can undergo excitation by the absorption of visible light, 
thereby generating the excited species 197*.  
The ensuing SET-process generates ruthenium(III) complex 198 and alkyl radical 199. As 
previously presented,[113,196a] the subsequent radical attack is most favorable at the 
position para to ruthenium. Accordingly, intermediate 200 is generated through the 
attack of radical 199. Next, an intramolecular SET and the successive rearomatization 
delivers ruthenacycle 202. At last, protodemetalation yields the meta-alkylated product 
96aa and regenerates the catalytically active ruthenium(II) species 203. 
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Scheme 3.23: Plausible catalytic cycle for the visible light-induced meta-C–H alkylation. 
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4 Summary and Outlook 
During the last decades C–H activation has emerged as a sustainable and powerful tool 
for the cost-efficient synthesis of APIs, crop protection agents, and functional materials.[24] 
Its benign characteristics in comparison to cross-coupling chemistry had a significant 
contribution in addressing challenging issues connected to ecological impacts and the 
declining availability of resources. Furthermore, the combination of C–H activation with 
environmentally benign transition metals and photoredox catalysis is just beginning to 
show its full potential and may further reduce the ecological impact of chemical 
transformations. 
In the first part of this thesis, the C-7 functionalization of indolines 133 by means of 
inexpensive and environmentally benign copper catalysis was investigated.[157] The 
developed catalytic system allowed for the facile chalcogenation of indolines 133 in the 
C-7 position. The versatility of the developed copper catalytic system was further 
demonstrated by the chalcogenation of indole substrates 134 in the C-2 position under 
otherwise identical conditions (Scheme 4.1). 
 
Scheme 4.1: Copper-catalyzed C–H chalcogenation of indoline 133 and indole derivatives 134. 
The protocol proved to be amenable to a broad range of indoline and indole substrates 
and the corresponding thiolation and selenylation products were obtained in good yields. 
The conducted mechanistic studies provided evidence for a reversible C–H activation step 
and the involvement of a SET-type process in the copper-catalyzed C–H chalcogenation. 
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Second, a dual cobalt photoredox system for the alkylation of azoles was devised and 
subsequently investigated. Although the protocol turned out to be limited to 1-
adamantane carboxylic acid (141) as alkyl radical precursor, the transformation displayed 
a broad scope and high functional group tolerance of azoles 14 or 140 (Scheme 4.2).[175] 
 
Scheme 4.2: Facile adamantylation by a dual cobalt photoredox catalytic system. 
Albeit with reduced yields, the catalytic system also allowed the functionalization of 
xanthine alkaloids. Ensuing detailed mechanistic studies, including fluorescence 
quenching studies, clearly underlined the light-dependent nature of the transformation 
and shed light onto the action of the employed photocatalyst.  
Considering the additional costs of external photocatalysts and the implications for the 
overall economy of the process in question, the development of protocols independent 
of additional photocatalysts is of great importance. To this end, in the course of this thesis 
the merger of C–H activation and photocatalysis was demonstrated with two unique and 
unprecedented applications.[189,197a] Previous copper-catalyzed C–H arylations as 
pioneered by Daugulis, Miura, and Ackermann required highly elevated temperatures and 
were therefore limited to some extent. By applying light irradiation an unprecedented 
mild copper-catalyzed C–H arylation could be realized.[189] Investigations regarding the 
scope of the protocol revealed its broad applicability, thus the methodology could be 
successfully applied to the synthesis of the natural product texamine (146a) and its 
derivatives (Scheme 4.3).  
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Scheme 4.3: Photo-induced copper-catalyzed arylation at ambient temperature. 
Furthermore, it was probed whether the methodology could be extended to the use of 
visible light in the absence of any external photocatalyst. To this end, an extensive 
optimization delivered proof that the C–H arylation can indeed proceed under visible light 
irradiation, yet with reduced efficacy. The employment of additional photocatalysts did 
not deliver superior results in comparison to the reaction in the absence of an additional 
photocatalyst. Additionally, preliminary mechanistic studies were conducted to gain initial 
insights into to underlying mechanism.  
Ackermann’s proposal of a radical mechanism[109] being involved in ruthenium-catalyzed 
meta-selective C–H functionalization had revolutionized the mechanistic understanding 
of these transformations. It was this proposal, which sparked the idea to utilize visible 
light to induce the key SET process. At first, the ruthenium-catalyzed 
difluoroalkylation[112a] was chosen as a model system and was thoroughly investigated. 
The obtained initial results confirmed the hypothesis that visible light could be used to 
induce ruthenium-catalyzed meta-C–H functionalizations. Further investigations focused 
on the use of secondary and tertiary alkyl halides 93 and 95 and delivered suitable 
conditions, that allowed for facile meta-C–H alkylation to proceed at ambient 
temperature.[197a] A broad range of decorated phenylpyridines 35 and tertiary alkyl 
bromides 95 proved compatible and the corresponding products were usually obtained in 
good yields (Scheme 4.4).  
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Scheme 4.4. Photo-induced ruthenium-catalyzed meta-selective C–H alkylation. 
Furthermore, the developed protocol proved applicable to other valuable biaryl 
structures and could easily be scaled without the need for additional optimization. The 
high versatility was further demonstrated by a late-stage diversification which yielded the 
corresponding piperidine. The ensuing mechanistic investigations provided valuable 
insights into the underlying mechanism of the transformation. First, monitoring of the 
conversion profile in dependence of irradiation and fluorescence quenching experiments 
provided valuable insights regarding the effect of the visible-light-irradiation. Second, 
experiments with radical scavengers further delivered strong experimental evidence for 
an underlying SET type mechanism.  
The displayed examples for the successful use of light to enable copper- and ruthenium-
catalyzed C–H functionalizations under unprecedented mild conditions highlight the 
tremendous potential of this field and it can be expected that further research in this area 
will deliver fertile results. 
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5 Experimental Section 
5.1 General Remarks 
All reactions involving reagents or products sensitive to moisture or air were performed 
under an atmosphere of nitrogen using standard Schlenk techniques and pre-dried 
glassware. If not mentioned otherwise, yields refer to isolated compounds, estimated to 
be >95% pure as determined by 1H-NMR. In case NMR yields are reported, they were 
determined using an internal standard. 
 
Vacuum 
The used Schlenk line was connected to a Vacuubrand® rotary vane pump. The following 
pressure was measured at the outlet of the used Schlenk line: 0.1 mbar. The values are 
not corrected. 
 
Melting points 
Melting points were measured using a Stuart Melting Point Apparatus SMP3 from 
BarloworldScientific. The given values are not corrected. 
 
Chromatography 
Thin layer chromatography (TLC) was performed on Merck, silica gel 60 F254 aluminum TLC 
plates. Visualization of the substances was achieved by exposure to UV light at 254 nm or 
by treatment of the plates with a chemical staining agent. Purification by column 
chromatography refers to flash column chromatography using Merck silica gel, grade 60 
(40–63 μm, 230-400 mesh ASTM) and pre-distilled solvents.  
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Gas Chromatography  
Sample analysis and reaction monitoring was performed via coupled gas chromatography-
mass spectrometry on a 7890B GC System from Agilent Technologies coupled with either 
a 5977A or a 5977B mass detector from Agilent Technologies. 
 
Nuclear Magnetic Resonance Spectroscopy (NMR) 
NMR spectra were recorded on Varian VX 300, Bruker Avance 300, Bruker Avance 400 and 
500 or Varian Inova 500 and 600 spectrometers in the solvent indicated. Chemical shifts 
are reported as δ values in ppm. 1H- and 13C-NMR spectra were referenced using the 
residual solvent signal.[204] The coupling constants J are reported in Hertz (Hz). 
 1H-NMR 13C-NMR 
CDCl3 7.26 77.16 
Abbreviations for the characterization of the signals are: s (singlet), d (doublet), t (triplet), 
q (quartet), dd (doublet of doublets), m (multiplet) and sbr (broad singlet) or analogous 
representations. For all spectra, a baseline and phase correction was performed. Mnova 
10 from Mestrelab Research was used for the processing and analysis of the spectra.  
 
Mass Spectrometry 
Electrospray ionization (ESI) and high-resolution mass spectra (HR-MS) spectra were 
recorded on either a time-of-flight mass spectrometer micrOTOF (ESI-TOF-MS) or a 
quadrupole time-of-flight maXis (ESI-QTOF-MS) spectrometer, both from Bruker Daltonic. 
 
Infrared Spectroscopy  
Infrared (IR) spectra were recorded on a Bruker Alpha-P ATR spectrometer. Liquid samples 
were measured as a film and solid samples were measured neat. The spectra were 
recorded in the range from 4000 to 400 cm⁻1. The analysis was performed using Opus 6 
from Bruker. Reported are the most significant peaks and their respective wave numbers 
(cm−1).  
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Photophysical measurements 
UV-Vis absorption spectra were measured on a JASCO V-770 spectrophotometer. 
Fluorescence spectra were recorded on a JASCO FP-8500 spectrofluorometer. 
Fluorescence spectra were recorded, if not otherwise noted, at the absorption maximum 
of the analyte, which was determined beforehand by UV-Vis spectroscopy. The analyte 
solutions were degassed by sparging with N2 prior to the measurements. 
Solvents 
Solvents used for column chromatography were purified by distillation under reduced 
pressure prior to use. Solvents used in reactions involving compounds sensitive to either 
air or moisture were dried, distilled and stored under inert atmosphere (argon or 
nitrogen) according to following standard procedures.[205] 
Solvents purified by a solvent purification system (SPS-800) from M. Braun: 
dichloromethane, toluene, diethyl ether, tetrahydrofuran, and dimethylformamide. 
Solvents dried and distilled over sodium with benzophenone as an indicator: toluene, 
xylenes, mesitylene, 1,4-dioxane, di-n-butyl ether, and dimethoxyethane. 
Solvents dried and distilled over CaH2: 1,2-dichloroethane, dimethylacetamide, dimethyl-
formamide, dimethylsulfoxide. 
Solvents dried over molecular sieves and degassed by freeze-pump-thaw cycles: 
acetonitrile (3 Å). 
Water was degassed by sparging with N2 and simultaneous sonification for 2 h.  
 
Light sources and experimental setups 
Reactions involving UV-light were performed in a Luzchem LZC-ICH2 photoreactor 
equipped with 16 UVC germicidal lamps (8 Watt, λmax = 254 nm). The LZC-ICH2 
photoreactor’s temperature control unit ensured, that the reactions could be performed 
in a temperature range close to ambient temperature. Reactions using blue light 
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irradiation were performed, if not noted otherwise, with Kessil A360N lamps. To ensure 
sufficient cooling and temperature control of the reaction setup, additional fans were 
applied. To further exclude thermal reactions, the temperature of the reaction mixtures 
was monitored once with a temperature probe connected to a multimeter (Voltcraft 
VC-960). The temperature of the reaction solution was measured and recorded every 30 s 
during the reaction (Figure 5.1, Figure 5.2 and Figure 5.3).  
 
Reagents 
Chemicals obtained from commercial suppliers (with a purity >95%) were used without 
further purification. The following compounds have been previously reported and were 
synthesized according to previously described literature protocols:  
N-Pyrimidyl indolines 133,[206] N-pyrimidyl indoles 134,[149a] carbazole 155a,[78] disulfides 
59,[207] diselenide 63b,[208] benzoxazoles 14,[209] [Co(dmgH)(dmgH2)Cl2] (139a),[210] 
tetrabutylammonium adamantanecarboxylate (167),[178] triazole 27b,[211] Ir-complex 
177,[212] Ir-complex 176,[213] dap-ligand,[214] [Cu(dap)2Cl],[215] phenyl pyridines 35,[109a,216] 
alkyl bromides 95,[217] [Ru2Cl3(p-cymene)][PF6].[218]  
 
The following chemicals were kindly supplied by the following coworkers: 
Karsten Rauch: [RuCl2(p-cymene)]2, [Cp*RhCl2]2, [Ru(O2CMes)2(p-cymene)], 
[Cp*IrCl2]2, [Ru(OAc)2(p-cymene)], [Ru(O2CAd)2(p-cymene)] 
Thomas Müller: disulfide 56d, purine derivative 163 
Nils Imse: benzothiazoles 140b-140j 
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5.2 General Procedures 
5.2.1 General Procedure A: Copper-Catalyzed C–H Chalcogenation 
To an oven-dried Schlenk tube were added indoline 133 or indole 134 (0.30 mmol, 
1.00 equiv), disulfide 59 or diselenide 63 (0.30 mmol, 1.00 equiv), and Cu(OAc)2H2O 
(12.0 mg, 20.0 mol %) under ambient conditions. Mesitylene (1.5 mL) was added and the 
mixture was stirred for 20 h at 140 °C. After cooling to ambient temperature, the reaction 
mixture was diluted with Et2O (10 mL) and filtered through a short pad of silica. The filtrate 
was concentrated, and the crude residue was purified by column chromatography on 
silica gel (n-pentane/Et2O) affording the corresponding products 72, 135, 137 or 138. 
5.2.2 General Procedure B: Visible Light-Induced Decarboxylative C–H Adamantylation 
To an oven-dried 10 mL vial were added the heteroarene 14, 140, 162 or 163 (0.40 mmol, 
1.00 equiv), 1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol, 3.00 equiv), K2HPO4 
(209 mg, 1.20 mmol, 3.00 equiv), 9-mesityl-10-methylacridinium perchlorate (161) 
(8.20 mg, 5.00 mol %) and [Co(dmgH)(dmgH2)Cl2] (139a) (11.6 mg, 8.00 mol %). After the 
vial was capped with a septum, it was evacuated and refilled with N2 for three times 
before DCE (1.5 mL) and H2O (0.5 mL) were added sequentially. If the heterocyclic 
substrate was a liquid, it was added at this point. The mixture was degassed and stirred 
for 24 h under visible light irradiation (Kessil A360N, Figure 5.1). After 24 h or 48 h, the 
mixture was diluted with CH2Cl2 (10 mL) and H2O (10 mL) and the layers were separated. 
The aqueous layer was extracted with CH2Cl2 (2 x 10 mL), the combined organic layers 
were dried over Na2SO4 and the solvent was removed under reduced pressure. The 
residue was purified by column chromatography on silica gel (n-pentane/Et2O) affording 
the corresponding products 142, 143, 164 or 165. 
Experimental Section 
124 
 
Figure 5.1: Internal temperature in the vial recorded during the reaction and experimental setup. 
 
5.2.3 General Procedure C: Photo-Induced Copper-Catalyzed C–H Arylation 
To an oven-dried 10 mL quartz tube heterocycle 14, 140, or 144 (0.25 mmol), iodoarene 
11 (1.25 mmol), copper(I) iodide (9.50 mg, 20.0 mol %), dimethylglycine (7.70 mg, 
30.0 mol %), LiOtBu (60.0 mg, 0.75 mmol), and Et2O (1.0 mL) were added under ambient 
atmosphere. The tube was capped with a septum and wrapped with Parafilm and stirred 
under 254 nm irradiation for 16 h (Luzchem LZC-ICH2 photoreactor, the temperature was 
maintained between 25 °C and 30 °C, Figure 5.2). After the indicated reaction time, the 
mixture was filtered over a short pad of silica (Et2O) and the solvent was removed under 
reduced pressure. The residue was purified by column chromatography on silica gel 
(n-pentane/Et2O) affording the corresponding products 15, 145, or 146. 
Figure 5.2: Internal temperature in the quartz tube recorded during the reaction. 
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5.2.4 General Procedure D: Visible Light-Enabled Ruthenium-Catalyzed 
meta-C–H Alkylation 
To an oven-dried 10 mL vial were added [RuCl2(p-cymene)]2 (12.2 mg, 5.00 mol %), 
diphenyl phosphate (30.0 mg, 30.0 mol %) and K2CO3 (111 mg, 0.80 mmol, 2.00 equiv). 
The vial was capped with a septum and wrapped with Parafilm. After the vial was 
evacuated and backfilled with N2 three times, 1,4-dioxane (2.0 mL) was added via syringe. 
Substrate 35 (0.40 mmol, 1.00 equiv) and alkyl bromide 95 (1.20 mmol, 3.00 equiv) were 
added sequentially and the reaction mixture was degassed. Finally, the puncture hole in 
the septum was sealed with electric tape. The reaction mixture was stirred for 24 h under 
visible light irradiation (2 x Kessil A360N, temperature was maintained between 25 °C and 
30 °C, Figure 5.3). After the indicated reaction time, the mixture was filtered over a short 
pad of silica (Et2O) and the solvent was removed under reduced pressure. The residue was 
purified by column chromatography on silica gel (n-pentane/Et2O) affording the 
corresponding products 96. 
Figure 5.3: Internal temperature in the vial recorded during the reaction and experimental setup. 
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5.3 Copper-Catalyzed C–H Chalcogenation 
5.3.1 Synthesis and Characterization of Starting Materials 
 
1-(Pyrimidin-2-yl)-1,2,3,4-tetrahydroquinoline (156a) 
Tetrahydroquinoline 156a was prepared according to a previously described 
procedure.[206] 1,2,3,4-Tetrahydroquinoline (666 mg, 5.00 mmol, 1.00 equiv) and 2-
chloropyrimidine (573 mg, 5.00 mmol, 1.00 equiv) were dissolved in a mixture of EtOH 
and H2O (4:1, 50 mL). At ambient temperature conc. HCl (1.0 mL) was added dropwise via 
syringe. After the addition, the solution was stirred for 16 h at 85 °C. The solution was 
concentrated under reduced pressure. To the residue H2O (20 mL) was added and the 
mixture was extracted with CH2Cl2 (3 x 50 mL). The combined organic phases were dried 
over Na2SO4 and the solvent was removed under reduced pressure. Purification of the 
residue by column chromatography yielded the desired product 156a (74.0 mg, 350 μmol, 
7%) as a yellow oil.  
1H-NMR (300 MHz, CDCl3): δ = 8.41 (d, J = 4.8 Hz, 2H), 7.74 (ddd, J = 8.2, 1.3, 0.5 Hz, 1H), 
7.21–7.11 (m, 2H), 7.04–6.97 (m, 1H), 6.66 (t, J = 4.8 Hz, 1H), 4.03 (t, J = 6.3 Hz, 2H), 2.80 
(t, J = 6.5 Hz, 2H), 2.02 (tt, J = 6.3, 6.5 Hz, 2H). 13C-NMR (76 MHz, CDCl3): δ = 161.3 (Cq), 
157.8 (CH), 139.6 (Cq), 131.1 (Cq), 128.7(CH), 125.6 (CH), 124.1 (CH), 123.4 (CH), 112.1 
(CH), 45.5 (CH2), 27.6 (CH2), 24.2 (CH2). IR (ATR): 1574, 1548, 1490, 1412, 1308, 1269, 
1209, 1185, 796, 752 cm⁻1. MS (ESI) m/z (relative intensity): 212 [M+H]+ (100), 176 (20). 
HR-MS (ESI): m/z calcd for C13H14N3+ [M+H]+ 212.1182, found 212.1175 
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5.3.2 Analytical Data 
 
7-(Phenylthio)-1-(pyrimidin-2-yl)-1H-indole (135aa) 
The general procedure A was followed using indoline 133a (59.2 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 135aa (61.0 mg, 200 μmol, 66%) as a pale yellow solid.  
M. p.: 130–131 °C. 1H-NMR (500 MHz, CDCl3): δ = 8.44 (d, J = 4.7 Hz, 2H), 7.29–7.02 (m, 
7H), 6.90 (dd, J = 8.0, 7.1 Hz, 1H), 6.72 (t, J = 4.8 Hz, 1H), 4.46 (t, J = 7.9 Hz, 2H), 3.14 (t, J = 
7.9 Hz, 2H). 13C-NMR (126 MHz, CDCl3): δ = 160.9 (Cq), 157.4 (CH), 144.0 (Cq), 138.4 (Cq), 
134.9 (Cq), 131.7 (CH), 131.3 (CH), 128.9 (CH), 126.7 (CH), 126.1 (Cq), 124.4 (CH), 123.2 
(CH), 113.0 (CH), 52.5 (CH2), 29.8 (CH2). IR (ATR): 1574, 1551, 1452, 1423, 1379, 800, 771, 
748, 724, 690 cm⁻1. MS (ESI) m/z (relative intensity): 328 [M+Na]+ (60) 306 [M+H]+ (100), 
197 [M–SPh]+ (50). HR-MS (ESI): m/z calcd for C18H16N3S+ [M+H]+ 306.1060, found 
306.1059. The analytical data are in accordance with those reported in the literature.[206] 
 
 
1-(Pyrimidin-2-yl)-7-(p-tolylthio)indoline (135ab) 
The general procedure A was followed using indoline 135a (59.2 mg, 0.30 mmol) and 
disulfide 59b (73.9 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 135ab (60.0 mg, 188 μmol, 63%) as a pale yellow solid.  
M. p.: 117–119 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.46 (d, J = 4.7 Hz, 2H), 7.21 (d, 
J =  8.1 Hz, 2H), 7.10–7.00 (m, 4H), 6.88 (dd, J = 8.0, 7.2 Hz, 1H), 6.72 (t, J = 4.8 Hz, 1H), 
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4.47 (t, J = 7.9 Hz, 2H), 3.14 (t, J = 7.9 Hz, 2H), 2.30 (s, 3H). 13C-NMR (76 MHz, CDCl3): δ = 
160.9 (Cq), 157.4 (CH), 143.5 (Cq), 137.0 (Cq), 134.7 (Cq), 134.4 (Cq), 132.2 (CH), 131.0 (CH), 
129.7 (CH), 127.2 (Cq), 124.3 (CH), 122.7 (CH), 112.9 (CH), 52.5 (CH2), 29.8 (CH2), 21.2 (CH3). 
IR (ATR): 1574, 1549, 1418, 1278, 794, 768, 725, 615, 529, 488 cm⁻1. MS (ESI) m/z (relative 
intensity): 320 [M+H]+ (100), 197 (M–STol] + (46). HR-MS (ESI): m/z calcd for C19H18N3S+ 
[M+H]+ 320.1216, found 320.1217. The analytical data are in accordance with those 
reported in the literature.[206] 
 
 
7-[(4-Chlorophenyl)thio]-1-(pyrimidin-2-yl)indoline (135ac) 
The general procedure A was followed using indoline 133a (59.2 mg, 0.30 mmol) and 
disulfide 59c (86.2 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 135ac (40.3 mg, 119 μmol, 40%) as a white solid. 
M. p.: 123–124 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.43 (d, J = 4.8 Hz, 2H), 7.21–7.04 (m, 
6H), 6.91 (dd, J = 8.0, 7.2 Hz, 1H), 6.73 (t, J = 4.8 Hz, 1H), 4.46 (t, J = 7.9 Hz, 2H), 3.15 (t, J = 
7.9 Hz, 2H). 13C-NMR (76 MHz, CDCl3): δ = 160.9 (Cq), 157.5 (CH), 144.2 (Cq), 137.3 (Cq), 
135.0 (Cq), 132.6 (Cq), 132.4 (CH), 131.8 (CH), 129.0 (CH), 125.7 (Cq), 124.5 (CH), 123.5 
(CH), 113.1 (CH), 52.4 (CH2), 29.8 (CH2). IR (ATR): 1574, 1551, 1420, 1090, 1011, 905, 816, 
795, 770, 725 cm⁻1. MS (ESI) m/z (relative intensity): 340 [M+H]+ (100) (35Cl), 197 [M–
SC6H4Cl]+ (51). HR-MS (ESI): m/z calcd for C18H15N335ClS+ [M+H]+ 340.0670, found 
340.0666. The analytical data are in accordance with those reported in the literature.[206] 
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7-[(4-Bromophenyl)thio]-1-(pyrimidin-2-yl)indoline (135ad) 
The general procedure A was followed using indoline 133a (59.2 mg, 0.30 mmol) and 
disulfide 59d (136 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 135ad (59.1 mg, 154 μmol, 51%) as a pale yellow solid. 
M. p.: 95–97 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.43 (d, J = 4.8 Hz, 2H), 7.36–7.27 (m, 2H), 
7.17–7.04 (m, 4H), 6.92 (dd, J = 8.0, 7.2 Hz, 1H), 6.73 (t, J = 4.8 Hz, 1H), 4.46 (t, J = 7.9 Hz, 
2H), 3.15 (t, J = 7.9 Hz, 2H). 13C-NMR (76 MHz, CDCl3): δ = 160.9 (Cq), 157.5 (CH), 144.3 
(Cq), 138.1 (Cq), 135.0 (Cq), 132.5 (CH), 131.9 (CH), 131.9 (CH), 125.4 (Cq), 124.5 (CH), 123.6 
(CH), 120.5 (Cq), 113.1 (CH), 52.4 (CH2), 29.8 (CH2). IR (ATR): 1574, 1549, 1417, 1378, 1083, 
1005, 810, 794, 768, 727 cm⁻1. MS (ESI) m/z (relative intensity): 384 [M+H]+ (100) (79Br), 
197 [M–SC6H4Br]+ (54). HR-MS (ESI): m/z calcd for C18H15N379BrS+ [M+H]+ 384.0165, found 
384.0158. The analytical data are in accordance with those reported in the literature.[206] 
 
 
2-Methyl-7-(phenylthio)-1-(pyrimidin-2-yl)indoline (135ba) 
The general procedure A was followed using indoline 133b (63.4 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 135ba (68.6 mg, 215 μmol, 72%) as an off-white solid. 
M. p.: 123–124 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.42 (d, J = 4.8 Hz, 2H), 7.23–7.09 (m, 
7H), 6.92 (dd, J = 7.9, 7.3 Hz, 1H), 6.70 (t, J = 4.8 Hz, 1H), 5.03–4.92 (m, 1H), 3.52 
(dd, J = 15.2, 8.6 Hz, 1H), 2.58 (d, J = 15.2 Hz, 1H), 1.45 (d, J = 6.5 Hz, 3H). 13C-NMR 
(101 MHz, CDCl3): δ = 160.5 (Cq), 157.4 (CH), 143.0 (Cq), 138.8 (Cq), 133.7 (Cq), 132.3 (CH), 
131.0 (CH), 128.8 (CH), 126.5 (CH), 126.4 (Cq), 124.4 (CH), 124.0 (CH), 113.0 (CH), 59.9 
(CH), 37.1 (CH2), 21.5 (CH3). IR (ATR): 1577, 1550, 1459, 1425, 794, 764, 742, 728, 701, 
685 cm⁻1. MS (ESI) m/z (relative intensity): 342 [M+Na]+ (70), 320 [M+H]+ (100) 211 [M–
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SPh]+ (28). HR-MS (ESI): m/z calcd for C19H17N3SNa+ [M+Na]+ 342.1035, found 342.1036. 
The analytical data are in accordance with those reported in the literature.[206] 
 
 
2-Methyl-1-(pyrimidin-2-yl)-7-(p-tolylthio)indoline (135bb) 
The general procedure A was followed using indoline 133b (63.4 mg, 0.30 mmol) and 
disulfide 59b (73.9 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 135bb (66.0 mg, 198 μmol, 66%) as a yellow oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.44 (d, J = 4.8 Hz, 2H), 7.15 (d, J = 8.1 Hz, 2H), 7.12–7.06 
(m, 2H), 7.02 (d, J = 8.1 Hz, 2H), 6.89 (dd, J = 7.6, 7.6 Hz, 1H), 6.70 (t, J = 4.8 Hz, 1H), 5.03–
4.93 (m, 1H), 3.52 (dd, J = 15.5, 8.6 Hz, 1H), 2.57 (d, J = 15.5 Hz, 1H), 2.29 (s, 3H), 1.45 (d, 
J = 6.5 Hz, 3H). 13C-NMR (101 MHz, CDCl3): δ = 160.6 (Cq), 157.4 (CH), 142.4 (Cq), 136.7 
(Cq), 134.8 (Cq), 133.5 (Cq), 131.9 (CH), 131.5 (CH), 129.7 (CH), 127.4 (Cq), 124.3 (CH), 123.5 
(CH), 112.9 (CH), 59.8 (CH), 37.1 (CH2), 21.5 (CH3), 21.2 (CH3). IR (ATR): 1576, 1549, 1453, 
1421, 1346, 793, 763, 729, 709, 489 cm⁻1. MS (ESI) m/z (relative intensity): 356 [M+Na]+ 
(100), 334 [M+H]+ (88) 211 [M–SC6H4Me]+ (19). HR-MS (ESI): m/z calcd for C20H19N3SNa+ 
[M+Na]+ 356.1192, found 356.1190. 
 
 
3-Methyl-7-(phenylthio)-1-(pyrimidin-2-yl)indoline (135ca) 
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The general procedure A was followed using indoline 133c (63.4 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 135ca (50.1 mg, 157 μmol, 52%) as a yellow oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.42 (d, J = 4.8 Hz, 2H), 7.27–7.22 (m, 2H), 7.21–7.11 (m, 
3H), 7.08 (dt, J = 7.9, 1.0 Hz, 1H), 7.04 (dt, J = 7.3, 1.2 Hz, 1H), 6.91 (dd, J = 7.9, 7.3 Hz, 1H), 
6.69 (t, J = 4.8 Hz, 1H), 4.62 (dd, J = 11.1, 8.2 Hz, 1H), 3.94 (dd, J = 11.1, 7.3 Hz, 1H), 3.50–
3.39 (m, 1H), 1.30 (d, J = 6.9 Hz, 3H). 13C-NMR (101 MHz, CDCl3): δ = 161.1 (Cq), 157.5 (CH), 
143.6 (Cq), 140.1 (Cq), 138.3 (Cq), 131.7 (CH), 131.4 (CH), 128.9 (CH), 126.7 (CH), 126.1 (Cq), 
124.5 (CH), 121.9 (CH), 112.9 (CH), 60.3 (CH2), 36.5 (CH), 18.9 (CH3). IR (ATR): 1574, 1550, 
1419, 1377, 907, 796, 774, 732, 689, 619 cm⁻1. MS (ESI) m/z (relative intensity): 342 
[M+Na]+ (100), 320 [M+H]+ (66), 211 [M–SPh]+ (22). HR-MS (ESI): m/z calcd for 
C19H17N3SNa+ [M+Na]+ 342.1035, found 342.1036. The analytical data are in accordance 
with those reported in the literature.[206] 
 
 
5-Methyl-7-(phenylthio)-1-(pyrimidin-2-yl)indoline (135da) 
The general procedure A was followed using indoline 133d (63.4 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 135da (59.0 mg, 185 μmol, 62%) as a yellow solid.  
M. p.: 135–137 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.41 (d, J = 4.8 Hz, 2H), 7.32–7.11 (m, 
5H), 6.94 (d, J = 0.8 Hz, 2H), 6.69 (t, J = 4.8 Hz, 1H), 4.44 (t, J = 7.8 Hz, 2H), 3.10 (t, J = 7.8 Hz, 
2H), 2.20 (s, 3H). 13C-NMR (126 MHz, CDCl3): δ = 161.0 (Cq), 157.3 (CH), 142.0 (Cq), 138.6 
(Cq), 135.0 (Cq), 134.1 (Cq), 132.0 (CH), 130.8 (CH), 128.7 (CH), 126.3 (CH), 125.4 (Cq), 124.3 
(CH), 112.7 (CH), 52.6 (CH2), 29.9 (CH2), 21.0 (CH3). IR (ATR): 1574, 1551, 1447, 1403, 1376, 
799, 746, 723, 698, 688 cm⁻1. MS (ESI) m/z (relative intensity): 342 [M+Na]+ (88), 320 
[M+H]+ (100), 211 [M–SPh]+ (22). HR-MS (ESI): m/z calcd for C19H17N3SNa+ [M+Na]+ 
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342.1035, found 342.1033. The analytical data are in accordance with those reported in 
the literature.[206] 
 
 
5-Methyl-1-(pyrimidin-2-yl)-7-(p-tolylthio)indoline (135db) 
The general procedure A was followed using indoline 133d (63.4 mg, 0.30 mmol) and 
disulfide 59a (73.9 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 135db (59.8 mg, 179 μmol, 60%) as a yellow solid.  
M. p.: 138–140 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.43 (d, J = 4.8 Hz, 2H), 7.19 (d, J = 8.1 Hz, 
2H), 7.03 (d, J = 8.1 Hz, 2H), 6.90 (s, 1H), 6.88 (s, 1H), 6.69 (t, J = 4.8 Hz, 1H), 4.45 (t, 
J = 7.8 Hz, 2H), 3.09 (t, J = 7.8 Hz, 2H), 2.30 (s, 3H), 2.18 (s, 3H). 13C-NMR (101 MHz, CDCl3): 
δ = 161.2 (Cq), 157.4 (CH), 141.5 (Cq), 136.7 (Cq), 134.9 (Cq), 134.6 (Cq), 134.1 (Cq), 131.8 
(CH), 131.3 (CH), 129.8 (CH), 126.5 (Cq), 123.9 (CH), 112.7 (CH), 52.6 (CH2), 29.9 (CH2), 21.2 
(CH3), 21.0 (CH3). IR (ATR): 1574, 1552, 1426, 1302, 1222, 1198, 794, 724, 618, 486 cm⁻1. 
MS (ESI) m/z (relative intensity): 356 [M+Na]+ (95), 334 [M+H]+ (100), 211 [M–SC6H4Me]+ 
(35). HR-MS (ESI): m/z calcd for C20H19N3SNa+ [M+Na]+ 356.1192, found 356.1188. 
 
 
5-Methoxy-7-(phenylthio)-1-(pyrimidin-2-yl)indoline (135ea) 
The general procedure A was followed using indoline 133e (68.2 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 2.5/1) yielded 135ea (62.8 mg, 187 μmol, 62%) as a yellow oil.  
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1H-NMR (400 MHz, CDCl3): δ = 8.42 (d, J = 4.8 Hz, 2H), 7.32–7.28 (m, 2H), 7.25–7.14 (m, 
3H), 6.73–6.70 (m, 1H), 6.68 (t, J = 4.8 Hz, 1H), 6.61 (d, J = 2.6 Hz, 1H), 4.45 (t, J = 7.8 Hz, 
2H), 3.62 (s, 3H), 3.09 (t, J = 7.8 Hz, 2H). 13C-NMR (101 MHz, CDCl3): δ = 161.1 (Cq), 157.4 
(CH), 156.8 (Cq), 137.9 (Cq), 137.7 (Cq), 136.3 (Cq), 131.6 (CH), 128.9 (CH), 127.1 (Cq), 126.9 
(CH), 115.4 (CH), 112.5 (CH), 110.4 (CH), 55.8 (CH3), 52.7 (CH2), 30.3 (CH2). IR (ATR): 1576, 
1550, 1448, 1430, 1407, 906, 795, 724, 690, 645 cm⁻1. MS (ESI) m/z (relative intensity): 
358 [M+Na]+ (100), 336 [M+H]+ (90) 227 [M–SPh]+ (22). HR-MS (ESI): m/z calcd for 
C19H17N3OSNa+ [M+Na]+ 358.0985, found 358.0984. The analytical data are in accordance 
with those reported in the literature.[206] 
 
 
5-Fluoro-7-(phenylthio)-1-(pyrimidin-2-yl)indoline (135fa) 
The general procedure A was followed using indoline 133f (64.6 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 135fa (67.0 mg, 207 μmol, 69%) as a pale yellow solid.  
M. p.: 129–130 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.45 (d, J = 4.8 Hz, 2H), 7.35–7.30 (m, 
2H), 7.29–7.20 (m, 3H), 6.82–6.78 (m, 1H), 6.75–6.70 (m, 2H), 4.49 (t, J = 7.9 Hz, 2H), 3.12 
(t, J = 7.9 Hz, 2H). 13C-NMR (101 MHz, CDCl3): δ = 161.0 (Cq), 159.6 (d, 1JC-F = 243.6 Hz, Cq), 
157.5 (CH), 139.8 (d, 4JC-F = 2.1 Hz, Cq), 137.0 (Cq), 136.6 (d, 3JC-F = 8.9 Hz, Cq), 132.4 (CH), 
129.2 (CH), 128.5 (d, 3JC-F = 8.4 Hz, Cq), 127.5 (CH), 116.6 (d, 2JC-F = 25.0 Hz, CH), 113.0 (CH), 
110.6 (d, 2JC-F = 24.2 Hz, CH), 52.8 (CH2), 30.1 (CH2). 19F{H}-NMR (282 MHz, CDCl3): 
δ = −119.2 (s). IR (ATR): 1575, 1549, 1452, 1427, 1405, 861, 796, 750, 699, 690 cm⁻1. MS 
(ESI) m/z (relative intensity): 346 [M+Na]+ (30), 324 [M+H]+ (100). HR-MS (ESI): m/z calcd 
for C18H14FN3SNa+ [M+Na]+ 346.0785, found 346.0796. The analytical data are in 
accordance with those reported in the literature.[206] 
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5-Chloro-7-(phenylthio)-1-(pyrimidin-2-yl)indoline (135ga) 
The general procedure A was followed using indoline 133g (69.5 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 135ga (66.0 mg, 194 μmol, 65%) as a white solid.  
M. p.: 142–144 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.44 (d, J = 4.8 Hz, 2H), 7.46–7.19 (m, 
5H), 7.08–7.00 (m, 2H), 6.74 (t, J = 4.8 Hz, 1H), 4.46 (t, J = 7.9 Hz, 2H), 3.12 (t, J = 7.9 Hz, 
2H). 13C-NMR (126 MHz, CDCl3): δ = 160.6 (Cq), 157.4 (CH), 142.5 (Cq), 137.1 (Cq), 136.5 
(Cq), 131.9 (CH), 130.3 (CH), 129.1 (CH), 128.9 (Cq), 128.0 (Cq), 127.3 (CH), 123.2 (CH), 113.2 
(CH), 52.7 (CH2), 29.8 (CH2). IR (ATR): 1574, 1553, 1436, 1402, 854, 799, 759, 696, 635, 
467 cm⁻1. MS (ESI) m/z (relative intensity): 362 [M+Na]+ (38), 340 [M+H]+ (100), 231 [M–
SPh]+ (22). HR-MS (ESI): m/z calcd for C18H14ClN3SNa+ [M+Na]+ 362.0489, found 362.0485. 
The analytical data are in accordance with those reported in the literature.[206] 
 
 
5-Chloro-1-(pyrimidin-2-yl)-7-(p-tolylthio)indoline (135gb) 
The general procedure A was followed using indoline 133g (69.5 mg, 0.30 mmol) and 
disulfide 59b (73.9 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1→2/1) yielded 135gb (66.8 mg, 189 μmol, 63%) as a white solid.  
M. p.: 93–95 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.46 (d, J = 4.8 Hz, 2H), 7.24 (d, J = 8.1 Hz, 
2H), 7.08 (d, J = 8.1 Hz, 2H), 7.02 (d, J = 2.0 Hz, 1H), 6.95 (d, J = 2.0 Hz, 1H), 6.74 (t, 
J = 4.7 Hz, 1H), 4.46 (t, J = 7.9 Hz, 2H), 3.11 (t, J = 7.9 Hz, 2H), 2.32 (s, 3H). 13C-NMR 
(101 MHz, CDCl3): δ = 160.9 (Cq), 157.5 (CH), 142.0 (Cq), 137.8 (Cq), 136.4 (Cq), 133.1 (Cq), 
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132.8 (CH), 130.1 (CH), 129.7 (CH), 129.1 (Cq), 129.0 (Cq), 122.8 (CH), 113.2 (CH), 52.7 
(CH2), 29.7 (CH2), 21.3 (CH3). IR (ATR): 1572, 1554, 1455, 1426, 1395, 859, 810, 797, 491, 
460 cm⁻1. MS (ESI) m/z (relative intensity): 376 [M+Na]+ (84), 354 [M+H]+ (100), 231 [M–
SC6H4Me]+ (35). HR-MS (ESI): m/z calcd for C19H1635ClN3SNa+ [M+Na]+ 376.0646, found 
376.0632. 
 
 
5-Bromo-7-(phenylthio)-1-(pyrimidin-2-yl)indoline (135ha) 
The general procedure A was followed using indoline 133h (82.8 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1→2/1) yielded 135ha (63.2 mg, 164 μmol, 55%) as an off-white solid.  
M. p.: 160–161 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.45 (d, J = 4.8 Hz, 2H), 7.32–7.13 (m, 
7H), 6.76 (t, J = 4.8 Hz, 1H), 4.46 (t, J = 8.0 Hz, 2H), 3.13 (t, J = 8.0 Hz, 2H). 13C-NMR 
(101 MHz, CDCl3): δ = 160.8 (Cq), 157.5 (CH), 143.1 (Cq), 137.2 (Cq), 136.9 (Cq), 133.3 (CH), 
131.8 (CH), 129.2 (CH), 128.5 (Cq), 127.4 (CH), 126.1 (CH), 116.4 (Cq), 113.3 (CH), 52.6 
(CH2), 29.6 (CH2). IR (ATR): 1572, 1551, 1457, 1392, 798, 745, 724, 698, 687, 478 cm⁻1. MS 
(ESI) m/z (relative intensity): 406 [M+Na]+ (41) (79Br), 384 [M+H]+ (100) (79Br), 275 
[M–SPh]+ (23). HR-MS (ESI): m/z calcd for C18H1479BrN3SNa+ [M+Na]+ 405.9984, found 
405.9974. The analytical data are in accordance with those reported in the literature.[206] 
 
 
7-(Phenylselanyl)-1-(pyrimidin-2-yl)indoline (137aa) 
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The general procedure A was followed using indoline 133a (59.2 mg, 0.30 mmol) and 
diselenide 63a (93.6 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 137aa (60.0 mg, 170 μmol, 57%) as a white solid.  
M. p.: 153–155 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.46 (d, J = 4.8 Hz, 2H), 7.52–7.44 (m, 
2H), 7.26–7.19 (m, 3H), 7.14 (dd, J = 7.9, 1.1 Hz, 1H), 7.08 (dd, J = 7.2, 1.1 Hz, 1H), 6.82 (dd, 
J = 7.9, 7.2 Hz, 1H), 6.72 (t, J = 4.8 Hz, 1H), 4.48 (t, J = 7.9 Hz, 2H), 4.48 (t, J = 7.9 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ = 160.9 (Cq), 157.5 (CH), 144.3 (Cq), 134.9 (Cq), 134.4 (Cq), 
134.2 (CH), 132.4 (CH), 129.1 (CH), 127.3 (CH), 124.4 (CH), 123.1 (CH), 122.9 (Cq), 112.8 
(CH), 51.6 (CH2), 29.6 (CH2). IR (ATR): 1573, 1549, 1452, 1424, 1378, 801, 769, 738, 691, 
466 cm⁻1. MS (ESI) m/z (relative intensity): 354 [M+H]+ (83) (80Se), 197 [M–SePh]+ (100). 
HR-MS (ESI): m/z calcd for C18H15N380SeNa+ [M+Na]+ 376.0332, found 376.0324. The 
analytical data are in accordance with those reported in the literature.[206] 
 
 
1-(Pyrimidin-2-yl)-7-(p-tolylselanyl)indoline (137ab) 
The general procedure A was followed using indoline 133a (59.2 mg, 0.30 mmol) and 
diselenide 63b (102 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 137ab (58.3 mg, 159 μmol, 53%) as a white solid.  
M. p.: 137–139 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.46 (d, J = 4.7 Hz, 2H), 7.40 (d, J = 8.0 Hz, 
2H), 7.09 (dd, J = 7.9, 1.1 Hz, 1H), 7.07–7.02 (m, 3H) 6.80 (dd, J = 7.9, 7.3 Hz, 1H), 6.72 (t, 
J = 4.8 Hz, 1H), 4.48 (t, J = 8.0 Hz, 2H), 3.14 (t, J = 8.0 Hz, 2H), 2.31 (s, 3H). 13C-NMR 
(101 MHz, CDCl3): δ = 160.9 (Cq), 157.6 (CH), 144.0 (Cq), 137.5 (Cq), 134.8 (CH), 134.3 (Cq), 
132.0 (CH), 130.9 (Cq), 130.0 (CH), 124.3 (CH), 123.5 (Cq), 122.8 (CH), 112.8 (CH), 51.6 
(CH2), 29.7 (CH2), 21.3 (CH3). IR (ATR): 1573, 1549, 1452, 1423, 1377, 804, 793, 767, 719, 
486 cm⁻1. MS (ESI) m/z (relative intensity): 390 [M+Na]+ (100) (80Se), 368 [M+H]+ (19) 
(80Se), 197 [M–SePh]+ (70). HR-MS (ESI): m/z calcd for C19H17N380SeNa+ [M+Na]+ 390.0481, 
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found 390.0479. The analytical data are in accordance with those reported in the 
literature.[206] 
 
 
2-Methyl-7-(phenylselanyl)-1-(pyrimidin-2-yl)indoline (137ba) 
The general procedure A was followed using indoline 133b (63.4 mg, 0.30 mmol) and 
diselenide 63a (93.6 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 137ba (61.7 mg, 168 μmol, 56%) as a white solid.  
M. p.: 138–140 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.44 (d, J = 4.8 Hz, 2H), 7.44 (dd, J = 6.6, 
3.1 Hz, 2H), 7.25–7.14 (m, 4H), 7.09 (dd, J = 7.2, 1.0 Hz, 1H), 6.83 (dd, J = 7.9, 7.3 Hz, 1H), 
6.71 (t, J = 4.8 Hz, 1H), 5.10–4.98 (m, 1H), 3.51 (dd, J = 15.6, 8.7 Hz, 1H), 2.60 (d, J = 15.6 Hz, 
1H), 1.47 (d, J = 6.5 Hz, 3H). 13C-NMR (76 MHz, CDCl3): δ = 160.5 (Cq), 157.6 (CH), 143.0 
(Cq), 135.1 (Cq), 134.1 (CH), 133.1 (Cq), 132.7 (CH), 129.1 (CH), 127.2 (CH), 124.4 (CH), 123.7 
(CH), 123.3 (Cq), 112.9 (CH), 58.9 (CH), 37.0 (CH2), 21.4 (CH3). IR (ATR): 1574, 1549, 1457, 
1435, 1424, 1381, 1372, 793, 761, 688 cm⁻1. MS (ESI) m/z (relative intensity): 390 [M+Na]+ 
(27) (80Se), 368 [M+H]+ (100) (80Se), 211 [M–SePh]+ (73). HR-MS (ESI): m/z calcd for 
C19H17N380SeNa+ [M+Na]+ 390.0481, found 390.0488.The analytical data are in accordance 
with those reported in the literature.[206] 
 
 
5-Methyl-7-(phenylselanyl)-1-(pyrimidin-2-yl)indoline (137da) 
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The general procedure A was followed using indoline 133d (63.4 mg, 0.30 mmol) and 
diselenide 63a (93.6 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 137da (59.5 mg, 162 μmol, 54%) as a white solid. 
M. p.: 155–157 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.43 (d, J = 4.8 Hz, 2H), 7.48–7.40 (m, 
2H), 7.25–7.17 (m, 3H), 6.96 (dd, J = 1.6, 0.7 Hz, 1H), 6.92–6.90 (m, 1H), 6.69 (t, J = 4.8 Hz, 
1H), 4.47 (t, J = 7.9 Hz, 2H), 3.10 (t, J = 7.9 Hz, 2H), 2.15 (s, 3H). 13C-NMR (101 MHz, CDCl3): 
δ = 161.1 (Cq), 157.5 (CH), 142.2 (Cq), 135.0 (Cq), 134.5 (Cq), 134.2 (Cq), 133.9 (CH), 132.7 
(CH), 129.1 (CH), 127.2 (CH), 124.2 (CH), 122.4 (Cq), 112.6 (CH), 51.7 (CH2), 29.7 (CH2), 20.9 
(CH3). IR (ATR): 1575, 1547, 1455, 1432, 1401, 1373, 793, 748, 737, 690 cm⁻1. MS (ESI) m/z 
(relative intensity): 390 [M+Na]+ (40) (80Se), 368 [M+H]+ (84) (80Se), 211 [M–SePh]+ (100). 
HR-MS (ESI): m/z calcd for C19H17N380SeNa+ [M+Na]+ 390.0481, found 390.0486. The 
analytical data are in accordance with those reported in the literature.[206] 
 
 
5-Fluoro-7-(phenylselanyl)-1-(pyrimidin-2-yl)indoline (137fa) 
The general procedure A was followed using indoline 133f (64.6 mg, 0.30 mmol) and 
diselenide 63a (93.6 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 137fa (68.4 mg, 185 μmol, 62%) as a pale yellow solid.  
M. p.: 139–140 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.45 (d, J = 4.8 Hz, 2H), 7.55–7.50 (m, 
2H), 7.31–7.23 (m, 3H), 6.81–6.76 (m, 2H), 6.73 (t, J = 4.8 Hz, 1H), 4.51 (t, J = 8.0 Hz, 2H), 
3.12 (t, J = 8.0 Hz, 2H). 13C-NMR (101 MHz, CDCl3): δ = 160.9 (Cq), 159.5 (d, 1JC-F = 244.3 Hz, 
Cq), 157.6 (CH), 140.3 (d, 4JC-F = 2.1 Hz, Cq), 136.1 (d, 3JC-F = 8.7 Hz, Cq), 134.9 (CH), 133.8 
(Cq), 129.4 (CH), 128.0 (CH), 124.6 (d, 3JC-F = 7.8 Hz, Cq), 117.9 (d, 2JC-F = 24.8 Hz, CH), 112.9 
(CH), 110.5 (d, 2JC-F = 24.0 Hz, CH), 51.9 (CH2), 29.9 (CH2). 19F{H}-NMR (282 MHz, CDCl3): 
δ = −119.5 (s). IR (ATR): 1575, 1453, 1427, 1405, 864, 797, 739, 691, 546, 465 cm⁻1. MS 
(ESI) m/z (relative intensity): 394 [M+Na]+ (20) (80Se), 372 [M+H]+ (100) (80Se), 215 [M–
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SePh]+ (72). HR-MS (ESI): m/z calcd for C18H14FN380SeNa+ [M+Na]+ 394.0230, found 
394.0237. The analytical data are in accordance with those reported in the literature.[206] 
 
 
5-Fluoro-1-(pyrimidin-2-yl)-7-(p-tolylselanyl)indoline (137fb) 
The general procedure A was followed using indoline 133f (64.6 mg, 0.30 mmol) and 
diselenide 63b (102 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 137fb (72.8 mg, 189 μmol, 63%) as a white solid.  
M. p.: 133–134 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.45 (d, J = 4.8 Hz, 2H), 7.43 (d, J = 
8.0 Hz, 2H), 7.08 (d, J = 8.0 Hz, 2H), 6.80–6.69 (m, 3H), 4.50 (t, J = 8.0 Hz, 2H), 3.11 (t, J = 
8.0 Hz, 2H), 2.33 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 160.8 (Cq), 159.5 (d, 1JC-F = 244.0 
Hz, Cq), 157.6 (CH), 140.0 (d, 4JC-F = 2.1 Hz, Cq), 138.2 (Cq), 136.0 (d, 3JC-F = 8.5 Hz, Cq), 135.3 
(CH), 130.2 (CH), 129.8 (Cq), 125.1 (d, 3JC-F = 7.7 Hz, Cq), 117.5 (d, 2JC-F = 24.9 Hz, CH), 112.8 
(CH), 110.2 (d, 2JC-F = 24.1 Hz, CH) 51.9 (CH2), 29.9 (CH2), 21.3 (CH3). 19F{H}-NMR (282 MHz, 
CDCl3): δ = −119.6 (s). IR (ATR):  1578, 1551, 1429, 1406, 906, 856, 793, 727, 546, 488 cm⁻1. 
MS (ESI) m/z (relative intensity): 408 [M+Na]+ (100) (80Se), 215 [M–SeC6H4Me]+ (65). 
HR-MS (ESI): m/z calcd for C19H16FN380SeNa+ [M+Na]+ 408.0386, found 408.0384.  
 
 
5-Chloro-7-(phenylselanyl)-1-(pyrimidin-2-yl)indoline (137ga) 
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The general procedure A was followed using indoline 133g (69.5 mg, 0.30 mmol) and 
diselenide 63a (93.6 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 137ga (61.0 mg, 158 μmol, 53%) as a white solid.  
M. p.: 154–156 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.46 (d, J = 4.8 Hz, 2H), 7.53–7.45 (m, 
2H), 7.31–7.22 (m, 3H), 7.07–7.05 (m, 1H), 7.04–7.02 (m, 1H), 6.75 (t, J = 4.8 Hz, 1H), 4.48 
(t, J = 8.0 Hz, 2H), 3.12 (t, J = 8.0 Hz, 2H). 13C-NMR (101 MHz, CDCl3): δ = 160.7 (Cq), 157.6 
(CH), 143.0 (Cq), 136.0 (Cq), 134.6 (CH), 133.9 (Cq), 131.3(CH), 129.4 (CH), 129.0 (Cq), 127.9 
(CH), 124.4 (Cq), 123.2 (CH), 113.1 (CH), 51.8 (CH2), 29.5 (CH2). IR (ATR): 1574, 1552, 1470, 
1443, 1401, 857, 799, 750, 695, 636 cm⁻1. MS (ESI) m/z (relative intensity): 388 [M+H]+ 
(100) (80Se), 231 [M–SePh]+ (63). HR-MS (ESI): m/z calcd for C18H14ClN380SeNa+ [M+Na]+ 
409.9932, found 409.9938. The analytical data are in accordance with those reported in 
the literature.[206] 
 
 
2-(Phenylthio)-1-(pyrimidin-2-yl)-1H-indole (72aa) 
The general procedure A was followed using indole 134a (58.6 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1) yielded 72aa (56.4 mg, 186 μmol, 62%) as a white solid.  
M. p.: 80–82 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.80 (d, J = 4.8 Hz, 2H), 8.43–8.39 (m, 1H), 
7.59–7.53 (m, 2H), 7.42 (ddd, J = 7.7, 1.4, 0.7 Hz, 1H) 7.39–7.31 (m, 3H), 7.26 (ddd, J = 8.5, 
7.2, 1.4 Hz, 1H), 7.19 (ddd, J = 7.6, 7.2, 1.1 Hz, 1H), 7.13 (t, J = 4.8 Hz, 1H), 6.25 (d, 
J = 0.8 Hz, 1H). 13C-NMR (101 MHz, CDCl3): δ = 158.0 (CH), 157.6 (Cq), 137.4 (Cq), 135.6 
(Cq), 135.2 (Cq), 133.1 (CH), 129.5 (Cq), 129.4 (CH), 128.3 (CH), 123.1 (CH), 122.4 (CH), 119.5 
(CH), 117.2 (CH), 114.3 (CH), 109.8 (CH). IR (ATR):  1562, 1446, 1423, 1345, 1303, 1207, 
741, 702, 691, 613 cm⁻1. MS (ESI) m/z (relative intensity): 326 [M+Na]+ (100), 304 [M+H]+ 
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(45). HR-MS (ESI): m/z calcd for C18H13N3SNa+ [M+Na]+ 326.0722, found 326.0726. The 
analytical data are in accordance with those reported in the literature.[219] 
 
 
1-(Pyrimidin-2-yl)-2-(p-tolylthio)-1H-indole (72ab) 
The general procedure A was followed using indole 134a (58.6 mg, 0.30 mmol) and 
disulfide 59b (73.9 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1) yielded 72ab (64.7 mg, 204 μmol, 68%) as a white solid.  
M. p.: 91–93 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.81 (d, J = 4.8 Hz, 2H), 8.47–8.42 (m, 1H), 
7.53–7.48 (m, 2H), 7.38 (ddd, J = 7.6, 1.5, 0.7 Hz, 1H), 7.26–7.15 (m, 4H), 7.14 (t, J = 4.8 Hz, 
1H), 6.12 (d, J = 0.7 Hz, 1H), 2.39 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 157.9 (CH), 157.6 
(Cq), 138.8 (Cq), 137.3 (Cq), 137.0 (Cq), 133.9 (CH), 131.1 (Cq), 130.3 (CH), 129.7 (Cq), 122.8 
(CH), 122.3 (CH), 119.3 (CH), 117.1 (CH), 114.4 (CH), 108.6 (CH), 21.4 (CH3). IR (ATR):  1561, 
1422, 1345, 1300, 1204, 797, 740, 612, 503, 399 cm⁻1. MS (ESI) m/z (relative intensity): 
340 [M+Na]+ (100), 318 [M+H]+ (63), 195 [M–SPh]+ (53). HR-MS (ESI): m/z calcd for 
C19H15N3SNa+ [M+Na]+ 340.0879, found 340.0874. The analytical data are in accordance 
with those reported in the literature.[219] 
 
 
2-[(2-Chlorophenyl)thio]-1-(pyrimidin-2-yl)-1H-indole (72af) 
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The general procedure A was followed using indole 134a (58.6 mg, 0.30 mmol) and 
disulfide 59f (86.2 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1) yielded 72af (25.2 mg, 74.6 μmol, 25%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.78 (d, J = 4.8 Hz, 2H), 8.37 (dd, J = 8.3, 0.9 Hz, 1H), 7.48 
(ddd, J = 7.8, 1.4, 0.7 Hz, 1H), 7.41 (ddd, J = 8.0, 8.0, 1.8 Hz, 2H), 7.33–7.10 (m, 5H), 6.43 
(d, J = 0.7 Hz, 1H). 13C-NMR (101 MHz, CDCl3): δ = 158.1 (CH), 157.4 (Cq), 137.7 (Cq), 135.5 
(Cq), 135.5 (Cq), 133.5 (CH), 131.8 (Cq), 130.1 (CH), 129.3 (Cq), 128.9 (CH), 127.5 (CH), 123.8 
(CH), 122.4 (CH), 120.0 (CH), 117.4 (CH), 114.3 (CH), 112.3 (CH). IR (ATR): 1561, 1418, 
1343, 1303, 1204, 1031, 792, 741, 612, 429 cm⁻1. MS (ESI) m/z (relative intensity): 360 
[M+Na]+ (35) (35Cl), 338 [M+H]+ (100) (35Cl), 258 [M–Pym]+ (95). HR-MS (ESI): m/z calcd for 
C18H13N3S35Cl+ [M+H]+ 338.0513, found 338.0507. The analytical data are in accordance 
with those reported in the literature.[219] 
 
 
2-(Naphthalen-2-ylthio)-1-(pyrimidin-2-yl)-1H-indole (72ag) 
The general procedure A was followed using indole 134a (58.6 mg, 0.30 mmol) and 
disulfide 59g (95.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 5/1) yielded 72ag (63.5 mg, 180 μmol, 60%) as an off-white solid.  
M. p.: 143–146 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.81 (d, J = 4.8 Hz, 2H), 8.45 (dd, J = 8.3, 
0.9 Hz, 1H), 8.10 (d, J = 1.2 Hz, 1H), 7.88–7.78 (m, 3H), 7.58 (dd, J = 8.6, 1.8 Hz, 1H), 7.55–
7.49 (m, 2H), 7.39 (ddd, J = 7.7, 1.3, 0.7 Hz, 1H), 7.31–7.23 (m, 1H), 7.22–7.16 (m, 1H), 7.14 
(t, J = 4.8 Hz, 1H), 6.26 (d, J = 0.7 Hz, 1H). 13C-NMR (126 MHz, CDCl3): δ = 157.9 (CH), 157.5 
(Cq), 137.3 (Cq), 135.6 (Cq), 133.8 (Cq), 132.9 (Cq), 132.4 (Cq), 132.2 (CH), 130.2 (CH), 129.5 
(Cq), 129.1 (CH), 127.8 (CH), 127.8 (CH), 126.7 (CH), 126.6 (CH), 123.1 (CH), 122.4 (CH), 
119.5 (CH), 117.1 (CH), 114.3 (CH), 109.9 (CH). IR (ATR): 1440, 1424, 1345, 815, 801, 790, 
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780, 742, 610, 478 cm⁻1. MS (ESI) m/z (relative intensity): 376 [M+Na]+ (76), 354 [M+H]+ 
(100), 169 (79). HR-MS (ESI): m/z calcd for C22H15N3SNa+ [M+Na]+ 376.0879, found 
376.0887. The analytical data are in accordance with those reported in the literature.[219] 
 
 
3-Methyl-2-(phenylthio)-1-(pyrimidin-2-yl)-1H-indole (72ba) 
The general procedure A was followed using indole 134b (62.8 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1) yielded 72ba (70.7 mg, 225 μmol, 75%) as a slightly yellow solid.  
M. p.: 102–104 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.75 (d, J = 4.8 Hz, 2H), 8.15–8.12 (m, 
1H), 7.64 (ddd, J = 7.8, 1.3, 0.8 Hz, 1H), 7.38 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 7.29 (ddd, J = 
7.8, 7.1, 1.1 Hz, 1H), 7.19–7.13 (m, 2H), 7.11 (t, J = 4.8 Hz, 1H), 7.09–7.04 (m, 3H), 2.38 (s, 
3H). 13C-NMR (126 MHz, CDCl3): δ = 158.1 (CH), 157.3 (Cq), 138.1 (Cq), 137.7 (Cq), 129.3 
(Cq), 128.8 (CH), 126.7 (CH), 125.4 (CH), 125.3(Cq), 125.0 (Cq), 125.0 (CH) 121.8 (CH), 119.3 
(CH), 117.6 (CH), 113.1 (CH), 10.3 (CH3). IR (ATR): 1559, 1442, 1419, 1339, 1308, 1196, 
742, 691 631, 474 cm⁻1. MS (ESI) m/z (relative intensity): 340 [M+Na]+ (100), 318 [M+H]+ 
(93), 209 [M–SPh]+ (53). HR-MS (ESI): m/z calcd for C19H15N3SNa+ [M+Na]+ 340.0879, 
found 340.0873. The analytical data are in accordance with those reported in the 
literature.[219] 
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5-Methyl-2-(phenylthio)-1-(pyrimidin-2-yl)-1H-indole (72ca) 
The general procedure A was followed using indole 134c (62.8 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1) yielded 72ca (59.7 mg, 188 μmol, 63%) as a yellow oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.78 (d, J = 4.8 Hz, 2H), 8.30 (d, J = 8.4 Hz, 1H), 7.58–7.52 
(m, 2H), 7.39–7.30 (m, 3H), 7.21–7.19 (m, 1H), 7.11 (t, J = 4.8 Hz, 1H), 7.07 (ddd, J = 8.5, 
1.8, 0.8 Hz, 1H), 6.17 (d, J = 0.8 Hz, 1H), 2.42 (s, 3H). 13C-NMR (126 MHz, CDCl3): δ = 157.8 
(CH), 157.5 (Cq), 135.6 (Cq), 135.3 (Cq), 135.3 (Cq), 132.9 (CH), 131.7 (Cq), 129.6 (Cq), 129.3 
(CH), 128.1 (CH), 124.5 (CH), 119.3 (CH), 116.9 (CH), 114.1 (CH), 109.7 (CH), 21.5 (CH3). IR 
(ATR): 1573, 1560, 1451, 1419, 1156, 798, 738, 726, 689, 630 cm⁻1. MS (ESI) m/z (relative 
intensity): 340 [M+Na]+ (100), 318 [M+H]+ (76), 209 [M–SPh]+ (30). HR-MS (ESI): m/z calcd 
for C19H15N3SNa+ [M+Na]+ 340.0879, found 340.0874. 
 
 
5-Methoxy-2-(phenylthio)-1-(pyrimidin-2-yl)-1H-indole (72da) 
The general procedure A was followed using indole 134d (67.6 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 5/1) yielded 72da (48.0 mg, 144 μmol, 48%) as a yellow oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.77 (d, J = 4.8 Hz, 2H), 8.35 (dd, J = 9.8, 0.8 Hz, 1H), 7.59–
7.56 (m, 2H), 7.40–7.34 (m, 3H), 7.12 (t, J = 4.8 Hz, 1H), 6.88–6.83 (m, 2H), 6.08 (d, J = 
0.8 Hz, 1H), 3.82 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 157.9 (CH), 157.6 (Cq), 155.7 (Cq), 
136.5 (Cq), 135.0 (Cq), 133.5 (CH), 132.3 (Cq), 130.3 (Cq), 129.5 (CH), 128.5 (CH), 116.9 (CH), 
115.5 (CH), 112.0 (CH), 109.1 (CH), 101.7 (CH), 55.8 (CH3). IR (ATR): 1463, 1426, 1323, 
1158, 826, 797, 753, 727, 962, 491 cm⁻1. MS (ESI) m/z (relative intensity): 356 [M+Na]+ 
(70), 334 [M+H]+ (100), 234 [M–SPh]+ (56). HR-MS (ESI): m/z calcd for C19H16N3OS+ [M+H]+ 
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334.1009, found 334.1002. The analytical data are in accordance with those reported in 
the literature.[219] 
 
 
5-Fluoro-2-(phenylthio)-1-(pyrimidin-2-yl)-1H-indole (72ea) 
The general procedure A was followed using indole 134e (64.0 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 9/1) yielded 72ea (55.0 mg, 171 μmol, 57%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.79 (d, J = 4.9 Hz, 2H), 8.41 (dd, J = 9.1, 4.7 Hz, 1H), 7.63–
7.57 (m, 2H), 7.43–7.36 (m, 3H), 7.15 (t, J = 4.8 Hz, 1H), 7.02 (ddd, J = 9.0, 2.6, 0.8 Hz, 1H), 
6.98–6.91 (m, 1H), 6.04 (d, J = 0.8 Hz, 1H). 13C-NMR (101 MHz, CDCl3): δ = 159.2 (d, 1JC-F = 
238.1 Hz, Cq), 158.0 (CH), 157.4 (Cq), 138.5 (Cq), 134.4 (Cq), 133.9 (CH), 133.7 (Cq), 130.4 
(d, 3JC-F = 10.3 Hz, Cq), 129.6 (CH), 128.8 (CH), 117.2 (CH), 115.6 (d, 3JC-F = 9.1 Hz, CH), 110.5 
(d, 2JC-F = 25.0 Hz, CH), 108.2 (d, 4JC-F = 4.1 Hz, CH), 104.5 (d, 2JC-F = 23.9 Hz, CH). 
19F{H}-NMR (282 MHz, CDCl3): δ = −121.57 (s). IR (ATR): 1563, 1421, 1154, 1108, 797, 777, 
749, 689, 561, 492 cm⁻1. MS (ESI) m/z (relative intensity): 360 [M+K]+ (76), 344 [M+Na]+ 
(100), 322 [M+H]+ (76), 213 [M–SPh]+ (28). HR-MS (ESI): m/z calcd for C18H12N3FSNa+ 
[M+Na]+ 344.0628, found 344.0618. 
 
5-Bromo-2-(phenylthio)-1-(pyrimidin-2-yl)-1H-indole (72fa) 
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The general procedure A was followed using indole 134f (82.2 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1) yielded 72fa (58.3 mg, 152 μmol, 51%) as a white solid.  
M. p.: 129–130 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.80 (d, J = 4.8 Hz, 2H), 8.32 (d, J = 
8.9 Hz, 1H), 7.61–7.55 (m, 2H), 7.50–7.47 (m, 1H), 7.43–7.35 (m, 3H), 7.29 (dd, J = 8.9, 
2.0 Hz, 1H), 7.17 (t, J = 4.8 Hz, 1H), 6.02 (d, J = 0.7 Hz, 1H). 13C-NMR (101 MHz, CDCl3): δ = 
158.0 (CH), 157.4 (Cq), 138.3 (Cq), 135.9 (Cq), 134.3 (Cq), 133.9 (CH), 131.3 (Cq), 129.8 (CH), 
128.9 (CH), 125.5 (CH), 121.8 (CH), 117.4 (CH), 116.1 (CH), 115.7 (Cq), 107.7 (CH). IR (ATR): 
1574, 1429, 1302, 1198, 794, 780, 747, 692, 628, 425 cm⁻1. MS (ESI) m/z (relative 
intensity): 404 [M+Na]+ (49) (79Br), 382 [M+H]+ (100) (79Br). HR-MS (ESI): m/z calcd for 
C18H12N379BrSNa+ [M+Na]+ 403.9828, found 403.9818. The analytical data are in 
accordance with those reported in the literature.[219] 
 
 
 
3-Methyl-2-(phenylselanyl)-1-(pyrimidin-2-yl)-1H-indole (138ba) 
The general procedure A was followed using indole 134b (62.8 mg, 0.30 mmol) and 
diselenide 63a (93.6 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 7/1) yielded 138ba (71.9 mg, 197 μmol, 66%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.78 (d, J = 4.8 Hz, 2H), 8.35–8.31 (m, 1H), 7.57 (ddd, J = 
7.7, 1.3, 0.7 Hz, 1H), 7.35 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 7.31–7.23 (m, 3H), 7.20–7.14 (m, 
3H), 7.12 (t, J = 4.8 Hz, 1H), 2.18 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 157.9 (CH), 157.7 
(Cq), 137.9 (Cq), 133.7 (Cq), 130.4 (Cq), 130.4 (CH) 129.1 (CH), 126.4 (CH), 124.4 (CH), 123.7 
(Cq), 123.6 (Cq), 121.9 (CH), 118.8 (CH), 117.1 (CH), 113.4 (CH), 11.3 (CH3). IR (ATR): 1559, 
1419, 1345, 1304, 1188, 732, 703, 688, 627, 615 cm⁻1. MS (ESI) m/z (relative intensity): 
388 [M+Na]+ (74) (80Se), 209 [M–SePh]+ (100). HR-MS (ESI): m/z calcd for C19H15N380SeNa+ 
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[M+Na]+ 388.0324, found 388.0314. The analytical data are in accordance with those 
reported in the literature.[219] 
 
 
3-Methyl-1-(pyrimidin-2-yl)-2-(p-tolylselanyl)-1H-indole (138bb) 
The general procedure A was followed using indole 134b (62.8 mg, 0.30 mmol) and 
diselenide 63b (102 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 8/1) yielded 138bb (82.8 mg, 219 μmol, 73%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.78 (d, J = 4.8 Hz, 2H), 8.35–8.31 (m, 1H), 7.56 (ddd, J = 7.7, 
1.4, 0.7 Hz, 1H), 7.34 (ddd, J = 8.3, 7.1, 1.4 Hz, 1H), 7.29–7.24 (m, 1H), 7.23–7.19 (m, 2H), 
7.12 (t, J = 4.8 Hz, 1H), 7.01–6.97 (m, 2H), 2.28 (s, 3H), 2.15 (s, 3H). 13C-NMR (101 MHz, 
CDCl3): δ = 157.8 (CH), 157.7 (Cq), 137.8 (Cq), 136.3 (Cq), 130.8 (CH), 130.5 (Cq), 129.9 (CH), 
129.8 (Cq), 124.2 (CH), 124.1 (Cq), 123.3 (Cq), 121.8 (CH), 118.6 (CH), 117.1 (CH), 113.3 
(CH), 21.1 (CH3), 11.2 (CH3). IR (ATR): 1560, 1421, 1346, 1305, 1181, 1014, 800, 742, 628, 
487 cm⁻1. MS (ESI) m/z (relative intensity): 402 [M+Na]+ (18) (80Se), 380 [M+H]+ (32) (80Se), 
209 [M–SeC6H4Me]+ (100). HR-MS (ESI): m/z calcd for C20H18N380Se+ [M+H]+ 380.0661, 
found 380.0647. 
 
 
1-(Phenylthio)-9-(pyrimidin-2-yl)-9H-carbazole (70aa) 
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The general procedure A was followed using carbazole 155a (73.6 mg, 0.30 mmol) and 
disulfide 59a (65.5 mg, 0.30 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 3/1) yielded 70aa (20.9 mg, 59.0 μmol, 20%) as a colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 8.78 (d, J = 4.8 Hz, 2H), 8.13–8.01 (m, 3H), 7.50–7.42 (m, 
2H), 7.39–7.04 (m, 8H). 13C-NMR (126 MHz, CDCl3): δ = 158.7 (Cq), 158.4 (CH), 141.3 (Cq), 
140.3 (Cq) 137.8 (Cq), 133.1 (CH), 129.8 (CH), 128.9 (CH), 127.1 (Cq), 127.0 (CH), 126.4 (CH), 
125.0 (Cq), 122.8 (CH), 122.3 (CH), 120.5 (Cq), 120.1 (CH), 119.7 (CH), 118.3 (CH), 112.6 
(CH). IR (ATR): 1562, 1449, 1413, 1335, 1211, 904, 723, 688, 647, 633 cm⁻1. MS (ESI) m/z 
(relative intensity): 376 [M+Na]+ (92), 354 [M+H]+ (100), 245 [M–SPh]+ (47). HR-MS (ESI): 
m/z calcd for C22H15N3SNa+ [M+Na]+ 376.0879, found 376.0867. The analytical data are in 
accordance with those reported in the literature.[78] 
 
 
8-(Phenylthio)-1-(pyrimidin-2-yl)-1,2,3,4-tetrahydroquinoline (157aa) 
The general procedure A was followed using tetrahydroquinoline 156a (63.4 mg, 
0.30 mmol) and disulfide 59a (65.5 mg, 0.30 mmol). Purification by column 
chromatography on silica gel (n-pentane/Et2O: 3/1) yielded 157aa (16.2 mg, 50.7 μmol, 
17%) as a colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 8.38 (d, J = 4.8 Hz, 2H), 7.27–6.96 (m, 8H), 6.64 (t, J = 4.8 Hz, 
1H), 4.02 (t, J = 6.9 Hz, 2H), 2.77 (t, J = 6.9 Hz, 2H), 2.03 (tt, J = 6.9, 6.9 Hz, 2H). 13C-NMR 
(76 MHz, CDCl3): δ = 161.6 (Cq), 157.6 (CH), 141.0 (Cq), 138.0 (Cq), 134.9 (Cq), 133.0 (Cq), 
131.5 (CH), 130.6 (CH), 128.8 (CH), 127.7 (CH), 126.3 (CH), 125.3 (CH), 112.0 (CH), 45.3 
(CH2), 27.1 (CH2), 24.5 (CH2). IR (ATR): 1577, 1550, 1413, 1299, 1187, 795, 777, 734, 689, 
637 cm⁻1. MS (ESI): m/z (relative intensity): 320 [M+H]+ (100), 210 [M–SPh]+ (22). HR-MS 
(ESI) m/z calcd for C19H18N3S+ [M+H]+ 320.1216, found 320.1213.  
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5.3.3 Mechanistic Studies 
5.3.3.1 Reaction in the Presence of Radical Scavengers 
 
To an oven-dried 25 mL Schlenk tube were added disulfide 59a (65.5 mg, 0.30 mmol, 
1.00 equiv), Cu(OAc)2H2O (12.0 mg, 0.06 mmol, 20.0 mol %) and radical scavenger 
(0.30 mmol, 1.00 equiv). A solution of indoline 133a (59.2 mg, 0.30 mmol, 1.00 equiv) in 
mesitylene (1.5 mL) was added via syringe and the resulting mixture was stirred under 
ambient air for 20 h at 140 °C. After cooling to ambient temperature, the reaction mixture 
was diluted with Et2O (10 mL) and filtered through a short pad of silica. The filtrate was 
concentrated, and the crude residue was purified by column chromatography 
(n-pentane/Et2O: 5/1). 
Table 5.1: Effect of Radical Scavengers on the reaction.[a] 
Entry Radical scavenger (1.00 equiv) Yield [%] 
1 -- 66 
2 TEMPO 23 
3 Galvinoxyl free radical -- 
4 BHT -- 
a Reaction conditions: 133a (0.30 mmol), 59a (0.30 mmol), Cu(OAc)2H2O (0.06 mmol, 20.0 mol %), 
mesitylene (1.5 mL), radical scavenger (1.00 equiv), 140 °C, 20 h, yields of isolated products. 
  
Experimental Section 
150 
5.3.3.2 H/D Exchange Experiments 
5.3.3.2.1 In the Absence of Disulfide 59a 
 
To an oven-dried 25 mL Schlenk tube was added Cu(OAc)2H2O (12.0 mg, 0.06 mmol, 
20.0 mol %). A solution of indoline 133a (59.2 mg, 0.30 mmol, 1.00 equiv) in mesitylene 
(1.3 mL) and CD3OD (0.2 mL) were added via syringe and the resulting mixture was stirred 
under ambient air for 20 h at 140 °C. After cooling to ambient temperature, the reaction 
mixture was diluted with Et2O (10 mL) and filtered through a short pad of silica. The filtrate 
was concentrated and the crude residue was purified by column chromatography on silica 
gel (n-pentane/Et2O: 3/1) yielding [D]n-133a (43.0 mg, 73%). 
 
Figure 5.4: 1H-NMR spectra of reisolated 133a. 
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To an oven-dried 25 mL Schlenk tube were added indole 134a (58.6 mg, 0.30 mmol) and 
Cu(OAc)2H2O (12.0 mg, 0.06 mmol, 20 mol %). Mesitylene (1.3 mL) and CD3OD (0.2 mL) 
were added via syringe and the resulting mixture was stirred under ambient air for 20 h 
at 140 °C. After cooling to ambient temperature, the reaction mixture was diluted with 
Et2O (10 mL) and filtered through a short pad of silica. The filtrate was concentrated and 
the crude residue was purified by column chromatography on silica gel (n-pentane/Et2O: 
5/1) yielding [D]n-134a (42.8 mg, 73%). 
 
Figure 5.5: 1H-NMR spectra of reisolated [D]n-134a. 
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5.3.3.2.2 In the Presence of Disulfide 59a 
 
To an oven-dried 25 mL Schlenk tube was added disulfide 59a (65.5 mg, 0.30 mmol, 
1.00 equiv) and Cu(OAc)2H2O (12.0 mg, 20 mol %). A solution of indoline 133a (59.2 mg, 
0.30 mmol, 1.00 equiv) in mesitylene (1.3 mL) and CD3OD (0.2 mL) were added via syringe 
and the resulting mixture was stirred under ambient air for 20 h at 140 °C. After cooling 
to ambient temperature, the reaction mixture was diluted with Et2O (10 mL) and filtered 
through a short pad of silica. The filtrate was concentrated, and the crude residue was 
purified by column chromatography on silica gel (n-pentane/Et2O: 3/1) yielding the 
product 135aa (9.0 mg, 10%) and reisolated [D]n-133a (50.0 mg, 85%). 
 
Figure 5.6: 1H-NMR spectra of reisolated [D]n-133a. 
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5.4 Visible Light-Induced Decarboxylative C–H Adamantylation 
5.4.1 Synthesis and Characterization of Starting Materials 
The following benzothiazoles 140b-140j have been prepared in the course of the bachelor 
thesis of N. Imse.[190] They were prepared according a previously described procedure 
starting from 2-aminobenzothiazoles.[220] For compounds that had not been reported 
before, the analytical data is given below. 
 
 
6-(Trifluoromethyl)benzo[d]thiazole (140d) 
M. p.: 36–40 °C. 1H-NMR (300 MHz, CDCl3): δ  = 9.16 (s, 1H), 8.29–8.27 (m, 1H), 8.26–8.22 
(m, 1H), 7.78–7.75 (m, 1H). 13C-NMR (126 MHz, CDCl3): δ = 156.7 (CH), 155.0 (Cq), 133.8 
(Cq), 127.8 (q, 2JC-F = 32.7 Hz, Cq), 124.1 (CH), 124.0 (q, 1JC-F = 272 Hz, Cq), 123.1 (q, 3JC-F = 
3.0 Hz, CH), 119.6 (q, 3JC-F = 4.1 Hz, CH). 19F-NMR (282 MHz, CDCl3): δ = -61.5 (s). IR (ATR): 
1315, 1293, 1160, 1102, 1077, 1046, 886, 843, 818, 718 cm⁻1. MS (ESI) m/z (relative 
intensity): 373 (100), 204 [M+H]+ (45). HR-MS (ESI): m/z calcd for C8H5F3NS+ [M+H]+ 
204.0089, found 204.0092. 
 
 
Benzo[d]thiazole-6-carbonitrile (140j) 
M. p.: 136–137 °C. 1H-NMR (300 MHz, CDCl3): δ  = 9.19 (s, 1H), 8.30 (s, 1H), 8.20 (d, J = 
8.5 Hz, 1H), 7.75 (dd, J = 8.5, 1.2 Hz, 1H). 13C-NMR (126 MHz, CDCl3): δ = 157.9 (CH), 155.4 
(Cq), 134.3 (Cq), 129.2 (CH), 126.9 (CH), 124.5 (CH), 118.5 (Cq), 109.3 (Cq). IR (ATR): 1469, 
1401, 1290, 1261, 897, 851, 833, 821, 772, 610 cm⁻1. MS (ESI) m/z (relative intensity): 161 
[M+H]+ (100). HR-MS (ESI): m/z calcd for C8H5N2S+ [M+H]+ 161.0168, found 161.0169. 
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Ethyl benzo[d]thiazole-6-carboxylate (140h) 
M. p.: 59–62 °C. 1H-NMR (300 MHz, CDCl3): δ  = 9.12 (s, 1H), 8.68 (s, 1H), 8.19-8.12 (m, 
2H), 4.40 (q, J = 7.2 Hz, 2H), 1.41 (t, J = 7.2 Hz, 3H). 13C-NMR (126 MHz, CDCl3): δ = 165.9 
(Cq), 157.0 (CH), 155.8 (Cq), 133.6 (Cq), 127.7 (Cq), 127.2 (CH), 124.0 (CH), 123.3 (CH), 61.3 
(CH2), 14.4 (CH3). IR (ATR): 1702, 1279, 1246, 1130, 1101, 1019, 856, 767, 746, 727 cm⁻1. 
MS (ESI) m/z (relative intensity): 208 [M+H]+ (100). HR-MS (ESI): m/z calcd for C10H10NO2S+ 
[M+H]+ 208.0427, found 208.0431. 
 
The following compound was prepared according to a modified literature procedure.[221] 
 
tert-Butyl benzo[d]oxazole-6-carboxylate (14f) 
To a solution of benzo[d]oxazole-6-carboxylic acid (510 mg, 3.13 mmol, 1.00 equiv) in 
CH2Cl2 (15 mL) DMF (0.1 mL) was added and the solution was cooled to 0 °C. Oxalyl 
chloride (597 mg, 4.70 mmol, 1.50 equiv) was added dropwise at 0 °C. The solution was 
allowed to warm to ambient temperature and was stirred for 1.5 h. A mixture of 
tert-butanol and pyridine (1:1, 6 mL) was added dropwise and the solution was stirred for 
20 h. The solvent was removed under reduced pressure and H2O (20 mL) and EtOAc 
(20 mL) were added. The phases were separated, and the aqueous phase was extracted 
with EtOAc (2 x 20 mL). The combined organic layers were washed with brine and dried 
over Na2SO4. The solvent was removed under reduced pressure yielding the crude product 
as a brown oil. Purification of the residue by column chromatography on silica gel 
(n-pentane/Et2O: 10/1→6/1) yielded 14f (360 mg, 1.64 mmol, 52%) as a white solid.  
 
M. p.: 70–72 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.20 (dd, J = 1.5, 0.6 Hz, 1H), 8.18 (s, 1H), 
8.03 (dd, J = 8.4, 1.5 Hz, 1H), 7.77 (dd, J = 8.4, 0.6 Hz, 1H), 1.60 (s, 9H). 13C NMR (76 MHz, 
Experimental Section 
155 
CDCl3): δ = 165.0 (Cq), 154.6 (CH), 149.6 (Cq), 143.4 (Cq), 129.8 (Cq), 126.1 (CH), 120.0 (CH), 
112.5 (CH), 81.5 (Cq), 28.2 (CH3). IR (ATR): 1700, 1316, 1299, 1166, 1114, 1066, 844, 771, 
748, 424 cm⁻1. MS (ESI) m/z (relative intensity): 337 (100), 242 [M+Na]+ (58), 220 [M+H]+ 
(3). HR-MS (ESI): m/z calcd for C12H14NO3+ [M+H]+ 220.0968, found 220.0961.  
 
5.4.2 Analytical Data 
 
2-[(3R,5R,7R)-Adamantan-1-yl]benzo[d]thiazole (142a) 
The general procedure B was followed using benzothiazole 140a (54.1 mg, 0.40 mmol) 
and 1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 24 h. Purification by 
column chromatography on silica gel (n-pentane/Et2O: 30/1) yielded 142a. (89.3 mg, 
331 μmol, 83%) as a white solid. 
M. p.: 103–104 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.00 (ddd, J = 8.2, 1.2, 0.7 Hz, 1H), 7.86 
(ddd, J = 7.2, 1.2, 0.7 Hz, 1H), 7.44 (ddd, J = 8.2, 7.2, 1.2 Hz, 1H), 7.32 (ddd, J = 8.2, 7.2, 1.2 
Hz, 1H), 2.18–2.12 (m, 9H), 1.86–1.81 (m, 6H). 13C NMR (101 MHz, CDCl3): δ = 182.3 (Cq), 
153.3 (Cq), 134.5 (Cq), 125.8 (CH), 124.5 (CH), 122.8 (CH), 121.7 (CH), 43.1 (CH2), 40.3 (Cq), 
36.7 (CH2), 28.7 (CH). IR (ATR): 2898, 2845, 1506, 1434, 1168, 999, 963, 754, 725, 680 
cm⁻1. MS (ESI) m/z (relative intensity): 270 [M+H]+ (100). HR-MS (ESI): m/z calcd for 
C17H20NS+ [M+H]+ 270.1311, found 270.1313. The analytical data are in accordance with 
those reported in the literature.[171a] 
 
 
2-[(3R,5R,7R)-Adamantan-1-yl]-6-methylbenzo[d]thiazole (142b) 
The general procedure B was followed using benzothiazole 140b (59.7 mg, 0.40 mmol) 
and 1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 24 h. After aqueous 
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workup, purification by column chromatography on silica gel (n-pentane/Et2O: 30/1) 
yielded 142b (60.6 mg, 214 μmol, 53%) as a white solid. 
M. p.: 132–133 °C. 1H-NMR (400 MHz, CDCl3): δ = 7.87 (d, J = 8.3 Hz, 1H), 7.65–7.62 (m, 
1H), 7.24 (ddd, J = 8.2, 1.7, 0.6 Hz, 1H), 2.46 (s, 3H), 2.16–2.11 (m, 9H), 1.83–1.80 (m, 
6H). 13C-NMR (101 MHz, CDCl3): δ = 181.2 (Cq), 151.4 (Cq), 134.6 (Cq), 134.5 (Cq), 127.3 
(CH), 122.2 (CH), 121.4 (CH), 43.1 (CH2), 40.2 (Cq), 36.7 (CH2), 28.7 (CH), 21.6 (CH3). IR 
(ATR): 2899, 2845, 1510, 1449, 1164, 1000, 835, 812, 679, 569 cm⁻1. MS (ESI) m/z (relative 
intensity): 284 [M+H]+ (100). HR-MS (ESI): m/z calcd for C18H22NS+ [M+H]+ 284.1467, found 
284.1471. The analytical data are in accordance with those reported in the literature.[222] 
 
 
2-[(3R,5R,7R)-Adamantan-1-yl]-6-methoxylbenzo[d]thiazole (142c) 
The general procedure B was followed using benzothiazole 140c (66.1 mg, 0.40 mmol) 
and 1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 24 h. Purification by 
column chromatography on silica gel (n-pentane/Et2O: 25/1) yielded 142c (70.2 mg, 
234 μmol, 59%) as a white solid. 
M. p.: 118–119 °C. 1H-NMR (400 MHz, CDCl3): δ = 7.87 (dd, J = 8.9, 0.4 Hz, 1H), 7.31 (d, 
J = 2.5 Hz, 1H), 7.03 (dd, J = 8.9, 2.5 Hz, 1H), 3.85 (s, 3H), 2.15–2.11 (m, 9H), 1.82-1.79 (m, 
6H). 13C-NMR (101 MHz, CDCl3) δ = 179.8 (Cq), 157.3 (Cq), 147.8 (Cq), 135.7 (Cq), 123.2 (CH), 
114.9 (CH), 104.4 (CH), 55.9 (CH3), 43.1 (CH2), 40.1 (Cq), 36.7 (CH2), 28.7 (CH). IR (ATR): 
2904, 1467, 1450, 1435, 1261, 1223, 1028, 1000, 834, 827 cm⁻1. MS (ESI) m/z (relative 
intensity): 300 [M+H]+ (100). HR-MS (ESI): m/z calcd for C18H22NOS+ [M+H]+ 300.1417, 
found 300.1419. The analytical data are in accordance with those reported in the 
literature.[222] 
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2-[(3R,5R,7R)-Adamantan-1-yl]-6-(trifluoromethyl)benzo[d]thiazole (142d) 
The general procedure B was followed using benzothiazole 140d (81.3 mg, 0.40 mmol) 
and 1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 48 h. Purification by 
column chromatography on silica gel (n-pentane/Et2O: 30/1) yielded 142d. (96.3 mg, 
285 μmol, 71%) as a white solid. 
M. p.: 183–184 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.15 (dq, J = 1.8, 0.7 Hz, 1H), 8.07 (dt, J 
= 8.6, 0.7 Hz, 1H), 7.68 (ddd, J = 8.6, 1.8, 0.7 Hz, 1H), 2.19–2.14 (m, 9H), 1.87–1.80 (m, 6H). 
13C-NMR (101 MHz, CDCl3): δ = 185.7 (Cq), 155.4 (Cq), 134.7 (Cq), 126.8 (q, 2JC-F = 32.7 Hz, 
Cq), 124.4 (q, 1JC-F = 272  Hz, Cq) 123.1 (CH), 122.8 (q, 3JC-F = 3.5 Hz, CH), 119.2 (q, 
3JC-F = 4.2 Hz, CH) 43.1 (CH2), 40.7 (Cq), 36.6 (CH2), 28.7 (CH). 19F{H}-NMR (376 MHz, CDCl3): 
δ = –61.3 (s). IR (ATR): 2911, 1317, 1278, 1163, 1112, 1085, 1001, 880, 829, 681 cm⁻1. 
MS (ESI) m/z (relative intensity): 338 [M+H]+ (13), 300 (100). HR-MS (ESI): m/z calcd for 
C18H19F3NS+ [M+H]+ 338.1185, found 338.1188. 
 
 
2-[(3R,5R,7R)-Adamantan-1-yl]-6-fluorobenzo[d]thiazole (142e) 
The general procedure B was followed using benzothiazole 140e (61.3 mg, 0.40 mmol) 
and 1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 24 h. Purification by 
column chromatography on silica gel (n-pentane/Et2O: 30/1) yielded 142e (62.1 mg, 
216 μmol, 54%) as a white solid. 
M. p.: 107–108 °C. 1H-NMR (400 MHz, CDCl3): δ = 7.91 (ddd, J = 8.9, 4.8, 0.4 Hz, 1H), 7.52 
(ddd, J = 8.2, 2.6, 0.4 Hz, 1H), 7.16 (ddd, J = 8.9, 8.2, 2.6 Hz, 1H), 2.16–2.12 (m, 9H), 1.83–
1.79 (m, 6H). 13C-NMR (101 MHz, CDCl3): δ = 182.0 (d, 5JC-F = 3.1 Hz, Cq), 160.2 (d, 1JC-F 
= 244.2 Hz, Cq), 149.9 (d, 4JC-F = 1.6 Hz, Cq), 135.5 (d, 3JC-F = 11.2 Hz, Cq), 123.6 (d, 3JC-F 
= 9.4 Hz, CH), 114.3 (d, 2JC-F = 24.6 Hz, CH), 107.8 (d, 3JC-F = 26.4 Hz, CH), 43.1 (CH2), 40.4 
(Cq), 36.6 (CH2), 28.7 (CH). 19F{H}-NMR (376 MHz, CDCl3): δ = –117.4 (s). IR (ATR): 2911, 
2889, 1454, 1245, 1161, 1001, 915, 836, 800, 791 cm⁻1. MS (ESI) m/z (relative intensity): 
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288 [M+H]+ (100). HR-MS (ESI): m/z calcd for C17H19NSF+ [M+H]+ 288.1217, found 
288.1219. 
 
 
2-[(3R,5R,7R)-Adamantan-1-yl]-6-chlorobenzo[d]thiazole (142f) 
The general procedure B was followed using benzothiazole 140f (67.9 mg, 0.40 mmol) and 
1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 30/1) yielded 142f (71.8 mg, 236 μmol, 
59%) as a white solid. 
M. p.: 145–146 °C. 1H-NMR (400 MHz, CDCl3): δ = 7.88 (dd, J = 8.7, 0.4 Hz, 1H), 7.81 (dd, 
J = 2.1, 0.4 Hz, 1H), 7.38 (dd, J = 8.7, 2.1 Hz, 1H), 2.16–2.11 (m, 9H), 1.84–1.79 (m, 6H). 13C-
NMR (101 MHz, CDCl3): δ = 182.8 (Cq), 151.9 (Cq), 135.8 (Cq), 130.4 (Cq), 126.6 (CH), 123.5 
(CH), 121.3 (CH), 43.1 (CH2), 40.4 (Cq), 36.6 (CH2), 28.7 (CH). IR (ATR): 2898, 2844, 1514, 
1435, 1259, 1097, 999, 802, 768, 680 cm⁻1. MS (ESI) m/z (relative intensity): 304 [M+H]+ 
(100). HR-MS (ESI): m/z calcd for C17H1935ClNS+ [M+H]+ 304.0921, found 304.0924. The 
analytical data are in accordance with those reported in the literature.[222] 
 
 
2-[(3R,5R,7R)-Adamantan-1-yl]-6-bromobenzo[d]thiazole (142g) 
The general procedure B was followed using benzothiazole 140g (85.6 mg, 0.40 mmol) 
and 1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 24 h. Purification by 
column chromatography on silica gel (n-pentane/Et2O: 30/1) yielded 142g (75.1 mg, 
216 μmol, 54%) as a white solid. 
M. p.: 182–183 °C. 1H-NMR (400 MHz, CDCl3): δ = 7.97 (dd, J = 2.0, 0.4 Hz, 1H), 7.82 (dd, 
J = 8.7, 0.4 Hz, 1H), 7.52 (dd, J = 8.7, 2.0 Hz, 1H), 2.16– 2.11 (m, 9H), 1.83–1.78 (m, 6H). 
13C-NMR (76 MHz, CDCl3): δ = 182.9 (Cq), 152.2 (Cq), 136.3 (Cq), 129.2 (CH), 124.2 (CH), 
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123.9 (CH), 118.0 (Cq), 43.0 (CH2), 40.4 (Cq), 36.6 (CH2), 28.6 (CH). IR (ATR): 2907, 2847, 
1438, 1269, 1086, 1000, 860, 814, 804, 682 cm⁻1. MS (ESI) m/z (relative intensity): 348 
[M+H]+ (100) (79Br). HR-MS (ESI): m/z calcd for C17H1979BrNS+ [M+H]+ 348.0416, found 
348.0420.  
 
 
Ethyl 2-[(3R,5R,7R)-adamantan-1-yl]benzo[d]thiazole-6-carboxylate (142h) 
The general procedure B was followed using benzothiazole 140h (82.9 mg, 0.40 mmol) 
and 1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 48 h. Purification by 
column chromatography on silica gel (n-pentane/Et2O: 15/1) yielded 142h (60.0 mg, 
176 μmol, 44%) as a white solid. 
M. p.: 131–133 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.58 (dd, J = 1.7, 0.6 Hz, 1H), 8.12 (dd, 
J = 8.6, 1.7 Hz, 1H), 8.00 (dd, J = 8.6, 0.6 Hz, 1H), 4.41 (q, J = 7.1 Hz, 2H), 2.16–2.12 (m, 9H), 
1.84–1.80 (m, 6H), 1.41 (t, J = 7.1 Hz, 3H). 13C-NMR (101 MHz, CDCl3): δ = 186.0 (Cq), 166.4 
(Cq), 156.3 (Cq), 134.4 (Cq), 127.1 (CH), 126.7 (Cq), 123.9 (CH), 122.4 (CH), 61.3 (CH2), 43.0 
(CH2), 40.7 (Cq), 36.6 (CH2), 28.6 (CH), 14.5 (CH3). IR (ATR): 2899, 1707, 1272, 1231, 1106, 
1001, 850, 772, 730, 681 cm⁻1. MS (ESI) m/z (relative intensity): 342 [M+H]+ (100). HR-MS 
(ESI): m/z calcd for C20H24NO2S+ [M+H]+ 342.1522, found 342.1524. 
 
 
1-{2-[(3R,5R,7R)-adamantan-1-yl]benzo[d]thiazol-6-yl}ethan-1-one (142i) 
The general procedure B was followed using benzothiazole 140i (70.9 mg, 0.40 mmol) and 
1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 48 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 5/1) yielded 142i (40.3 mg, 129 μmol, 32%) 
as a white solid. 
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M. p.: 121–122 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.50 (dd, J = 1.6, 0.8 Hz, 1H), 8.04 (dd, 
J = 8.6, 1.6 Hz, 1H), 8.01 (dd, J = 8.6, 0.8 Hz, 1H), 2.67 (s, 3H), 2.18–2.12 (m, 9H), 1.84–1.80 
(m, 6H). 13C-NMR (101 MHz, CDCl3): δ = 197.4 (Cq), 186.6 (Cq), 156.4 (Cq), 134.9 (Cq), 133.5 
(Cq), 126.1 (CH), 122.7 (CH), 122.6 (CH), 43.0 (CH2), 40.8 (Cq), 36.6 (CH2), 28.6 (CH), 27.0 
(CH3). IR (ATR): 2916, 2878, 1676, 1451, 1348, 1267, 1236, 1004, 824, 586 cm⁻1. MS (ESI) 
m/z (relative intensity): 312 [M+H]+ (100). HR-MS (ESI): m/z calcd for C19H22NOS+ [M+H]+ 
312.1417, found 312.1419. 
 
 
2-[(3R,5R,7R)-Adamantan-1-yl]benzo[d]thiazole-6-carbonitrile (142j) and 2-[(1S,3S)-
Adamantan-1-yl]-2,3-dihydrobenzo[d]thiazole-6-carbonitrile (142j’) 
The general procedure B was followed using benzothiazole 140j (64.1 mg, 0.40 mmol) and 
1-adamantanecarboxylic acid (141) (180 mg, 0.90 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 10/1→5/1) yielded benzothiazole 142j 
(21.0 mg, 71.3 μmol, 18%) and the dihydrobenzothiazole 142j’ (35.0 mg, 118 μmol, 30%) 
as white solids. 
2-[(3R,5R,7R)-Adamantan-1-yl]benzo[d]thiazole-6-carbonitrile (142j) 
M. p.: 172-173 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.19 (dd, J = 1.6, 0.7 Hz, 1H), 8.04 (dd, 
J = 8.5, 0.6 Hz, 1H), 7.68 (dd, J = 8.5, 1.6 Hz, 1H), 2.15 (s, 9H), 1.83 (s, 6H). 13C-NMR 
(101 MHz, CDCl3): δ = 187.0 (Cq), 155.8 (Cq), 135.1 (Cq), 129.1 (CH), 126.6 (CH), 123.6 (CH), 
119.1 (Cq), 108.0 (Cq), 43.0 (CH2), 40.9 (Cq), 36.5 (CH2), 28.6 (CH). IR (ATR): 2898, 2855, 
2230, 1506, 1448, 1156, 996, 871, 817, 595 cm⁻1. MS (ESI) m/z (relative intensity): 474 
(100), 318 (90), 317 [M+Na]+ (79), 295 [M+H]+ (72). HR-MS (ESI): m/z calcd for 
C18H18N2SNa+ [M+Na]+ 317.1083, found 317.1080. The analytical data are in accordance 
with those reported in the literature.[222] 
2-[(1S,3S)-Adamantan-1-yl]-2,3-dihydrobenzo[d]thiazole-6-carbonitrile (142j’) 
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M. p.: 56-58 °C. 1H-NMR (400 MHz, CDCl3): δ = 7.20–7.09 (m, 2H), 6.45 (d, J = 8.1 Hz, 1H), 
5.08 (d, J = 2.1 Hz, 1H), 4.79 (s, 1H), 2.03 (t, J = 3.2 Hz, 3H), 1.76–1.68 (m, 3H), 1.67–1.56 
(m, 6H), 1.53–1.46 (m, 3H). 13C-NMR (101 MHz, CDCl3): δ = 151.2 (Cq), 130.8 (CH), 127.1 
(Cq), 124.1 (CH), 120.2 (Cq), 106.9 (CH), 100.8 (Cq), 78.6 (CH), 38.8 (Cq), 37.8 (CH2), 36.9 
(CH2), 28.1 (CH). IR (ATR): 3348, 2900, 2846, 2209, 1586, 1489, 1448, 1192, 811, 585 cm⁻1. 
MS (ESI) m/z (relative intensity): 319 [M+Na]+ (42), 297 [M+H]+ (81), 231 (100). HR-MS 
(ESI): m/z calcd for C18H20N2SNa+ [M+Na]+ 319.1239, found 319.1236. 
 
 
2-[(3R,5R,7R)-Adamantan-1-yl]-5-(tert-butyl)benzo[d]oxazole (143b) 
The general procedure B was followed using benzoxazole 14b (66.1 mg, 0.40 mmol) and 
1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 48 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 20/1) yielded 143b (56.0 mg, 182 μmol, 
45%) as a white solid. 
M. p.: 159–160 °C. 1H-NMR (600 MHz, CDCl3): δ = 7.74 (dd, J = 2.0, 0.6 Hz, 1H), 7.39 (dd, 
J = 8.6, 0.6 Hz, 1H), 7.34 (dd, J = 8.6, 2.0 Hz, 1H), 2.15–2.13 (m, 6H), 2.12–2.10 (m, 3H), 
1.81 (t, J = 2.9 Hz, 6H), 1.36 (s, 9H). 13C-NMR (126 MHz, CDCl3): δ = 173.2 (Cq), 148.5 (Cq), 
147.5 (Cq), 141.2 (Cq), 121.9 (CH), 116.4 (CH), 109.5 (CH), 40.5 (CH2), 36.7 (CH2), 36.3 (Cq), 
35.0 (Cq), 32.0 (CH3), 28.2 (CH). IR (ATR): 2906, 2849, 1561, 1480, 1452, 1272, 1041, 924, 
800 cm⁻1. MS (ESI) m/z (relative intensity): 332 [M+Na]+ (2), 310 [M+H]+ (100). HR-MS 
(ESI): m/z calcd for C21H28NO [M+H]+ 310.2165, found 310.2168. 
 
 
2-[(3R,5R,7R)-Adamantan-1-yl]-5-bromobenzo[d]oxazole (143c) 
The general procedure B was followed using benzoxazole 14c (79.2 mg, 0.40 mmol) and 
1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 48 h. Purification by column 
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chromatography on silica gel (n-pentane/Et2O: 20/1) yielded 143c (56.1 mg, 169 μmol, 
42%) as a white solid. 
M. p.:135–136 °C. 1H-NMR (600 MHz, CDCl3): δ = 7.80 (d, J = 1.9 Hz, 1H), 7.38 (dd, J = 8.4, 
1.9 Hz, 1H), 7.34 (d, J = 8.4 Hz, 1H), 2.14–2.11 (m, 9H), 1.84–1.77 (m, 6H). 13C-NMR 
(126 MHz, CDCl3): δ = 174.2 (Cq), 150.0 (Cq), 143.0 (Cq), 127.3 (CH), 122.8 (CH), 116.7 (Cq), 
111.6 (CH), 40.3 (CH2), 36.6 (CH2), 36.4 (Cq), 28.1 (CH). IR (ATR): 2905, 2849, 1555, 1444, 
1253, 1040, 907, 871, 798, 682 cm⁻1. MS (ESI) m/z (relative intensity): 334 [M+H]+ (97) 
(81Br), 332 [M+H]+ (100) (79Br). HR-MS (ESI): m/z calcd for C17H1979BrNO+ [M+H]+ 332.0645, 
found 332.0648. 
 
 
2-[(3R,5R,7R)-Adamantan-1-yl]-6-methylbenzo[d]oxazole (143d) 
The general procedure B was followed using benzoxazole 14d (53.3 mg, 0.40 mmol) and 
1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 48 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 20/1) yielded 143d (53.0 mg, 198 μmol, 
50%) as a white solid. 
M. p.: 112–114 °C. 1H-NMR (400 MHz, CDCl3): δ = 7.55 (d, J = 8.1 Hz, 1H), 7.29–7.27 (m, 
1H), 7.11–7.08 (m, 1H), 2.46 (s, 3H), 2.16–2.10 (m, 9H), 1.83–1.79 (m, 6H). 13C-NMR 
(101 MHz, CDCl3): δ = 172.6 (Cq), 150.9 (Cq), 139.1 (Cq), 134.7 (Cq), 125.2 (CH), 119.1 (CH), 
110.7 (CH), 40.4 (CH2), 36.6 (CH2), 36.2 (Cq), 28.1 (CH), 21.8 (CH3). IR (ATR): 2908, 2849, 
1566, 1451, 1263, 1234, 1040, 919, 809, 602 cm⁻1. MS (ESI) m/z (relative intensity): 290 
[M+Na]+ (9), 268 [M+H]+ (100). HR-MS (ESI): m/z calcd for C18H22NO [M+H]+ 268.1696, 
found 268.1697. 
 
 
2-[(3R,5R,7R)-Adamantan-1-yl]-6-chlorobenzo[d]oxazole (143e) 
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The general procedure B was followed using benzoxazole 14e (50.2 mg, 0.40 mmol) and 
1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 48 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 10/1) yielded 143e (52.5 mg, 182 μmol, 
46%) as a white solid. 
M. p.: 150–152 °C. 1H-NMR (400 MHz, CDCl3): δ = 7.58 (dd, J = 8.5, 0.4 Hz, 1H), 7.50–7.46 
(m, 1H), 7.26 (dd, J = 8.5, 2.0 Hz, 1H), 2.16–2.10 (m, 9H), 1.84–1.78 (m, 6H). 13C-NMR 
(101 MHz, CDCl3): δ = 173.8 (Cq), 150.9 (Cq), 140.2 (Cq), 130.0 (Cq), 124.7 (CH), 120.3 (CH), 
111.2 (CH), 40.3 (CH2), 36.6 (CH2), 36.3 (Cq), 28.0 (CH). IR (ATR): 2915, 2851, 1609, 1564, 
1460, 1039, 819, 800, 702, 599 cm⁻1. MS (ESI) m/z (relative intensity): 288 [M+H]+ (60). 
HR-MS (ESI): m/z calcd for C17H19NO35Cl [M+H]+ 288.1150, found 288.1153. 
 
 
tert-Butyl 2-[(3R,5R,7R)-adamantan-1-yl]benzo[d]oxazole-6-carboxylate (143f) 
The general procedure B was followed using benzoxazole 14f (87.7 mg, 0.40 mmol) and 
1-adamantanecarboxylic acid (141) (216 mg, 1.20 mmol) for 48 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 10/1) yielded 143f (52.8 mg, 161 μmol, 
40%) as a white solid. 
M. p.: 116–118 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.12 (dd, J = 1.5, 0.6 Hz, 1H), 7.98 (dd, 
J = 8.3, 1.5 Hz, 1H), 7.67 (dd, J = 8.3, 0.6 Hz, 1H), 2.17–2.10 (m, 9H), 1.83–1.79 (m, 6H), 
1.60 (s, 9H). 13C-NMR (101 MHz, CDCl3): δ = 175.6 (Cq), 165.5 (Cq), 150.3 (Cq), 145.0 (Cq), 
128.6 (Cq), 125.8 (CH), 119.1 (CH), 112.0 (CH), 81.3 (Cq), 40.2 (CH2), 36.5 (CH2), 36.5 (Cq), 
28.4 (CH3), 28.0 (CH). IR (ATR): 2904, 1710, 1291, 1268, 1244, 1154, 1044, 943, 777 cm⁻1. 
MS (ESI) m/z (relative intensity): 354 [M+H]+ (100), 298 (14). HR-MS (ESI): m/z calcd for 
C22H28NO3 [M+H]+ 354.2064, found 354.2064. 
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8-[(3R,5R,7R)-Adamantan-1-yl]-1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione (164) 
The general procedure B was followed using caffeine 162 (77.6 mg, 0.40 mmol) and 1-
adamantanecarboxylic acid (141) (180 mg, 1.20 mmol) for 48 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 1/1) yielded 164 (80.4 mg, 245 μmol, 61%) 
as a white solid. 
M. p.: 263–264 °C. 1H-NMR (400 MHz, CDCl3): δ = 4.15 (s, 3H), 3.54 (s, 3H), 3.37 (s, 3H), 
2.16–2.08 (m, 9H), 1.81–1.74 (m, 6H). 13C-NMR (101 MHz, CDCl3): δ = 159.6 (Cq), 155.8 
(Cq), 151.9 (Cq), 147.2 (Cq), 108.2 (Cq), 40.0 (CH2), 36.9 (Cq), 36.6 (CH2), 34.5 (CH3), 29.7 
(CH3), 28.3 (CH), 28.0 (CH3). IR (ATR): 2895, 1700, 1660, 1539, 1426, 1361, 1223, 982, 
743 cm⁻1. MS (ESI) m/z (relative intensity): 329 [M+H]+ (100). HR-MS (ESI): m/z calcd for 
C18H25N4O2+ [M+H]+ 329.1972, found 329.1969.  
The analytical data are in accordance with those reported in the literature.[145c] 
 
 
8-[(3R,5R,7R)-Adamantan-1-yl]-7-[2-(methoxymethoxy)propyl]-1,3-dimethyl-3,7-
dihydro-1H-purine-2,6-dione (165) 
The general procedure B was followed using substrate 163 (85.0 mg, 0.30 mmol) and 1-
adamantanecarboxylic acid (141) (162 mg, 0.90 mmol) for 48 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 10/1) yielded 165 (53.5 mg, 129 μmol, 
43%) as a white solid. 
M. p.: 147–148 °C. 1H-NMR (400 MHz, CDCl3): δ = 4.55–4.46 (m, 2H), 4.41 (dd, J = 14.0, 
3.6 Hz, 1H), 4.28–4.22 (m, 2H), 3.56 (s, 3H), 3.38 (s, 3H), 3.01 (s, 3H), 2.25–2.06 (m, 9H), 
Experimental Section 
165 
1.80–1.75 (m, 6H), 1.27 (d, J = 6.3 Hz, 3H). 13C-NMR (101 MHz, CDCl3): δ = 160.8 (Cq), 155.4 
(Cq), 151.9 (Cq), 147.8 (Cq), 107.6 (Cq), 95.3 (CH2), 73.1 (CH), 55.2 (CH3), 52.4 (CH2), 41.4 
(CH2), 37.6 (Cq), 36.6 (CH2), 29.7 (CH3), 28.5 (CH), 28.1 (CH3), 18.4 (CH3). IR (ATR): 2890, 
1165, 1536, 1426, 1382, 1137, 1105, 1035, 743 cm⁻1. MS (ESI) m/z (relative intensity): 439 
[M+Na]+ (100), 417 [M+H]+ (99). HR-MS (ESI): m/z calcd for C22H32N4O4Na+ [M+Na]+ 
439.2316, found 439.2319. 
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5.4.3 Mechanistic Studies 
5.4.3.1 Reaction in the Presence of Radical Scavengers 
 
 
To an oven-dried 10 mL vial were added benzothiazole 140a (0.40 mmol, 1.00 equiv), 
1-adamantanecarboxylic acid (141) (1.20 mmol, 3.00 equiv), K2HPO4 (209 mg, 1.20 mmol, 
3.00 equiv), 9-mesityl-10-methylacridinium perchlorate (8.2 mg, 5.00 mol %), 
Co(dmgH)2Cl2 (11.6 mg, 8.00 mol %), and radical scavenger (0.40 mmol, 1.00 equiv). After 
the vial was capped with a septum it was evacuated and refilled with N2 for three times 
before DCE (1.5 mL) and H2O (0.5 mL) were added sequentially. The mixture was degassed 
and stirred for 24 h under visible light irradiation. After 24 h the mixture was diluted with 
CH2Cl2 (10 mL) and H2O (10 mL) and the phases were separated. The aqueous layer was 
extracted with CH2Cl2 (2 x 10 mL), the combined organic phases were dried over Na2SO4 
and the solvent was removed under reduced pressure. The residue was purified by 
column chromatography on silica gel (n-pentane or n-hexane/Et2O = 10/1) affording the 
corresponding product 142a. 
Table 5.2: Effect of Radical Scavengers on the reaction.[a] 
Entry Radical scavenger (1.0 equiv) Yield [%] 
1 -- 84 
2 TEMPO 34 
3 Galvinoxyl free radical -- 
4 BHT 53 
5 BHT (3.0 equiv) 36 
aTEMPO = (2,2,6,6-Tetramethylpiperidin-1-yl)oxidanyl. BHT = 2,6-Di-tert-butyl-4-methylphenol, 
yield of isolated product. 
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5.4.3.2 Competition Experiment Between Benzothiazoles 140 
 
The general procedure B was followed using benzothiazole 140e (61.3 mg, 0.40 mmol) 
and 140b (-Me, 59.7 mg, 0.40 mmol) as well as 1-adamantanecarboxylic acid (141) 
(72.0 mg, 0.40 mmol). After aqueous workup and removal of remaining solvent, the crude 
mixture was analyzed by 1H/19F-NMR spectroscopy (Figure 5.7 and Figure 5.8) using 4-
fluoroanisole as internal standard (14.5 mg, 0.115 mmol).  
  
Figure 5.7: 1H-NMR spectra of the reaction mixture after aqueous workup. 
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Figure 5.8: 19F-NMR spectra of the reaction mixture after aqueous workup. 
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5.4.3.3 Effect of Light: On/Off Plot 
According to the general procedure B, five independent reaction were set up and placed 
in front of the LEDs. The reactions were sequentially stirred under visible light irradiation 
and in the absence of light. Every two hours a reaction was removed from the setup and 
workup was performed according to the general procedure. After a total of ten hours the 
obtained isolated yields were plotted against the reaction time. 
 
Figure 5.9: Effect of visible light irradiation. 
 
5.4.3.4 Fluorescence quenching experiments 
Sample solutions were prepared in DCE with c([Acr-Mes]+(ClO)4⁻ = 1.6 x 10⁻7 M and 
varying concentrations of the respective quencher, added to each sample from a stock 
solution. Stern-Volmer experiments were conducted with a fixed excitation wavelength 
of 430 nm and detection at 518 nm (emission maximum). Plotting of the I0/I value against 
the concentration of the potential quencher yielded the following graphs. 
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Figure 5.10: Fluorescence quenching of 161 with 140a. 
 
 
Figure 5.11: Fluorescence quenching of 161 with 1-adamantanecarboxylic acid (141). 
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Figure 5.12: Fluorescence quenching of 161 with the carboxylate 167. 
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5.5 Photo-Induced Copper-Catalyzed C–H Arylation 
5.5.1 Photo-Induced Copper-Catalyzed C–H Arylation using UV Irradiation 
5.5.1.1 Analytical Data 
 
2-(m-Tolyl)benzo[d]thiazole (145ac) 
The general procedure C was followed using benzo[d]thiazole (140a) (33.8 mg, 
0.25 mmol) and 1-iodo-3-methylbenzene (11c) (273 mg, 1.25 mmol). Purification by 
column chromatography on silica gel (n-pentane/Et2O: 30/1→20/1) yielded 145ac 
(39.5 mg, 211 μmol,70%) as a slightly yellow liquid. 
1H-NMR (400 MHz, CDCl3): δ = 8.08 (ddd, J = 8.2, 1.2, 0.7 Hz, 1H), 7.96–7.94 (m, 1H), 7.90 
(ddd, J = 8.0, 1.3, 0.7 Hz, 1H), 7.89–7.85 (m, 1H), 7.50 (ddd, J = 8.3, 7.2, 1.3 Hz, 1H), 7.39 
(ddd, J = 8.1, 7.2, 1.0 Hz, 2H), 7.33–7.29 (m, 1H), 2.46 (s, 3H). 13C-NMR (101 MHz, CDCl3): 
δ = 168.5 (Cq), 154.3 (Cq), 139.0 (Cq), 135.2 (Cq), 133.7 (Cq), 131.9 (CH), 129.1 (CH), 128.1 
(CH), 126.4 (CH), 125.2 (CH), 125.0 (CH), 123.3 (CH), 121.7 (CH), 21.5 (CH3). IR (ATR): 1503, 
1483, 1471, 1456, 1434, 1312, 1255, 785, 757, 728 cm⁻1. MS (EI) m/z (relative intensity): 
226 [M+H]+ (100). HR-MS (ESI): m/z calcd for C14H12NS, [M+H]+ 226.0685, found 226.0686. 
The analytical data are in accordance with those reported in the literature.[223] 
 
 
5-(Benzo[d][1,3]dioxol-5-yl)-2-phenyloxazole (146a) 
The general procedure C was followed using 5-(benzo[d][1,3]dioxol-5-yl)oxazole (144) 
(47.3 mg, 0.25 mmol) and iodobenzene (11a) (255 mg, 1.25 mmol). Purification by column 
chromatography (n-pentane/Et2O: 5/1) yielded 146a (41.1 mg, 155 μmol, 62%) as a pale 
yellow solid.  
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M. p.: 136–138 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.10–8.06 (m, 2H), 7.51–7.41 (m, 3H), 
7.31 (s, 1H), 7.24 (dd, J = 8.1, 1.7 Hz, 1H), 7.17 (d, J = 1.5 Hz, 1H), 6.88 (d, J = 8.1 Hz, 1H), 
6.01 (s, 2H). 13C-NMR (101 MHz, CDCl3): δ = 160.8 (Cq), 151.3 (Cq), 148.4 (Cq), 148.0 (Cq), 
130.3 (CH), 128.9 (CH), 127.6 (Cq), 126.3 (CH), 122.5 (CH), 122.4 (Cq), 118.5 (CH), 109.0 
(CH), 105.0 (CH), 101.5 (CH2). IR (ATR): 1484, 1242, 1032, 928, 873, 817, 802, 705, 696, 
680 cm⁻1. MS (ESI): m/z (relative intensity): 288 [M+Na]+ (100), 266 [M+H]+ (71). HR-MS 
(ESI): m/z calcd for C16H12NO3+ [M+H]+ 266.0812, found 266.0813. The analytical data are 
in accordance with those reported in the literature.[224] 
 
 
5-(Benzo[d][1,3]dioxol-5-yl)-2-(m-tolyl)oxazole (146c) 
The general procedure C was followed using 5-(benzo[d][1,3]dioxol-5-yl)oxazole (144) 
(47.3 mg, 0.25 mmol) and 1-iodo-3-methylbenzene (11c) (273 mg, 1.25 mmol). 
Purification by column chromatography (n-pentane/Et2O: 5/1) yielded 146c (41.8 mg, 
150 μmol, 60%) as a pale yellow solid. 
M. p.: 86–88 °C. 1H-NMR (400 MHz, CDCl3): δ  = 7.92–7.86 (m, 2H), 7.36 (dd, J = 7.7, 7.7 Hz, 
1H), 7.29 (s, 1H), 7.28–7.21 (m, 2H), 7.17 (dd, J = 1.7, 0.4 Hz, 1H), 6.87 (dd, J = 8.1, 0.4 Hz, 
1H), 6.00 (s, 2H), 2.43 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 160.9 (Cq), 151.2 (Cq), 148.3 
(Cq), 148.0 (Cq), 138.7 (Cq), 131.1 (CH), 128.8 (CH), 127.5 (Cq), 126.9 (CH), 123.5 (CH), 122.4 
(CH), 122.4 (Cq), 118.5 (CH), 109.0 (CH), 104.9 (CH), 101.5 (CH2), 21.5 (CH3). IR (ATR): 1482, 
1449, 1225, 1037, 963, 931, 800, 786, 719, 685 cm⁻1. MS (ESI): m/z (relative intensity): 
302 [M+Na]+ (100), 280 [M+H]+ (51). HR-MS (ESI): m/z calcd for C17H14NO3+ [M+H]+ 
280.0968, found 280.0969. 
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5-(Benzo[d][1,3]dioxol-5-yl)-2-(3-(trifluoromethyl)phenyl)oxazole (146d) 
The general procedure C was followed using 5-(benzo[d][1,3]dioxol-5-yl)oxazole (144) 
(47.3 mg, 0.25 mmol) and 1-iodo-3-(trifluoromethyl)benzene (11d) (340 mg, 1.25 mmol). 
Purification by column chromatography (n-pentane/Et2O: 5/1) yielded 146d (53.2 mg, 
160 μmol, 64%) as a pale yellow solid.  
M. p.: 152–153 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.35–8.30 (m, 1H), 8.27–8.22 (m, 1H), 
7.71–7.67 (m, 1H), 7.62–7.56 (m, 1H), 7.32 (s, 1H), 7.24 (dd, J = 8.1, 1.7 Hz, 1H), 7.16 (dd, 
J = 1.7, 0.4 Hz, 1H), 6.88 (dd, J = 8.1, 0.4 Hz, 1H), 6.01 (s, 2H). 13C-NMR (101 MHz, CDCl3): 
δ = 159.3 (Cq), 152.0 (Cq), 148.4 (Cq), 148.3 (Cq), 131.6 (q, 2JC-F = 33.2 Hz, Cq), 129.5 (CH), 
129.3 (CH), 128.3 (Cq), 126.7 (q, 3JC-F = 4.1 Hz, CH), 123.9 (q, 1JC-F = 273.0 Hz, Cq), 123.1 (q, 
3JC-F = 4.0 Hz, CH), 122.7 (CH), 121.9 (Cq), 118.7 (CH), 109.0 (CH), 105.0 (CH), 101.6 (CH2). 
19F{H}-NMR (282 MHz, CDCl3): δ = −62.9 (s). IR (ATR): 1481, 1264, 1118, 1105, 1035, 935, 
861, 808, 726, 692 cm⁻1. MS (ESI) m/z (relative intensity): 356 [M+Na]+ (30), 334 [M+H]+ 
(100). HR-MS (ESI): m/z calcd for C17H11NO3F3+ [M+H]+ 334.0686, found 334.0681. 
 
 
5-(Benzo[d][1,3]dioxol-5-yl)-2-(3-fluorophenyl)oxazole (146e) 
The general procedure C was followed using 5-(benzo[d][1,3]dioxol-5-yl)oxazole (144) 
(47.3 mg, 0.25 mmol) and 1-fluoro-3-iodobenzene (11e) (278 mg, 1.25 mmol). Purification 
by column chromatography (n-pentane/Et2O: 5/1) yielded 146e (50.1 mg, 177 μmol, 71%) 
as a pale yellow solid. 
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M. p.: 131–133 °C. 1H-NMR (400 MHz, CDCl3): δ  = 7.85 (ddd, J = 7.8, 1.5, 1.0 Hz, 1H), 7.75 
(ddd, J = 9.6, 2.3, 1.4 Hz, 1H), 7.43 (ddd, J = 8.0, 5.7 Hz, 1H), 7.30 (s, 1H), 7.22 (dd, J = 8.1, 
1.7 Hz, 1H), 7.18–7.08 (m, 2H), 6.87 (dd, J = 8.1, 0.4 Hz, 1H), 6.01 (s, 2H). 13C-NMR 
(101 MHz, CDCl3): δ = 163.1 (d, 1JC-F = 246.0 Hz, Cq), 159.6 (d, 4JC-F = 4.0 Hz, Cq), 151.7 (Cq), 
148.4 (Cq), 148.2 (Cq), 130.6 (d, 3JC-F = 8.3 Hz, CH), 129.5 (d, 3JC-F = 8.7 Hz, Cq), 122.6 (CH), 
122.1 (Cq), 122.0 (d, 4JC-F = 3.1 Hz, CH), 118.6 (CH), 117.2 (d, JC-F = 21.4 Hz, CH), 113.2 (d, 
2JC-F = 24.0 Hz, CH), 109.0 (CH), 105.0 (CH), 101.6 (CH2). 19F{H}-NMR (282 MHz, 
CDCl3): δ = −112.1 (s). IR (ATR): 1502, 1446, 1237, 1034, 933, 856, 802, 787, 724, 675 cm⁻1. 
MS (ESI) m/z (relative intensity): 306 [M+Na]+ (62), 284 [M+H]+ (100), 242 (60). HR-MS 
(ESI): m/z calcd for C16H11NO3F+ [M+H]+ 284.0717, found 284.0719. 
 
 
5-(Benzo[d][1,3]dioxol-5-yl)-2-(4-(trifluoromethyl)phenyl)oxazole (146f) 
The general procedure C was followed using 5-(benzo[d][1,3]dioxol-5-yl)oxazole (144) 
(47.3 mg, 0.25 mmol) and 1-iodo-4-(trifluoromethyl)benzene (11f) (340 mg, 1.25 mmol). 
Purification by column chromatography (n-pentane/Et2O: 5/1) yielded 146f (60.3 mg, 
181 μmol, 72%) as a colorless solid. 
M. p.: 152–153 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.17 (dd, J = 8.9, 0.8 Hz, 2H), 7.72 (dd, 
J = 8.9, 0.7 Hz, 2H), 7.33 (s, 1H), 7.23 (dd, J = 8.1, 1.7 Hz, 1H), 7.16 (dd, J = 1.8, 0.4 Hz, 1H), 
6.88 (dd, J = 8.1, 0.4 Hz, 1H), 6.02 (s, 2H). 13C-NMR (101 MHz, CDCl3): δ = 159.3 (Cq), 152.1 
(Cq), 148.4 (Cq), 148.4 (Cq), 131.8 (q, 2JC-F = 33.2 Hz, Cq), 130.3 (Cq), 126.5 (CH), 126.0 (q, 
3JC-F = 4.1 Hz, CH), 124.0 (q, 1JC-F = 272.0 Hz, Cq), 122.8 (CH), 121.9 (Cq), 118.8 (CH), 109.1 
(CH), 105.0 (CH), 101.6 (CH2). 19F{H}-NMR (282 MHz, CDCl3): δ = −62.8 (s). IR (ATR): 1480, 
1321, 1231, 1102, 1077, 1038, 1016, 846, 811, 704 cm⁻1. MS (ESI) m/z (relative intensity): 
334 [M+H]+ (97). HR-MS (ESI): m/z calcd for C17H11NO3F3+ [M+H]+ 334.0686, found 
334.0675. 
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5-(Benzo[d][1,3]dioxol-5-yl)-2-(4-chlorophenyl)oxazole (146g) 
The general procedure C was followed using 5-(benzo[d][1,3]dioxol-5-yl)oxazole (144) 
(47.3 mg, 0.25 mmol) and 1-chloro-4-iodobenzene (11g) (298 mg, 1.25 mmol). 
Purification by column chromatography (n-pentane/Et2O: 5/1) yielded 146g (52.1 mg, 
174 μmol, 69%) as a colorless solid. 
M. p.: 160–161 °C. 1H-NMR (400 MHz, CDCl3): δ  = 8.01–7.96 (m, 2H), 7.45–7.40 (m, 2H), 
7.28 (s, 1H), 7.20 (dd, J = 8.1, 1.7 Hz, 1H), 7.13 (d, J = 1.7 Hz, 1H), 6.86 (d, J = 8.1 Hz, 1H), 
6.00 (s, 2H). 13C-NMR (101 MHz, CDCl3): δ = 159.8 (Cq), 151.5 (Cq), 148.4 (Cq), 148.1 (Cq), 
136.3 (Cq), 129.2 (CH), 127.5 (CH), 126.1 (Cq), 122.6 (Cq), 122.1 (CH), 118.5 (CH), 109.0 
(CH), 104.9 (CH), 101.6 (CH2). IR (ATR): 1488, 1451, 1238, 1092, 1031, 1010, 930, 830, 800, 
729 cm⁻1. MS (ESI): m/z (relative intensity): 322 [M+Na]+ (100), 300 [M+H]+ (76). HR-MS 
(ESI) m/z calcd for C16H10NO335ClNa+ [M+Na]+ 322.0241, found 322.0246. 
 
 
2-(3-Fluorophenyl)-5-methylbenzo[d]oxazole (15ge) 
The general procedure C was followed using 5-methylbenzo[d]oxazole (14g) (33.3 mg, 
0.25 mmol) and 1-fluoro-3-iodobenzene (11e) (278 mg, 1.25 mmol). Purification by 
column chromatography (n-pentane/Et2O: 15/1) yielded 15ge (38.3 mg, 169 μmol, 67%) 
as a colorless solid.  
M. p.: 87–89 °C. 1H-NMR (400 MHz, CDCl3): δ  = 8.02 (ddd, J = 7.8, 1.6, 1.0 Hz, 1H), 7.92 
(ddd, J = 9.5, 2.6, 1.5 Hz, 1H), 7.56–7.54 (m, 1H), 7.51–7.42 (m, 2H), 7.24–7.15 (m, 2H), 
2.49 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 163.1 (d, 1JC-F = 247.0 Hz, Cq), 162.0 (d, 4JC-F = 
3.5 Hz, Cq), 149.2 (Cq), 142.3 (Cq), 134.8 (Cq), 130.7 (d, 3JC-F = 8 Hz, CH), 129.5 (d, 
3JC-F = 9.0 Hz, Cq), 126.8 (CH), 123.4 (d, 4JC-F = 3.2 Hz, CH), 120.2 (CH), 118.5 (d, 2JC-F = 21.4 
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Hz, CH), 114.6 (d, 2JC-F = 24.0 Hz, CH), 110.2 (CH), 21.7 (CH3). 19F{H}-NMR (282 MHz, CDCl3): 
δ = −111.9 (s). IR (ATR): 1557, 1471, 1448, 1262, 1211, 876, 789, 724, 676, 598 cm⁻1. MS 
(ESI) m/z (relative intensity): 228 [M+H]+ (100). HR-MS (ESI): m/z calcd for C14H11NOF+ 
[M+H] + 228.0819, found 228.0824. 
 
 
2-(4-Chlorophenyl)-5-methylbenzo[d]oxazole (15gg) 
The representative procedure C was followed using 5-methylbenzo[d]oxazole (14g) 
(33.3 mg, 0.25 mmol) and 1-chloro-4-iodobenzene (11g) (298 mg, 1.25 mmol). 
Purification by column chromatography (n-pentane/Et2O: 15/1) yielded 15gg (43.8 mg, 
179 μmol, 72%) as a colorless solid.  
M. p.: 145–147 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.17–8.13 (m, 2H), 7.55–7.53 (m, 1H), 
7.50–7.45 (m, 2H), 7.43 (dd, J = 8.3, 0.6 Hz, 1H), 7.18–7.14 (m, 1H), 2.48 (s, 3H). 13C-NMR 
(101 MHz, CDCl3): δ = 162.2 (Cq), 149.1 (Cq), 142.3 (Cq), 137.7 (Cq), 134.7 (Cq), 129.3 (CH), 
128.9 (CH), 126.6 (CH), 126.0 (Cq), 120.1 (CH), 110.1 (CH), 21.7 (CH3). IR (ATR): 1477, 1403, 
1089, 1052, 1008, 839, 827, 795, 729, 502 cm⁻1. MS (ESI) m/z (relative intensity): 244 
[M+H]+ (100). HR-MS (ESI): m/z calcd for C14H11NO35Cl+ [M+H]+ 244.0524, found 244.0522. 
The analytical data are in accordance with those reported in the literature.[225] 
 
The following benzothiazoles 145bc to 145hc were synthesized by N. Imse during the 
course of his bachelor thesis:[190] 
 
6-Methyl-2-(m-tolyl)benzo[d]thiazole (145bc) 
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The general procedure C was followed using benzo[d]thiazole 140b (37.8 mg, 0.25 mmol) 
and iodobenzene 11c (273 mg, 1.25 mmol). Purification by column chromatography 
(n-pentane/Et2O: 60:1→20:1) yielded 145bc (34.2 mg, 143 μmol, 57%) as an orange solid.  
M. p.: 84–86 °C. 1H-NMR (300 MHz, CDCl3): δ = 7.94 (d, J = 8.4 Hz, 1H), 7.92–7.90 (m, 1H), 
7.85–7.81 (m, 1H), 7.66–7.65 (m, 1H), 7.35 (dd, J = 7.6, 7.6 Hz, 1H), 7.30–7.25 (m, 2H), 2.47 
(s, 3H), 2.43 (s, 3H). 13C-NMR (126 MHz, CDCl3): δ = 167.2 (Cq), 152.3 (Cq), 138.8 (Cq), 135.3 
(Cq), 135.3 (Cq), 133.7 (Cq), 131.6 (CH), 128.9 (CH), 127.9 (CH), 127.9 (CH) 124.8 (CH), 122.7 
(CH), 121.4 (CH), 21.7 (CH3), 21.5 (CH3). IR (ATR): 1448, 1258, 1165, 831, 814, 795, 779, 
686, 651, 572 cm⁻1. MS (ESI) m/z (relative intensity): 240 [M+H]+ (100). HR-MS (ESI): m/z 
calcd for C15H14NS+ [M+H]+ 240.0841, found 240.0840. 
 
 
6-Methoxy-2-(m-tolyl)benzo[d]thiazole (145cc) 
The general procedure C was followed using benzo[d]thiazole 140c (41.2 mg, 0.25 mmol) 
and iodobenzene 11c (273 mg, 1.25 mmol). Purification by column chromatography 
(n-pentane/Et2O: 60:1→20:1) yielded 145cc (29.6 mg, 116 μmol, 46%) as an orange solid.  
M. p.: 103 °C. 1H-NMR (300 MHz, CDCl3): δ = 7.93 (dd, J = 8.9, 0.5 Hz, 1H), 7.88-7.86 (m, 
1H), 7.81–7.77 (m, 1H), 7.34–7.31 (m, 2H), 7.27–7.23 (m, 1H), 7.07 (dd, J = 9.0, 2.6 Hz, 1H), 
3.86 (s, 3H), 2.42 (s, 3H). 13C-NMR (126 MHz, CDCl3): δ = 165.8 (Cq), 157.8 (Cq), 148.7 (Cq), 
138.8 (Cq), 136.4 (Cq), 133.7 (Cq), 131.4 (CH), 128.9 (CH), 127.7 (CH), 124.6 (CH), 123.7 
(CH), 115.6 (CH), 104.3 (CH), 56.0 (CH3), 21.6 (CH3). IR (ATR): 1600, 1457, 1428, 1263, 
1225, 1026, 830, 820, 789, 688 cm⁻1. MS (ESI) m/z (relative intensity): 256 [M+H]+ (100). 
HR-MS (ESI) m/z calcd for C15H14NOS+ [M+H]+ 256.0791, found 256.0788. 
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2-(m-Tolyl)-6-(trifluoromethyl)benzo[d]thiazole (145dc) 
The general procedure C was followed using benzo[d]thiazole 140d (50.8 mg, 0.25 mmol) 
and iodobenzene 11c (273 mg, 1.25 mmol). Purification by column chromatography 
(n-pentane/Et2O: 60:1→20:1) yielded 145dc (43.2 mg, 147 μmol, 55%) as an orange solid.  
M. p.: 110 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.17–8.16 (m, 1H), 8.12 (dd, J = 8.6, 0.6 Hz, 
1H), 7.93–7.91 (m, 1H), 7.86 (dd, J = 7.6, 1.8 Hz, 1H), 7.70 (dd, J = 8.6, 1.8 Hz, 1H), 7.40–
7.31 (m, 2H), 2.44 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 171.5 (Cq), 156.2 (Cq), 139.2 (Cq), 
135.2 (Cq), 133.1 (Cq), 132.7 (CH), 129.2 (CH), 128.4 (CH), 127.4 (q, 2JC-F = 32.6 Hz, Cq), 125.2 
(CH), 124.4 (q, 1JC-F= 272.2 Hz, Cq), 123.5 (CH), 123.5 (q, 3JC-F= 3.4 Hz, CH), 119.4 (q, 3JC-F = 
4.2 Hz, CH), 21.5 (CH3). 19F{H}-NMR (282 MHz, CDCl3): δ = −61.4 (s). IR (ATR): 1319, 1251, 
1159, 1139, 1110, 1086, 1054, 834, 789, 686 cm⁻1. MS (ESI) m/z (relative intensity): 294 
[M+H]+ (100). HR-MS (ESI): m/z calcd for C15H11F3NS+ [M+H]+ 294.0559, found 294.0562. 
 
 
6-Fluoro-2-(m-tolyl)benzo[d]thiazole (145ec) 
The general procedure C was followed using benzo[d]thiazole 140e (38.6 mg, 0.25 mmol) 
and iodobenzene 11c (273 mg, 1.25 mmol). Purification by column chromatography 
(n-pentane/Et2O: 35:1→20:1) yielded 145ec (24.1 mg, 99.1 μmol, 39%) as an orange solid.  
M. p.: 78–80 °C. 1H-NMR (400 MHz, CDCl3): δ = 7.98 (dd, J = 8.8, 4.7 Hz, 1H), 7.88–7.87 (m, 
1H), 7.82–7.79 (m, 1H), 7.57–7.54 (m, 1H), 7.36 (dd, J = 7.6, 7.6 Hz, 1H), 7.30–7.27 (m, 1H), 
7.23–7.17 (m, 1H), 2.43 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 168.2 (d, 4JC-F = 3.5 Hz, Cq), 
160.6 (d, 1JC-F = 245.0 Hz, Cq), 150.9 (d, 4JC-F = 1.8 Hz, Cq), 139.1 (Cq), 136.2 (d, 3JC-F = 11.2 Hz, 
Cq), 133.4 (Cq), 132.0 (CH), 129.1 (CH), 128.0 (CH), 124.8 (CH), 124.2 (d, 3JC-F = 9.4 Hz, CH), 
115.0 (d, 2JC-F = 24.7 Hz, CH), 108.0 (d, 2JC-F = 26.9 Hz, CH), 21.5 (CH3). 19F{H}-NMR 
(282 MHz, CDCl3): δ = −116.0 (s). IR (ATR): 1451, 1307, 1247, 1191, 1167, 840, 807, 775, 
686, 583 cm⁻1. MS (ESI) m/z (relative intensity): 244 [M+H]+ (100). HR-MS (ESI): m/z calcd 
for C14H11FNS+ [M+H]+ 244.0591, found 244.0596. 
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6-Chloro-2-(m-tolyl)benzo[d]thiazole (145fc) 
The general procedure C was followed using benzo[d]thiazole 140f (41.0 mg, 0.25 mmol) 
and iodobenzene 11c (273 mg, 1.25 mmol). Purification by column chromatography 
(n-pentane/Et2O: 60:1→20:1) yielded 145fc (27.5 mg, 106 μmol, 44%) as an orange solid.  
M. p.: 125–128 °C. 1H-NMR (400 MHz, CDCl3): δ = 7.94 (dd, J = 8.7, 0.4 Hz, 1H), 7.88–7.87 
(m, 1H), 7.84 (dd, J = 2.1, 0.4 Hz, 1H), 7.82–7.80 (m, 1H), 7.42 (dd, J = 8.7, 2.1 Hz, 1H), 7.36 
(dd, J = 7.6, 7.6 Hz, 1H), 7.31–7.28 (m, 1H), 2.43 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 
168.9 (Cq), 152.8 (Cq), 139.1 (Cq), 136.3 (Cq), 133.3 (Cq), 132.3 (CH), 131.2 (Cq) 129.1 (CH), 
128.1 (CH), 127.2 (CH), 125.0 (CH), 124.0 (CH), 121.3 (CH), 21.5 (CH3). IR (ATR): 1305, 1248, 
1169, 1095, 1023, 852, 816, 804, 771, 759 cm⁻1. MS (ESI) m/z (relative intensity): 260 
[M+H]+ (100). HR-MS (ESI): m/z calcd for C14H1135ClNS+ [M+H]+ 260.0295, found 260.0296. 
 
 
6-Bromo-2-(m-tolyl)benzo[d]thiazole (145gc) 
The general procedure C was followed using benzo[d]thiazole 140gc (53.5 mg, 0.25 mmol) 
and iodobenzene 11c (273 mg, 1.25 mmol). Purification by column chromatography 
(n-pentane/Et2O: 60:1→20:1) yielded 145gc (15.6 mg, 51.2 μmol, 21%) as an orange solid.  
M. p.: 117–122 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.00 (dd, J = 2.0, 0.5 Hz, 1H), 7.89–7.88 
(m, 2H), 7.83–7.80 (m, 1H), 7.56 (dd, 8.7, 2.0 Hz, 1H), 7.36 (dd, J = 7.6, 7.6 Hz, 1H), 7.31–
7.28 (m, 1H), 2.43 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 169.0 (Cq), 153.1 (Cq), 139.1 (Cq), 
136.8 (Cq), 133.2 (Cq), 132.3 (CH), 129.9 (CH), 129.1 (CH), 128.1 (CH), 125.0 (CH), 124.4 
(CH), 124.3 (CH), 118.8 (Cq), 21.5 (CH3). IR (ATR): 1435, 1248, 1168, 1088, 853, 814, 800, 
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771, 684, 699 cm⁻1. MS (ESI) m/z (relative intensity): 304 [M+H]+ (51), 236 (100). HR-MS 
(ESI): m/z calcd for C14H1179BrNS+ [M+H]+: 303.9790, found 303.9793. 
 
 
Ethyl 2-(m-tolyl)benzo[d]thiazole-6-carboxylate (145hc) 
The general procedure C was followed using benzo[d]thiazole 140h (51.8 mg, 0.25 mmol) 
and iodobenzene 11c (273 mg, 1.25 mmol). Purification by column chromatography 
(n-pentane/Et2O: 60:1→20:1) yielded 145hc (16.8 mg, 56.5 μmol, 23%) as an orange solid.  
M. p.: 99–101 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.60 (dd, J = 1.7, 0.6 Hz, 1H), 8.15 (dd, J = 
8.6, 1.7 Hz, 1H), 8.05 (dd, J = 8.5, 0.6 Hz, 1H), 7.93–7.92 (m, 1H), 7.88–7.85 (m, 1H), 7.37 
(dd, J = 7.6, 7.6 Hz, 1H), 7.33–7.30 (m, 1H), 4.41 (q, J = 7.1 Hz, 2H), 2.44 (s, 3H), 1.42 (t, 
J = 7.1 Hz, 3H). 13C-NMR (101 MHz, CDCl3): δ = 171.9 (Cq), 166.3 (Cq), 157.1 (Cq), 139.2 (Cq), 
135.1 (Cq), 133.3 (Cq), 132.6 (CH), 129.2 (CH), 128.4 (CH), 127.7 (CH), 127.4 (Cq), 125.2 
(CH), 123.9 (CH), 122.9 (CH), 61.4 (CH2), 21.5 (CH3), 14.5 (CH3).IR (ATR): 1709, 1265, 1246, 
1224, 1109, 1026, 783, 767, 725, 684 cm⁻1. MS (ESI) m/z (relative intensity): 298 [M+H]+ 
(100). HR-MS (ESI): m/z calcd for C17H16NO2S+ [M+H]+ 298.0896, found 298.0897. 
 
5.5.2 Photo-Induced Copper-catalyzed C–H Arylation Using Visible Light 
5.5.2.1 Analytical Data 
 
1-Benzyl-4-phenyl-1H-1,2,3-triazole (175) 
To an oven-dried 10 mL vial triazole 27b (90.0 mg, 0.25 mmol, 1.00 equiv), copper(I) 
iodide (9.5 mg, 20 mol %), LiOtBu (60 mg, 0.75 mmol, 3.00 equiv), and DMF (1.0 mL) were 
added. The tube was capped with a septum and wrapped with Parafilm and stirred under 
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254 nm irradiation for 16 h (Luzchem LZC-ICH2 photoreactor, the temperature was 
maintained between 25 °C and 30 °C, Figure 5.2). After the indicated reaction time, the 
mixture was filtered over a short pad of silica (Et2O) and the solvent was removed under 
reduced pressure. The residue was purified by column chromatography on silica gel (n-
pentane/Et2O: 2/1) affording the corresponding triazole 175 (27.5 mg, 117 μmol, 47%) as 
an off-white solid. 
M. p.: 129–130 °C. 1H-NMR (400 MHz, CDCl3): δ 7.82–7.78 (m, 2H), 7.66 (s, 1H), 7.42–7.36 
(m, 5H), 7.34–7.28 (m, 3H), 5.57 (s, 2H). 13C-NMR (101 MHz, CDCl3): δ = 148.3 (Cq), 134.8 
(Cq), 130.7 (Cq), 129.3 (CH), 128.9 (CH), 128.9 (CH), 128.3 (CH), 128.2 (CH), 125.8 (CH), 
119.6 (CH), 54.3 (CH2). IR (ATR): 1450, 1223, 1045, 971, 767, 727, 694, 588, 506, 480 cm⁻1. 
MS (ESI) m/z (relative intensity): 258 [M+Na]+ (12), 236 [M+H]+ (100). HR-MS (ESI): m/z 
calcd for C15H14N3+ [M+H]+ 236.1182, found 236.1184. The analytical data are in 
accordance with those reported in the literature.[226] 
 
 
2-(3-Fluorophenyl)benzo[d]thiazole (145ae) 
To an oven-dried 10 mL vial were added copper(I) chloride (5.0 mg, 20 mol %) and LiOtBu 
(60 mg, 0.75 mmol, 3.00 equiv). The vial was capped with a septum and wrapped with 
Parafilm and Et2O (1.0 mL) was added. Benzo[d]thiazole (140a) (33.8 mg, 0.25 mmol), and 
iodobenzene 11e (278 mg, 1.25 mmol) were sequentially added via syringe. The mixture 
was irradiated for 16 h using a Kessil A-360N blue LED. The mixture was filtered over a 
short pad of silica (Et2O) and the solvent was removed under reduced pressure. 
Purification of the residue by column chromatography (n-pentane/Et2O: 25:1→20:1) 
yielded 145ae (31.0 mg, 135 μmol, 54%) as a slightly orange solid.  
M. p.: 85–86 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.09 (d, J = 8.1 Hz, 1H), 7.91 (ddd, J = 8.0, 
1.3, 0.7 Hz, 1H), 7.88–7.79 (m, 2H), 7.54–7.36 (m, 3H), 7.18 (ddd, J = 8.0, 7.5, 1.9 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ = 166.5 (d, 4JC-F = 3.2 Hz, Cq), 163.1 (d, 1JC-F = 247.2 Hz, Cq), 
154.1 (Cq), 135.8 (d, 3JC-F = 8.1 Hz, Cq), 135.2 (Cq), 130.7 (d, 3JC-F = 8.2 Hz, CH), 126.7 (CH), 
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125.6 (CH), 123.6 (CH), 123.4 (d, 4JC-F = 3.0 Hz, CH), 121.8 (CH), 117.9 (d, 2JC-F = 21.4 Hz, 
CH), 114.4 (d, 2JC-F = 23.5 Hz, CH). 19F-NMR (378 MHz, CDCl3): δ = (−112.0)–(−112.1) (m). 
IR (ATR): 1443, 1259, 878, 810, 779, 751, 728, 676, 520, 449 cm⁻1. MS (ESI) m/z (relative 
intensity): 230 [M+H]+ (100). HR-MS (ESI): m/z calcd for C13H9FNS+, [M+H]+ 230.0434, 
found 230.0436. The analytical data are in accordance with those reported in the 
literature.[227] 
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5.5.2.2 Mechanistic Studies 
5.5.2.2.1 Fluorescence Quenching Studies 
Sample solutions were prepared in MeCN with c(Ir(ppy)3) = 1.6 x 10-8 M and varying 
concentrations of the respective quencher. The experiments were conducted with a fixed 
excitation wavelength of 430 nm and detection at 520 nm (emission maximum). Plotting 
of the I0/I value against the concentration of the potential quencher yielded the following 
graphs.  
 
Figure 5.13: Fluorescence quenching of Ir(ppy)3 with 3-iodotoluene (11c). 
 
Figure 5.14: Fluorescence quenching of Ir(ppy)3 with benzothiazole (140a). 
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Figure 5.15: Fluorescence quenching of Ir(ppy)3 with CuI. 
 
 
Figure 5.16: Fluorescence quenching of Ir(ppy)3 with CuI (in DMSO). 
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5.6 Visible Light-Induced Ruthenium-Catalyzed meta-C–H Functionalizations 
5.6.1 Visible Light-Induced Ruthenium-Catalyzed meta-C–H Difluoromethylation 
5.6.1.1 Analytical Data 
 
Ethyl 2,2-difluoro-2-[3-(pyridin-2-yl)phenyl]acetate (185a) 
The general procedure D was followed using 2-phenylpyridine (35a) (46.6 mg, 0.30 mmol) 
and ester 100 (183 mg, 0.90 mmol). Purification by column chromatography on silica gel 
(n-pentane/Et2O: 10/1) yielded 185a (29.8 mg, 107 μmol, 36%) as colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 8.69 (dd, J = 4.8, 1.6 Hz, 1H), 8.22 (ddd, J = 1.8, 0.9, 0.9 Hz, 1H), 8.15–
8.12 (m, 1H), 7.79–7.71 (m, 2H), 7.66–7.62 (m, 1H), 7.55 (ddd, J = 7.8, 7.8, 0.6 Hz, 1H), 7.25 
(ddd, J = 6.7, 4.8, 2.0 Hz, 1H), 4.29 (q, J = 7.1 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H). 13C-NMR 
(101 MHz, CDCl3): δ = 164.1 (t, 2JC-F = 35.1 Hz, Cq), 156.2 (Cq), 149.8 (CH), 140.0 (Cq), 136.9 
(CH), 133.4 (t, 2JC-F = 25.6 Hz, Cq), 129.4 (t, 4JC-F = 1.7 Hz, CH), 129.1 (CH), 125.9 (t, 3JC-F = 
6.1 Hz, CH), 123.9 (t, 3JC-F = 6.3 Hz, CH), 122.6 (CH), 120.6 (CH), 114.6 (t, 1JC-F = 252.0, Cq), 
63.2 (CH2), 13.9 (CH3). 19F-NMR (282 MHz, CDCl3): δ = −103.74. IR (ATR): 2984, 1761, 1584, 
1462, 1291, 1228, 1102, 1018, 778, 745 cm⁻1. MS (ESI) m/z (relative intensity): 278 [M+H]+ 
(100). HR-MS (ESI): m/z calcd for C15H14F2NO2+ [M+H]+ 278.0987, found 278.0988. The 
analytical data are in accordance with those reported in the literature.[112a] 
5.6.1.2 Mechanistic Studies 
5.6.1.2.1 Fluorescence Quenching Experiments 
Sample solutions were prepared in 1,4-dioxane with c(Ir(ppy)3) = 1.6 x 10-8 M and varying 
concentrations of the respective quencher, added to each sample from a stock solution. 
Stern-Volmer experiments were conducted with a fixed excitation wavelength of 430 nm 
and detection at 520 nm (emission maximum). Plotting of the I0/I value against the 
concentration of the potential quencher yielded the following graphs.  
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Figure 5.17: Fluorescence quenching of Ir(ppy)3 with 2-phenylpyridine (35a). 
 
 
Figure 5.18: Fluorescence quenching of Ir(ppy)3 with 100. 
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5.6.2 Visible Light-Enabled Ruthenium-catalyzed meta-C–H Tertiary Alkylation  
5.6.2.1 Analytical Data 
 
2-[3-(tert-Butyl)phenyl]pyridine (96aa) 
The general procedure D was followed using 2-phenylpyridine (35a) (62.1 mg, 0.40 mmol) 
and alkyl bromide 95a (164 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 5/1) yielded 96aa (67.7 mg, 320 μmol, 
80%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.72 (ddd, J = 4.8, 1.3, 1.3 Hz, 1H), 8.07 (dd, J = 1.9, 1.9 Hz, 
1H), 7.78 (ddd, J = 7.4, 1.5, 1.5 Hz, 1H), 7.75–7.70 (m, 2H), 7.50–7.40 (m, 2H), 7.25–7.19 
(m, 1H), 1.41 (s, 9H). 13C-NMR (101 MHz, CDCl3): δ = 158.2 (Cq), 151.7 (Cq), 149.7 (CH), 
139.3 (Cq), 136.7 (CH), 128.6 (CH), 126.2 (CH), 124.3 (CH), 124.1 (CH), 122.0 (CH), 120.8 
(CH), 35.0 (Cq), 31.5 (CH3). IR (ATR): 2962, 1584, 1565, 1461, 1431, 1252, 771, 740, 699, 
613 cm⁻1. MS (ESI) m/z (relative intensity): 212 [M+H]+ (100). HR-MS (ESI): m/z calcd for 
C15H18N+ [M+H]+ 212.1434, found 212.1437. The analytical data are in accordance with 
those reported in the literature.[109a] 
 
 
1-[3-(tert-Butyl)phenyl]-1H-pyrazole (189a) 
The general procedure D was followed using 1-phenylpyrazole (57.7 mg, 0.40 mmol) and 
alkyl bromide 95a (164 mg, 1.20 mmol) for 24 h at 60 °C. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 5/1) yielded 189a (51.3 mg, 256 μmol, 
64%) as colorless oil. 1H-NMR (400 MHz, CDCl3): δ = 7.92 (dd, J = 2.5, 0.7 Hz, 1H), 7.80–
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7.71 (m, 2H), 7.45 (ddd, J = 7.7, 2.2, 1.4 Hz, 1H), 7.40–7.31 (m, 2H), 6.46 (dd, J = 2.5, 1.8 Hz, 
1H), 1.38 (s, 9H). 13C-NMR (101 MHz, CDCl3): δ = 153.1 (Cq), 141.0 (CH), 140.2 (Cq), 129.1 
(CH), 127.1 (CH), 123.8 (CH), 117.0 (CH), 116.6 (CH), 107.5 (CH), 35.1 (Cq), 31.4 (CH3). IR 
(ATR): 2962, 1608, 1589, 1518, 1391, 1044, 947, 787, 746, 698  cm⁻1. MS (ESI) m/z (relative 
intensity): 201 [M+H]+ (100). HR-MS (ESI): m/z calcd for C13H17N2+ [M+H]+ 201.1386, found 
201.1390. The analytical data are in accordance with those reported in the literature.[113] 
 
 
2-[3-(tert-Butyl)phenyl]pyrimidine (191a) 
The general procedure D was followed using 1-phenylpyrimidine (62.5 mg, 0.40 mmol) 
and alkyl bromide 95a (164 mg, 1.20 mmol) for 24 h at 60 °C. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 2/1) yielded 191a (13.5 mg, 63.6 μmol, 
16%) as colorless oil. 
1H-NMR (500 MHz, CDCl3): δ = 8.81 (d, J = 4.8 Hz, 2H), 8.51 (dd, J = 1.9, 1.9 Hz, 1H), 8.26 
(ddd, J = 7.7, 1.7, 1.2 Hz, 1H), 7.54 (ddd, J = 7.8, 2.1, 1.2 Hz, 1H), 7.44 (dd, J = 7.7, 7.7 Hz, 
1H), 7.17 (t, J = 4.8 Hz, 1H), 1.41 (s, 9H). 13C-NMR (126 MHz, CDCl3): δ = 165.3 (Cq), 157.3 
(CH), 151.7 (Cq), 137.4 (Cq) 128.5 (CH), 128.1 (CH), 125.6 (CH), 125.2 (CH), 119.1 (CH), 35.0 
(Cq), 31.6 (CH3). IR (ATR): 2961, 1567, 1554, 1420, 1404, 1260, 786, 700, 648, 635 cm⁻1. 
MS (ESI) m/z (relative intensity): 213 [M+H]+ (100). HR-MS (ESI): m/z calcd for C14H17N2+ 
[M+H]+ 213.1386, found 213.1391. The analytical data are in accordance with those 
reported in the literature.[113] 
 
2-[3-(1-Methylcyclohexyl)phenyl]pyridine (96ab) 
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The general procedure D was followed using 2-phenylpyridine (35a) (62.1 mg, 0.40 mmol) 
and alkyl bromide 95b (213 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 5/1) yielded 96ab (63.3 mg, 252 μmol, 
63%) as a colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 8.71 (ddd, J = 4.8, 1.4, 1.4 Hz, 1H), 8.04 (dd, J = 2.0, 0.8 Hz, 
1H), 7.81–7.69 (m, 3H), 7.50–7.40 (m, 2H), 7.21 (ddd, J = 5.6, 4.9, 2.9 Hz, 1H), 2.24–1.98 
(m, 2H), 1.73–1.38 (m, 8H), 1.26 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 158.3 (Cq), 150.8 
(Cq), 149.8 (CH), 139.5 (Cq), 136.7 (CH), 128.7 (CH), 126.8 (CH), 124.8 (CH), 124.1 (CH), 
122.0 (CH), 120.9 (CH), 38.2 (Cq), 38.1 (CH2), 30.4 (CH3), 26.5 (CH2), 22.8 (CH2). IR (ATR): 
2926, 2856, 1584, 1462, 1431, 907, 772, 729, 701, 613 cm⁻1. MS (ESI) m/z (relative 
intensity): 252 [M+H]+ (100). HR-MS (ESI): m/z calcd for C18H22N+ [M+H]+ 252.1747, found 
252.1749.  
 
 
2-[3-(1-Methylcyclopentyl)phenyl]pyridine (96ac) 
The general procedure D was followed using 2-phenylpyridine (35a) (62.1 mg, 0.40 mmol) 
and alkyl bromide 95c (196 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 5/1) yielded 96ac (63.3 mg, 329 μmol, 
82%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.71 (ddd, J = 4.8, 1.5, 1.5 Hz, 1H), 8.00 (ddd, J = 1.7, 1.0, 
1.0 Hz, 1H), 7.80–7.75 (m, 1H), 7.75–7.71 (m, 2H), 7.46–7.36 (m, 2H), 7.25–7.18 (m, 1H), 
2.06– 1.96 (m, 2H), 1.94–1.72 (m, 6H), 1.33 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ = 158.2 
(Cq), 152.1 (Cq), 149.7 (CH), 139.3 (Cq), 136.7 (CH), 128.5 (CH), 127.0 (CH), 124.8 (CH), 124.2 
(CH), 122.0 (CH), 120.8 (CH), 47.4 (Cq), 39.8 (CH2), 29.6 (CH3), 23.9 (CH2). IR (ATR): 2956, 
1585, 1565,1462, 1432, 907,772, 428, 701, 644 cm⁻1. MS (ESI) m/z (relative intensity): 238 
[M+H]+ (100). HR-MS (ESI): m/z calcd for C17H20N+ [M+H]+ 238.1590, found 238.1595.  
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2-[3-(tert-Pentyl)phenyl]pyridine (96ad) 
The general procedure D was followed using 2-phenylpyridine (35a) (62.1 mg, 0.40 mmol) 
and alkyl bromide 95d (181 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 5/1) yielded 96ad (63.3 mg, 284 μmol, 
71%) as a colorless oil.  
1H-NMR (600 MHz, CDCl3): δ = 8.71 (ddd, J = 4.8, 1.2, 1.2 Hz, 1H), 8.00 (ddd, J = 2.3, 1.0, 
1.0 Hz, 1H), 7.81–7.76 (m, 1H), 7.75–7.70 (m, 2H), 7.44–7.38 (m, 2H), 7.21 (dddd, J = 5.7, 
4.8, 2.6, 0.6 Hz, 1H), 1.73 (q, J = 7.4 Hz, 2H), 1.37 (s, 6H), 0.73 (t, J = 7.4 Hz, 3H). 13C-NMR 
(126 MHz, CDCl3): δ = 158.1 (Cq), 150.0 (Cq), 149.6 (CH), 139.2 (Cq), 136.6 (CH), 128.4 (CH), 
126.8 (CH), 124.7 (CH), 124.1 (CH), 121.9 (CH), 120.8 (CH), 38.3 (Cq), 37.1 (CH2), 28.7 (CH3), 
9.4 (CH3). IR (ATR): 2964, 1585, 1565, 1462, 1431, 907, 773, 729, 701, 644 cm⁻1. MS (ESI) 
m/z (relative intensity): 248 [M+Na]+ (26), 226 [M+H]+ (100). HR-MS (ESI): m/z calcd for 
C16H20N+ [M+H]+ 226.1590, found 226.1592.  
 
 
2-[3-(2-Methylpentan-2-yl)phenyl]pyridine (96ae) 
The general procedure D was followed using 2-phenylpyridine (35a) (62.1 mg, 0.40 mmol) 
and alkyl bromide 95e (198 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 5/1) yielded 96ae (78.4 mg, 328 μmol, 
82%) as a colorless oil.  
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1H-NMR (400 MHz, CDCl3): δ = 8.71 (ddd, J = 4.8, 1.5, 1.5 Hz, 1H), 8.00 (ddd, J = 1.7, 1.7, 
1.0 Hz, 1H), 7.81–7.75 (m, 1H), 7.75–7.71 (m, 2H), 7.44–7.39 (m, 2H), 7.24–7.18 (m, 1H), 
1.69–1.62 (m, 2H), 1.38 (s, 6H), 1.20–1.08 (m, 2H), 0.84 (t, J = 7.3 Hz, 3H). 13C-NMR 
(101 MHz, CDCl3): δ = 158.2 (Cq), 150.5 (Cq), 149.7 (CH), 139.2 (Cq), 136.7 (CH), 128.5 (CH), 
126.7 (CH), 124.6 (CH), 124.2 (CH), 122.0 (CH), 120.8 (CH), 47.3 (CH2), 38.1 (Cq), 29.1 (CH3), 
18.1 (CH2), 14.9 (CH3). IR (ATR): 2957, 1585, 1565, 1462, 1432, 907, 772, 729, 700, 
644 cm⁻1. MS (ESI) m/z (relative intensity): 240 [M+H]+ (100). HR-MS (ESI): m/z calcd for 
C17H22N+ [M+H]+ 240.1747, found 240.1741.  
 
 
2-[3-(2-Methylpentan-2-yl)phenyl]pyridine (96af) 
The general procedure D was followed using 2-phenylpyridine (35a) (62.1 mg, 0.40 mmol) 
and alkyl bromide 95f (273 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 6/1) yielded 96af (96.0 mg, 319 μmol, 80%) 
as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.75 (ddd, J = 4.9, 1.4, 1.4 Hz, 1H), 8.08 (d, J = 2.4 Hz, 1H), 
7.86–7.74 (m, 3H), 7.53–7.45 (m, 2H), 7.30–7.23 (m, 3H), 7.20–7.11 (m, 3H), 2.48–2.41 (m, 
2H), 2.07–2.00 (m, 2H), 1.49 (s, 6H). 13C-NMR (101 MHz, CDCl3): δ = 158.2 (Cq), 149.8 (CH), 
149.8 (Cq), 143.2 (Cq), 139.5 (Cq), 136.8 (CH), 128.7 (CH), 128.4 (CH), 128.4 (CH), 126.8 
(CH), 125.7 (CH), 124.7 (CH), 124.5 (CH), 122.1 (CH), 120.9 (CH), 46.8 (CH2), 38.3 (Cq), 31.5 
(CH2), 29.2 (CH3). IR (ATR): 2961, 1584, 1565, 1461, 1431, 908, 773, 732, 697, 613 cm⁻1. 
MS (ESI) m/z (relative intensity): 302 [M+H]+ (100). HR-MS (ESI): m/z calcd for C22H24N+ 
[M+H]+ 302.1903, found 302.1907. 
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3-Hydroxypropyl 2-methyl-2-[3-(pyridin-2-yl)phenyl]propanoate (96ag) 
The general procedure D was followed using phenyl pyridine 35a (62.1 mg, 0.40 mmol) 
and alkyl bromide 95g (270 mg, 1.20 mmol) for 48 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 2/1) yielded 96ag (30.5 mg, 102 μmol, 
25%) as colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.64 (ddd, J = 4.9, 1.8, 0.9 Hz, 1H), 7.92 (d, J = 1.1 Hz, 1H), 
7.79–7.66 (m, 3H), 7.47–7.39 (m, 2H), 7.25 (ddd, J = 7.4, 4.9, 1.4 Hz, 1H), 4.28 (t, J = 6.0 Hz, 
2H), 3.51 (sbr, 1H), 3.46 (t, J = 6.0 Hz, 2H), 1.79 (tt, J = 6.0, 6.0 Hz, 2H), 1.63 (s, 6H). 13C-NMR 
(101 MHz, CDCl3): δ = 177.1 (Cq), 157.7 (Cq), 149.6 (CH), 145.8 (Cq), 139.7 (Cq), 137.2 (CH), 
128.9 (CH), 126.0 (CH), 125.5 (CH), 125.2 (CH), 122.4 (CH), 121.4 (CH), 61.5 (CH2), 58.1 
(CH2), 47.1 (Cq), 31.2 (CH2), 26.8 (CH3). IR (ATR): 3350, 2971, 1722, 1463, 1253, 1146, 1050, 
770, 744, 699 cm⁻1. MS (ESI) m/z (relative intensity): 322 [M+Na]+ (65), 300 [M+H]+ (100). 
HR-MS (ESI): m/z calcd for C18H22NO3+ [M+H]+ 300.1594, found 300.1597. 
 
2-[3-(tert-Butyl)phenyl]-4-methylpyridine (96ca) 
The general procedure D was followed using phenyl pyridine 35c (67.7 mg, 0.40 mmol) 
and alkyl bromide 95a (164 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 5/1) yielded 96ca (68.1 mg, 302 μmol, 
76%) as a colorless oil. 
1H-NMR (400 MHz, CDCl3): δ = 8.57 (dd, J = 5.0, 0.8 Hz, 1H), 8.04 (ddd, J = 1.9, 1.9, 0.5 Hz, 
1H), 7.76 (ddd, J = 7.4, 1.8, 1.3 Hz, 1H), 7.54 (ddd, J = 1.6, 0.8, 0.8 Hz, 1H), 7.46 (ddd, J = 7.8, 
2.0, 1.3 Hz, 1H), 7.44–7.38 (m, 1H), 7.05 (ddd, J = 5.0, 1.6, 0.7 Hz, 1H), 2.41 (s, 3H), 1.41 (s, 
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9H). 13C-NMR (101 MHz, CDCl3): δ = 158.1 (Cq), 151.6 (Cq), 149.5 (CH), 147.7 (Cq), 139.5 
(Cq), 128.5 (CH), 126.0 (CH), 124.3 (CH), 124.1 (CH), 123.1 (CH), 121.8 (CH), 35.0 (Cq), 31.5 
(CH3), 21.3 (CH3). IR (ATR): 2963, 1599, 1468, 1257, 907, 826, 797, 727, 701, 644 cm⁻1. MS 
(ESI) m/z (relative intensity): 226 [M+H]+ (100). HR-MS (ESI): m/z calcd for C16H20N+ [M+H]+ 
226.1590, found 226.1595. 
 
 
2-[3-(tert-Butyl)-4-methoxyphenyl]-4-methylpyridine (96da) 
The general procedure D was followed using phenyl pyridine 35d (79.7 mg, 0.40 mmol) 
and alkyl bromide 95a (164 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 3/1) yielded 96da (74.0 mg, 290 μmol, 
72%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.52 (dd, J = 5.0, 0.8 Hz, 1H), 7.95 (d, J = 2.3 Hz, 1H), 7.79 
(dd, J = 8.5, 2.3 Hz, 1H), 7.48 (ddd, J = 1.6, 0.8, 0.8 Hz, 1H), 6.99 (ddd, J = 5.0, 1.6, 0.8 Hz, 
1H), 6.96 (d, J = 8.5 Hz, 1H), 3.89 (s, 3H), 2.39 (s, 3H), 1.46 (s, 9H). 13C-NMR (101 MHz, 
CDCl3): δ = 159.5 (Cq), 157.9 (Cq), 149.4 (CH), 147.5 (Cq), 138.5 (Cq), 131.7 (Cq), 125.8 (CH), 
125.6 (CH), 122.4 (CH), 121.0 (CH), 111.7 (CH), 55.2 (CH3), 35.1 (Cq), 29.9 (CH3), 21.3 (CH3). 
IR (ATR): 2956, 1603, 1454, 1279, 1235, 1179, 1029, 907, 811, 727 cm⁻1. MS (ESI) m/z 
(relative intensity): 256 [M+H]+ (100). HR-MS (ESI): m/z calcd for C17H22NO+ [M+H]+ 
256.1696, found 256.1699. The analytical data are in accordance with those reported in 
the literature.[109a] 
 
 
Experimental Section 
195 
2-[3-(tert-Butyl)phenyl]-4-methoxypyridine (96ea) 
The general procedure D was followed using phenyl pyridine 35e (74.1 mg, 0.40 mmol) 
and alkyl bromide 95a (164 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 3/1→2:1) yielded 96ea (61.5 mg, 255 
μmol, 64%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.53 (dd, J = 5.7, 0.5 Hz, 1H), 8.02 (ddd, J = 1.9 1.9, 0.5 Hz, 
1H), 7.73 (ddd, J = 7.5, 1.8, 1.3 Hz, 1H), 7.47 (ddd, J = 7.8, 2.0, 1.3 Hz, 1H), 7.43–7.38 (m, 
1H), 7.23 (dd, J = 2.5, 0.5 Hz, 1H), 6.77 (dd, J = 5.7, 2.4 Hz, 1H), 3.90 (s, 3H), 1.40 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ = 166.4 (Cq), 160.0 (Cq), 151.7 (Cq), 151.0 (CH), 139.4 (Cq), 
128.5 (CH), 126.2 (CH), 124.3 (CH), 124.2 (CH), 107.9 (CH), 107.3 (CH), 55.3 (CH3), 35.0 (Cq), 
31.5 (CH3). IR (ATR): 2962, 1590, 1472, 1211, 1036, 908, 798, 729, 701 cm⁻1. MS (ESI) m/z 
(relative intensity): 242 [M+H]+ (100). HR-MS (ESI): m/z calcd for C16H20NO+ [M+H]+ 
242.1539, found 242.1539. 
 
 
2-[3-(tert-Butyl)-4-methoxyphenyl]pyridine (96ba) 
The general procedure D was followed using phenyl pyridine 35b (74.0 mg, 0.40 mmol) 
and alkyl bromide 95a (164 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 3/1) yielded 96ba (28.0 mg, 116 μmol, 
29%) as pale-yellow oil.  
1H-NMR (500 MHz, CDCl3): δ = 8.66 (ddd, J = 4.8, 1.8, 1.0 Hz, 1H), 7.96 (d, J = 2.3 Hz, 1H), 
7.80 (dd, J = 8.4, 2.3 Hz, 1H), 7.72–7.64 (m, 2H), 7.16 (ddd, J = 7.1, 4.8, 1.4 Hz, 1H), 6.97 
(d, J = 8.5 Hz, 1H), 3.90 (s, 3H), 1.45 (s, 9H). 13C-NMR (126 MHz, CDCl3): δ = 160.0 (Cq), 
158.0(Cq), 149.6 (CH), 138.5 (Cq), 136.6 (CH), 131.6 (Cq), 125.8 (CH), 125.6 (CH), 121.3 (CH), 
120.1 (CH), 111.7 (CH), 55.3 (CH3), 35.2 (Cq), 29.8 (CH3). IR (ATR): 1586, 1463, 1439, 1429, 
Experimental Section 
196 
1271, 1235, 1180, 1092, 1027, 779 cm⁻1. MS (ESI) m/z (relative intensity): 242 [M+H]+ 
(100). HR-MS (ESI): m/z calcd for C16H20NO+ [M+H]+ 242.1539, found 242.1541. The 
analytical data are in accordance with those reported in the literature.[109a] 
 
 
2-[3-(tert-Butyl)-2-methoxyphenyl]pyridine (96fa) 
The general procedure D was followed using phenyl pyridine 35f (74.1 mg, 0.40 mmol) 
and alkyl bromide 95a (164 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 3/1) yielded 96fa (54.6 mg, 226 μmol, 57%) 
as colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.73 (ddd, J = 4.9, 1.8, 1.0 Hz, 1H), 7.78–7.67 (m, 2H), 7.47 
(dd, J = 7.6, 1.8 Hz, 1H), 7.36 (dd, J = 7.9, 1.8 Hz, 1H), 7.22 (ddd, J = 7.2, 4.9, 1.5 Hz, 1H), 
7.14–7.08 (m, 1H), 3.33 (s, 3H), 1.44 (s, 9H).13C-NMR (101 MHz, CDCl3): δ = 158.0 (Cq), 
149.9 (CH), 149.8 (Cq), 143.0 (Cq), 136.2 (CH), 134.3 (Cq), 130.0 (CH), 127.5 (CH), 124.7 
(CH), 123.5 (CH), 121.8 (CH), 61.4 (CH3), 35.3 (Cq), 31.0 (CH3). IR (ATR): 1588, 1428, 1409, 
1224, 1088, 1006, 778, 746, 674, 615 cm⁻1. MS (ESI) m/z (relative intensity): 242 [M+H]+ 
(100). HR-MS (ESI): m/z calcd for C16H20NO+ [M+H]+ 242.1539, found 242.1539. 
 
 
2-[3-(tert-Butyl)phenyl]-5-fluoropyridine (96ga) 
The general procedure D was followed using phenyl pyridine 35g (69.3 mg, 0.40 mmol) 
and alkyl bromide 95a (164 mg, 1.20 mmol) for 24 h. Purification by column 
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chromatography on silica gel (n-pentane/Et2O: 9/1) yielded 96fa (25.0 mg, 109 μmol, 27%) 
as colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.55 (d, J = 2.9 Hz, 1H), 7.99 (dd, J = 1.9, 1.9 Hz, 1H), 7.74–
7.68 (m, 2H), 7.50–7.37 (m, 3H), 1.40 (s, 9H). 13C-NMR (101 MHz, CDCl3): δ = 158.9 
(d, 1JC–F = 256.0 Hz, Cq), 154.5 (d, 1JC–F = 3.9 Hz, Cq), 151.9 (Cq), 138.4 (Cq), 137.8 (d, 2JC–F 
= 23.4 Hz, CH), 128.8 (CH), 126.2 (CH), 124.2 (CH), 124.0 (CH), 123.6 (d, 2JC–F = 18.5 Hz, CH), 
121.6 (d, 3JC–F = 4.2 Hz, CH), 35.0 (Cq), 31.5 (CH3). 19F-NMR (378 MHz, CDCl3): δ = −130.2 
(dd, J = 8.1, 4.3 Hz). IR (ATR): 2963, 1469, 1421, 1254, 1237, 1224, 835, 796, 700, 569 cm⁻1. 
MS (ESI) m/z (relative intensity): 252 [M+Na]+ (10), 230 [M+H]+ (100). HR-MS (ESI): m/z 
calcd for C15H17NF+ [M+H]+ 230.1340, found 230.1334. The analytical data are in 
accordance with those reported in the literature.[109a] 
 
 
2-[3-(tert-Butyl)-5-fluorophenyl]pyridine (96ha) 
The general procedure D was followed using phenyl pyridine 35h (69.3 mg, 0.40 mmol) 
and alkyl bromide 95a (164 mg, 1.20 mmol) for 24 h. Purification by column 
chromatography on silica gel (n-pentane/Et2O: 9/1) yielded 96ha (35.2 mg, 153 μmol, 
38%) as colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.70 (ddd, J = 4.8, 1.8, 1.0 Hz, 1H), 7.81 (dd, J = 1.6, 1.6 Hz, 
1H), 7.75 (ddd, J = 8.0, 7.3, 1.8 Hz, 1H), 7.69 (ddd, J = 8.0, 1.2, 1.2 Hz, 1H), 7.50 (ddd, J = 
9.7, 2.5, 1.5 Hz, 1H), 7.24 (ddd, J = 7.3, 4.7, 1.2 Hz, 1H), 7.14 (ddd, J = 10.6, 2.4, 1.7 Hz, 1H), 
1.38 (s, 9H). 13C-NMR (126 MHz, CDCl3): δ = 163.7 (d, 1JC–F = 244.2 Hz, Cq), 157.1 (d, 4JC–F = 
3.0 Hz, Cq), 154.7 (d, 3JC–F = 6.8 Hz, Cq), 150.1 (CH), 141.5 (d, 3JC–F = 8.0 Hz, Cq), 137.2 (CH), 
122.8 (CH), 121.1 (CH), 120.0 (d, 4JC–F = 2.3 Hz, CH), 113.5 (d, 2JC–F = 21.8 Hz, CH), 111.4 (d, 
2JC–F = 22.9 Hz, CH), 35.5 (d, 4JC–F = 1.7 Hz, Cq), 31.8 (CH3). 19F-NMR (282 MHz, CDCl3): δ = 
−113.8 (dd, J = 10.2, 10.2 Hz). IR (ATR): 2965, 1586, 1567, 1429, 1412, 942, 866, 781, 733, 
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697 cm⁻1. MS (ESI) m/z (relative intensity): 230 [M+H]+ (100). HR-MS (ESI): m/z calcd for 
C15H17NF+ [M+H]+ 230.1340, found 230.1341. 
 
 
2-[3-(tert-Butyl)phenyl]piperidine (192) 
Following a modified literature procedure,[228] to an oven-dried 10 mL Schlenk flask was 
added 2-[3-(tert-butyl)phenyl]pyridine (96aa) (21.1 mg, 100 μmol, 1.00 equiv) and 
aqueous HCl (20%, 2.0 mL). The resulting solution was cooled in an ice bath and Sm 
(180 mg, 1.20 mmol, 12.0 equiv) was added portion wise over a period of 10 min. The 
reaction mixture was allowed to warm to ambient temperature and was then stirred for 
additional 20 min. The mixture was again put in an ice bath and the pH value was adjusted 
to pH = 8 by addition of aqueous NaOH solution (2 M). The aqueous layer was extracted 
with CH2Cl2 (3 x 20 mL). The combined organic layers were washed with H2O (20 mL) and 
dried over Na2SO4. Removal of the solvent yielded the crude product, which was purified 
by column chromatography on silica gel (CH2Cl2/MeOH: 98/2 to 95/5) to yield the product 
192 (13.6 mg, 62.6 μmol, 63%) as a pale yellow oil. 
1H-NMR (600 MHz, CD2Cl2): δ = 7.37 (dd, J = 1.9, 1.9 Hz, 1H), 7.25 (ddd, J = 7.8, 2.1, 1.4 Hz, 
1H), 7.22 (dd, J = 7.6 Hz, 1H), 7.15 (ddd, J = 7.2, 1.8, 1.8 Hz, 1H), 3.56 (dd, J = 10.5, 2.7 Hz, 
1H), 3.16–3.11 (m, 1H), 2.76 (ddd, J = 11.6, 11.6, 2.9 Hz, 1H), 1.90–1.83 (m, 1H), 1.83 (sbr, 
1H), 1.77–1.70 (m, 1H), 1.65–1.58 (m, 1H), 1.53–1.42 (m, 3H), 1.30 (s, 9H). 13C-NMR 
(101 MHz, CDCl3): δ =151.3 (Cq), 145.3 (Cq), 128.2 (CH), 124.1 (CH), 123.9 (CH), 123.8 (CH), 
63.0 (CH), 48.0 (CH2), 35.2 (CH2), 34.9 (Cq), 31.6 (CH3), 26.0 (CH2), 25.7 (CH2). IR (ATR): 
2931, 2853, 1440, 1364, 1324, 1108, 792, 758, 706, 537 cm⁻1. MS (ESI) m/z (relative 
intensity): 218 [M+H]+ (100). HR-MS (ESI): m/z calcd for C15H24N+ 218.1903 [M+H]+, found 
218.1906.  
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5.6.2.2 Mechanistic Studies 
5.6.2.2.1 meta-C‒H Alkylation in the Presence of Typical Radical Scavengers 
 
To an oven-dried 10 mL vial were added [RuCl2(p-cymene)]2 (12.2 mg, 5.0 mol %), 
diphenyl phosphate (30.0 mg, 30.0 mol %), and K2CO3 (111 mg, 0.80 mmol, 2.0 equiv) and, 
in case the radical scavenger was a solid, the radical scavenger (10 mol %). The vial was 
capped with a septum and wrapped with Parafilm. After the vial was evacuated and 
backfilled with N2 three times, 1,4-dioxane (2.0 mL) was added via syringe. 2-
Phenylpyridine (35a) (62.1 mg, 0.40 mmol, 1.00 equiv) and tert-butyl bromide (95a) 
(164 mg, 1.20 mmol, 3.00 equiv) were added sequentially - in case the radical scavenger 
was a liquid, it was added now - and the reaction mixture was degassed. Finally, the 
puncture hole in the septum was sealed with electrical tape. The reaction mixture was 
stirred for 24 h under visible light irradiation. After 24 h the mixture was filtered over a 
short pad of silica (Et2O) and the solvent was removed under reduced pressure. The 
residue was purified by column chromatography on silica gel (n-pentane/Et2O = 5/1) 
affording product 96aa. 
Table 5.3: Effect of typical radical scavengers on the reaction.a 
Entry Radical scavenger (10 mol %) Yield [%] 
1 -- 80 
2 TEMPO -- 
3 Galvinoxyl free radical -- 
4 BHT 48 
5 1,1-Diphenylethylene 17 
a Yield of isolated product. 
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5.6.2.2.2 Competition Experiments Between Alkyl Halides  
 
The general procedure was followed using 2-phenylpyridine (35a) (62.1 mg, 0.40 mmol) 
and alkyl bromides 95a (82.2 mg, 0.60 mmol, 1.50 equiv) and 93c (106 mg, 0.60 mmol, 
1.50 equiv). After 24 h of irradiation, the mixture was filtered over a short pad of silica 
(Et2O) and the solvent was removed under reduced pressure. The crude mixture was 
analyzed by 1H-NMR spectroscopy using CH2Br2 as internal standard (17.6 mg, 
0.101 mmol). 
 
Figure 5.19: 1H-NMR spectra of the crude reaction mixture. 
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5.6.2.2.3 Effect of Light: On/Off Plot 
According to the general procedure, a reaction containing mesitylene as internal standard 
was set up and placed in front of the LEDs. The reaction was sequentially stirred under 
visible light irradiation and in the absence of light. Every two hours an aliquot of 50 μL was 
removed via syringe and analyzed by 1H-NMR spectroscopy. After a total of 8 h the 
determined yields were plotted against the reaction time.  
 
Figure 5.20: Effect of visible light irradiation. 
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5.6.2.2.4 Fluorescence Quenching Experiments 
Sample solutions were prepared in 1,4-dioxane with c(Ru) = 1.6 x 10-6 M and varying 
concentrations of tert-butyl bromide (95a), added to each sample from a stock solution. 
The experiments were conducted with a fixed excitation wavelength of 430 nm and 
detection at 493 nm (emission maximum). Plotting of the I0/I value against the 
concentration of the potential quencher yielded the following graphs.  
 
Figure 5.21: Fluorescence quenching of 196 with complex with 95a. 
 
Figure 5.22: Fluorescence quenching of chloro-ruthenacycle 194 in the presence of 10.0 equiv. of 
substrate 35a with 95a. 
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Figure 5.23: Fluorescence quenching of chloro-ruthenacycle 194 in the presence of 10.0 equiv. of 
substrate 35a and 30.0 mol % diphenyl phosphate with 95a. 
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The following benzothiazoles 140d to 140h were prepared and characterized by N. Imse. 
 
 
 
 
Appendix 
254 
 
  
Appendix 
255 
 
 
 
  
Appendix 
256 
 
 
 
 
Appendix 
257 
 
 
 
 
Appendix 
258 
 
 
Appendix 
259 
 
 
Appendix 
260 
 
 
Appendix 
261 
 
 
Appendix 
262 
 
  
Appendix 
263 
 
 
Appendix 
264 
 
  
Appendix 
265 
 
 
Appendix 
266 
 
 
Appendix 
267 
 
 
Appendix 
268 
 
 
Appendix 
269 
 
 
 
 
 
Appendix 
270 
 
 
 
 
Appendix 
271 
 
 
Appendix 
272 
 
 
 
Appendix 
273 
 
 
Appendix 
274 
 
 
Appendix 
275 
 
 
 
Appendix 
276 
 
 
Appendix 
277 
 
 
 
Appendix 
278 
 
 
 
 
Appendix 
279 
 
 
 
Appendix 
280 
 
 
 
Appendix 
281 
 
 
 
Appendix 
282 
 
  
Appendix 
283 
 
 
 
Appendix 
284 
 
  
Appendix 
285 
 
 
 
Appendix 
286 
 
  
Appendix 
287 
 
 
 
Appendix 
288 
 
 
Appendix 
289 
 
  
Appendix 
290 
 
 
 
 
Appendix 
291 
Compounds 145bc to 145hc were prepared and characterized by N. Imse: 
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